UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

X  Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

 For the fiscal year ended April 30, 2022.2023.

Or

 Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

 For the transition period from ___________to___________.

Commission file number 0-23248

SIGMATRON INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

Picture 1

Delaware

(State or other jurisdiction

of incorporation or organization)

2201 Landmeier Rd., Elk Grove Village, IL

(Address of principal executive offices)

Registrant’s telephone number, including area code: 847-956-8000

Securities registered pursuant to Section 12(b) of the Act:

36-3918470

(I.R.S. Employer

Identification Number)

60007

(Zip Code)

ASDAQ Capital Market

Title of each class

Common Stock $0.01 par value per share

Trading Symbol

SGMA

Name of each exchange on which registered

The NASDAQ Capital Market

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. oYes ý No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. oYes ý No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

ý Yes o No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ý Yes o No


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer o Accelerated Filer o Non-accelerated Filer ý Smaller Reporting Company ý

Emerging Growth Company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. o

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. o

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive- based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). o

Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Act.) oYes ý No

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant as of October 31, 2021,2022, the last business day of the registrant’s most recently completed second fiscal quarter was $32,302,037$23,548,787 based on the closing sale price of $8.80$4.73 per share as reported by NASDAQ Capital Market as of such date.

The number of outstanding shares of the registrant’s Common Stock, $0.01 par value, as of July 20, 202214, 2023 was 6,071,288.6,091,288.

DOCUMENTS INCORPORATED BY REFERENCE

Certain sections or portions of the definitive proxy statement of SigmaTron International, Inc., for use in connection with its 20222023 annual meeting of stockholders, which the Company intends to file within 120 days of the fiscal year ended April 30, 2022,2023, are incorporated by reference into Part III of this Form 10-K.

2


TABLE OF CONTENTS

PART I

ITEM 1.

BUSINESS

4

ITEM 1A.

RISK FACTORS

1413

ITEM IB.

UNRESOLVED STAFF COMMENTS

2322

ITEM 2.

PROPERTIES

2422

ITEM 3.

LEGAL PROCEEDINGS

2523

ITEM 4.

MINE SAFETY DISCLOSURES

2523

PART II

ITEM 5.

MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

2524

ITEM 6.

RESERVED

2624

ITEM 7.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

2624

ITEM 7A.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS

40

ITEM 8.

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

40

ITEM 9.

CHANGES AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

40

ITEM 9A.

CONTROLS AND PROCEDURES

40

ITEM 9B.

OTHER INFORMATION

41

ITEM 9C.

DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTION

41

PART III

ITEM 10.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

41

ITEM 11.

EXECUTIVE COMPENSATION

41

ITEM 12.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

41

ITEM 13.

CERTAIN RELATIONSHIPS, RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

4142

ITEM 14.

PRINCIPAL ACCOUNTANT FEES AND SERVICES

4142

PART IV

ITEM 15.

EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

4342

ITEM 16.

FORM 10-K SUMMARY

4342

SIGNATURES

4846


3


PART I

ITEM 1. BUSINESS

CAUTIONARY NOTE:

In addition to historical financial information, this discussion of the business of SigmaTron International, Inc. (“SigmaTron”), its wholly-owned subsidiaries Standard Components de Mexico S.A., AbleMex, S.A. de C.V., Digital Appliance Controls de Mexico, S.A. de C.V., Spitfire Controls (Vietnam) Co. Ltd., and Spitfire Controls (Cayman) Co. Ltd., Wagz, Inc., wholly-owned foreign enterprises Wujiang SigmaTron Electronics Co., Ltd. and Wujiang SigmaTron Electronic Technology Co., Ltd. and, its international procurement office, SigmaTron International Inc. Taiwan branchBranch, and Wagz, Inc. (19 percent ownership as of April 1, 2023) (“Wagz”), (collectively, the “Company”) and other Items in this Annual Report on Form 10-K contain forward-looking statements concerning the Company’s business or results of operations. Words such as “continue,” “anticipate,” “will,” “expect,” “believe,” “plan,” and similar expressions identify forward-looking statements. These forward-looking statements are based on the current expectations of the Company. Because these forward-looking statements involve risks and uncertainties, the Company’s plans, actions and actual results could differ materially. Such statements should be evaluated in the context of the direct and indirect risks and uncertainties inherent in the Company’s business including, but not necessarily limited to, the risks inherent in any merger, acquisition or business combination (including the December 2021 acquisition of Wagz,Inc.); the Company’s continued dependence on certain significant customers; the continued market acceptance of products and services offered by the Company and its customers; pricing pressures from the Company’s customers, suppliers and the market; the activities of competitors, some of which may have greater financial or other resources than the Company; the variability of the Company’s operating results; the results of long-lived assets and goodwill impairment testing; the ability to achieve the expected benefits of acquisitions as well as the expenses of acquisitions; the collection of aged account receivables; the variability of the Company’s customers’ requirements; the impact of inflation on the Company’s operating results; the availability and cost of necessary components and materials; the impact acts of war may have to the supply chain;chain and the Company’s customers; the ability of the Company and its customers to keep current with technological changes within its industries; regulatory compliance, including conflict minerals; the continued availability and sufficiency of the Company’s credit arrangements; the costs of borrowing under the Company’s senior and subordinated credit facilities, including under the rate indices that replaced LIBOR; increasing interest rates; the ability to meet the Company’s financial and restrictive covenants under its loan agreements; changes in U.S., Mexican, Chinese, Vietnamese or Taiwanese regulations affecting the Company’s business; the turmoil in the global economy and financial markets; the spread ofpublic health crises, including COVID-19 and variants (commonly known as “COVID-19”) which has threatened the Company’s financial stability by causing a disruption to the Company’s global supply chain, and caused plant closings or reduced operations thus reducing output at those facilities; the continued availability of scarce raw materials, exacerbated by global supply chain disruptions, necessary for the manufacture of products by the Company; the stability of the U.S., Mexican, Chinese, Vietnamese and Taiwanese economic, labor and political systems and conditions; global business disruption caused by the Russia invasion of Ukraine and related sanctions; currency exchange fluctuations; and the ability of the Company to manage its growth. These and other factors which may affect the Company’s future business and results of operations are identified throughout this Annual Report on Form 10-K, and as risk factors, may be detailed from time to time in the Company’s filings with the Securities and Exchange Commission. These statements speak as of the date of such filings, and the Company undertakes no obligation to update such statements in light of future events or otherwise unless otherwise required by law.

Overview

SigmaTron is a Delaware corporation, which was organized on November 16, 1993, and commenced operations when it became the successor to all of the assets and liabilities of SigmaTron L.P., an Illinois limited partnership, through a reorganization on February 8, 1994 as part of going public.

ThePrior to April 1, 2023, the Company operatesoperated in two reportable segments as an independent provider of electronic manufacturing services (“EMS”), and as a provider of products to the pet technology (“Pet Tech”) market. The EMS segment

4


market. The majority of the Pet Tech Segment was sold, effective as of April 1, 2023, and following such date, the Company operates in one reportable segment, the EMS segment. The EMS segment includes printed circuit board assemblies, electro-mechanical subassemblies and completely assembled (box-build) electronic products. The Pet Tech segment offersoffered electronic products such as the Freedom Smart Dog Collar ™, a wireless, geo-mapped fence, and wellness system, and apparel and accessories.

Except as otherwise noted, the description of the Company’ business below reflects its continuing operations. Refer to Note P - Discontinued Operations, to the consolidated financial statements for activity associated with discontinued operations.

The Company provides manufacturing and assembly services ranging from the assembly of individual components to the assembly and testing of box-build electronic products. The Company has the ability to produce assemblies requiring mechanical as well as electronic capabilities. The products assembled by the Company are then incorporated into finished products sold in various industries, particularly industrial electronics, consumer electronics and medical/life sciences. In some instances, the Company manufactures and assembles the completed finished product for its customers.

In connection with the production of assembled products, the Company provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; (6) assistance in obtaining product approval from governmental and other regulatory bodies and (7) compliance reporting. The Company provides these manufacturing services through an international network of facilities located in the United States, Mexico, China, Vietnam and Taiwan.

The Company began its Pet Technology operations after the December 2021 acquisition of Wagz, Inc., discussed During the fourth quarter of fiscal 2023, the Company exited its active involvement in the Pet Tech business that is conducted by Wagz through the sale by the Company of a majority stake in Wagz, effective as of April 1, 2023. See “Recent Developments” below under “Recent Developments”.for additional information.

The Company’s headquarters is in Elk Grove Village, Illinois, United States of America (“U.S.”) which also operates as a manufacturing facility. In addition, the Company has manufacturing facilities in Union City, California, U.S.; Acuna, Coahuila, Mexico (“MX”); Chihuahua, Chihuahua, MX; and Tijuana, Baja California, MX; Suzhou, Jiangsu Province, China; and Bien Hoa City, Dong Nai Province, Vietnam. In addition, the Company maintains an International Procurement Office and Compliance and Sustainability Center (“IPO”) in Taipei, Taiwan. The Company also provides design services in Elgin, Illinois, U.S. and Portsmouth, New Hampshire, U.S. and warehousing services in Del Rio, Texas, U.S.; El Paso, Texas, U.S.; Elk Grove Village, Illinois, U.S.; and San Diego, California, U.S..U.S. The Company has an information technology office in Taichung, Taiwan.

The Company’s international footprint provides our customers with flexibility within the Company to manufacture in China, Mexico, Vietnam or the U.S. We believe this strategy will continue to serve the Company well as its customers continuously evaluate their supply chain strategies.

For the fiscal year ended April, 30 2022,2023, the Company reported pre-tax profitincome of approximately $14,000,000 and$17,200,000 from continuing operations. The Company reported sales of approximately $379,000,000.$414,400,000. The fiscal year end revenue results increased 36%9.5%, compared to the prior fiscal year. The higher sales related to both increased customer demand and price increases passed on to customers for raw material and other operating cost increases. These results were obtained despite unprecedentedcontinued electronic component shortages in the marketplace, which continued from the prior fiscal year.marketplace. This has led to lower productivity on occasion, rapidly growing inventory levels and pressure on working capital, as the marketplace has remained volatile. 

The Company’s backlog remains at an all-time high with demand staying strong across the vast majority of markets and customers the Company serves. The Company has several new customers that the Company expects to begin shipping to in the first half of fiscal year 2023. However, the electronic component marketplace remains volatile in terms of bothcontinued supply and price. The continuedchain shortages could impact the Company’s ability to ship the backlog on a timely basis.  This is a problem faced by almost every customer and competitor in the EMS industry, and the Company does not anticipateanticipates the situation improving through fiscal 2023.2024.  The Company’s supply chain and operations teams continue to face challenges which we believe will remain foras it starts fiscal year 2023.  The Company does not see any signs of weakening in semiconductor demand across all markets, nor does the Company see any additional semiconductor production capacity coming online anytime soon. 2024.

5


Recent Developments

On May 29, 2020, SigmaTron and Wagz, Inc. (“Wagz”), a Pet Tech company, entered into a Convertible Secured Promissory Note in the principal sum of up to $4,052,478.  Between January 27, 2021 and December 31, 2021, Wagz issued additional convertible secured promissory notes and secured promissory notes aggregating $7,947,522 and $1,380,705, respectively (collectively, the “Notes”) which were accounted for as Notes receivable in the Company’s Consolidated Balance Sheet of Item 15(a) Exhibits and Financial Statement Schedules. The Notes were due (the “Maturity Date”) on the earliest to occur of (a) December 31, 2021 or, if the closing of the Company’s then proposed acquisition of Wagz (the “Closing”) did not occur due to the Company’s termination, that date which is twelve (12) months after the date of such termination, (b) upon the closing of a sale of all or substantially all of the assets or common stock of Wagz (other than the Closing), or (c) an Event of Default (as defined in the Notes). Interest was payable at the rate of four percent (4%) per annum and was payable on the Maturity Date. The Notes were collateralized by substantially all assets of Wagz. The Notes did not meet the accounting definition of a security and were accounted for under ASC 310, Receivables, at amortized cost.

Wagz has developed and brought to market a high tech pet collar and has multiple other products in development. Wagz is an Internet of Things (“IoT”) company which both owns intellectual property and secures recurring revenue through subscriptions for its services.

On December 31, 2021, the Company acquired 100% of the stock of Wagz under the terms of the Agreement and Plan of Merger dated July 19, 2021, as amended by the First Amendment to Agreement and Plan of Merger dated December 7, 2021 (the “Merger Agreement”). Prior to the acquisition, the Company had an investment in Wagz of $600,000, and held Convertible Secured Promissory Notes issued by Wagz of $12,000,000 and Secured Promissory Notes issued by Wagz of $1,380,705. Pursuant to the Merger Agreement, prior to the acquisition, the Convertible Secured Promissory Notes converted to 12,000,000 shares of Wagz common stock, resulting in a 25.5% ownership in Wagz. As described in Note F – Acquisition of Item 15(a) Exhibits and Financial Statement Schedules,Disposition, the Company’s 25.5% equity interest in Wagz common stock was remeasured to fair value of $6,299,765, resulting in a non-cash impairment charge of $6,300,235.$6,300,235 in fiscal 2022.

Pursuant to the Merger Agreement, 2,443,870 shares of common stock of the Company were issued in the merger for a value of $25,245,177, of which 1,546,592 shares are allocated to Wagz shareholders (excluding the Company) for a total value of $15,976,295, and 897,278 shares are allocated to the Company and treated as treasury stock for a total value of $9,268,881, recorded in the Consolidated Statements of Changes in Stockholders’ Equity of Item 15(a) Exhibits and Financial Statement Schedules under Issuance of stock for acquisition and Purchase of treasury stock related to acquisition, respectively. The treasury shares were retired as of April 30, 2022.

On July 18, 2022, SigmaTron,During the fourth quarter of fiscal 2023, the Company exited its active involvement in the Pet Tech business that is conducted by Wagz through the sale by the Company of a majority stake in Wagz, effective as of April 1, 2023. The Company entered into a Stock Purchase Agreement (“SPA”) by and among the Company, Wagz, Vynetic LLC, a Delaware limited liability company (“Buyer”), and Terry B. Anderton, co-founder of Wagz and principal of Buyer (“Anderton”), pursuant to which the Company sold to Buyer 81% of the issued and outstanding shares of common stock of Wagz (the “Shares”) for the purchase price of one dollar. Under the SPA, the Company also agreed to provide a $900,000 working capital term loan (the “Wagz Loan”) to Wagz during the month of April 2023. The Company agreed to work with Wagz as an EMS provider pursuant to a manufacturing agreement, but the Company did not commit to extending any further financial support beyond the Wagz Loan. On April 28, 2023, the sale of the majority interest in Wagz pursuant to the SPA was consummated with effect as of April 1, 2023, and as a result, as of the closing, the Company holds a minority 19% ownership of the Shares and Buyer holds a majority 81% of the Shares.

OnMarch2,2023, the Company received an EventofDefaultandReservationofRightsnoticefromeachofJPMorgan Chase Bank, N.A. (“Lender”) amended, lender under the Credit Agreement dated as of January 29, 2021, by entering into theCompany’s Amended and Restated Credit Agreement (the “Facility” or “Credit Agreement”). The Facility, as amended, allows the Company to borrow on a revolving basis up to the lesser of (i) $70,000,000 or (ii) an amount equal to a percentage of the eligible receivable borrowing base plus a percentage of the inventory borrowing base minus any reserves established by Lender. The Facility bears interest at the adjusted REVSOFR30 rate (as defined in the Credit Agreement). The interest rate per annum applicable to the Facility will be the Adjusted Term SOFR Rate (“SOFR”), plusAgreement(“JPM the Applicable Margin of 2.0%. The Notice”),maturity date of the Facility was extended to July 18, 2027.

and

In connection with the closing of the Credit Agreement, Lender and The Private Credit Group of TCW Asset Management Company LLC, as administrative agent (the “Agent”(“Agent”) under, and other lenders party to the Company’s Term Loan Agreement (as defined below), entered into (theTCWLenders”)(“TCW Notice”togetherwiththe Intercreditor Agreement, dated July 18, 2022, and acknowledged by SigmaTron and Wagz (the “ICA”JPMNotice,the“Notices”), to set forth and govern. The Notices indicated the lenders’ respective lien priorities, rights and remediesoccurrence of certain events of default under the JPM Credit Agreement and the Term Loan Agreement. See Note I – Long-term Debt, for more information.

The Facility is secured by: (a) OnApril28,2023,theCompanyenteredinto(i)a first priority security interest in SigmaTron’s Waiver,ConsentandAmendment No.1tothe JPM CreditAgreement(“JPMWaiver”) withWagzandJPM,aslender, which waived certain events of default under and Wagz’s: (i) accounts and inventory (excluding Term Priority Mexican Inventoryamended certain terms of the (as defined inJPMCreditAgreementand(ii)a Waiver,Consent andAmendmentNo.1totheCreditAgreement(“TCW Waiver”) withWagz,theTCWLendersand Agent (collectivelywiththeTCWLendersandJPM,the“LenderParties”), which waived certain events of default under and amended certain terms of the IntercreditorTerm LoanAgreement(togetherwiththeJPMCredit Agreement (“ICA”the “Credit Agreements”)).See Note E – Long-term Debt, for more information.

As described above, theCompanyexiteditsactiveinvolvementinthePet Techbusinessthat wasconductedby Wagzthrough thesalebytheCompanyofamajoritystakein Wagz,effective as of April1,2023. Inconnectionwiththe Waivers and certain inventory in transit, (ii) deposit accounts, (iii) proceedssuch sale, the Lender Parties agreed to release Wagz and its property from the lien of business interruption insurance that constitute the Lender Parties under the Credit Agreements.ABL BI Insurance Share

(as defined in the ICA), (iv) certain other property, including payment intangibles,

6


instruments, equipment, software and hardware and similar systems, books and records, to the extent related to the foregoing, and (v) all proceeds of the foregoing, in each case, now owned or hereafter acquired (collectively, the “ABL Priority Collateral”); and (b) a second priority security interest in Term Priority Collateral (as defined below) other than (i) real estate and (ii) unless Lender requests a pledge thereof following July 18, 2022, the equity interests of SigmaTron’s foreign subsidiaries.

On July 18, 2022, SigmaTron, Wagz and The Private Credit Group of TCW Asset Management Company LLC, as administrative agent (the “Agent”), and other Lenders party thereto (collectively, “TCW”) entered into a Credit Agreement (the “Term Loan Agreement”) pursuant to which TCW made a term loan to the Company in the principal amount of $40,000,000 (the “TCW Term Loan”). The TCW Term Loan bears interest at a rate per annum applicable to the Term Loan Facility based on the Adjusted Term SOFR Rate (“SOFR”), plusthe Applicable Margin of 7.50% (as defined in the Term Loan Agreement). The Term Loan will have a SOFR floor of 1.00%. The maturity date of the TCW Term Loan is July 18, 2027.

The TCW Term Loan is secured by: (a) a first priority security interest in all property of SigmaTron and Wagz that does not constitute ABL Priority Collateral, which includes: (i) SigmaTron’s and Wagz’s real estate other than SigmaTron’s Del Rio, Texas, warehouses, (ii) SigmaTron’s and Wagz’s machinery, equipment and fixtures (but excluding ABL Priority Equipment (as defined in the ICA)), (iii) the Term Priority Mexican Inventory (as defined in the ICA), (iv) SigmaTron’s stock in its direct and indirect subsidiaries, (v) SigmaTron’s and Wagz’s general intangibles (excluding any that constitute ABL Priority Collateral), goodwill and intellectual property, (vi) the proceeds of business interruption insurance that constitute Term BI Insurance Share (as defined in the ICA), (vii) tax refunds, and (viii) all proceeds thereof, in each case, now owned or hereafter acquired (collectively, the “Term Priority Collateral”); and (b) a second priority security interest in all collateral that constitutes ABL Priority Collateral. Also, SigmaTron’s three Mexican subsidiaries pledged all of their assets as security for the TCW Term Loan.

A pandemic of respiratory diseases, including variants (commonly known as “COVID-19”) began to spread globally, including to the United States, in early 2020. The full impact of the COVID-19 outbreak is inherently uncertain at the time of this report. The COVID-19 outbreak has resulted in travel restrictions and in some cases, prohibitions of non-essential activities, disruption and shutdown of certain businesses and greater uncertainty in global financial markets.The Company cannot predict the extent to which the COVID-19 outbreak will continue to impact its business or operating results, which are highly dependent on inherently uncertain future developments, including the severity and duration of the COVID-19 outbreak and the actions taken by governments and businesses in relation to COVID-19 containment. The Company has adopted several measures in response to the COVID-19 outbreak. For more information on the potential impact of the COVID-19 pandemic on the Company, see “Item 1A. Risk Factors – Our financial condition and results of operations have been impacted and may in the future be adversely affected by the ongoing COVID-19 outbreak.”

Products and Services

The Company provides a broad range of electronic and electromechanical manufacturing related outsourcing solutions for its customers. These solutions incorporate the Company’s knowledge and expertise in the EMS industry to provide its customers with an international network of manufacturing facilities, advanced manufacturing technologies, complete supply chain management, responsive and flexible customer service, as well as product design, test and engineering support. The Company’s EMS solutions are available from inception of product concept through the ultimate delivery of a finished product. Such technologies and services include the following:

Manufacturing and Testing Services: The Company’s core business is the assembly and testing of all types of electronic printed circuit board assemblies (“PCBA”) and often incorporating these PCBAs into electronic modules used in all types of devices and products that depend on electronics for their operation. This assembly work utilizes state of the art manufacturing and test equipment to deliver highly reliable products to the Company’s customers. The Company supports new product introduction (“NPI”), low volume / volume/high mix as well as high volume/low mix assembly work at all levels of assembly and test complexity. From simple component assembly through the most complicated industry testing, the Company offers services required to build the vast majority of electronic devices commercially required in the market today.

7


Design Services: To complement the manufacturing services it offers its customers, the Company also offers design for manufacturability (“DFM”), and design for test (“DFT”) review services to help customers ensure that the products they have designed are optimized for production and testing. The Company also offers complete product design services for certain markets.

Supply Chain Management: The Company provides complete supply chain management for the procurement of components needed to build customers’ products. This includes the procurement and management of all types of electronic components and related mechanical parts such as plastics and metal. The Company’s resources supporting this activity are provided both on a plant specific basis as well as globally through its IPO in Taipei, Taiwan. Each of its sites is linked together using the same Enterprise Resource Planning (“ERP”) system and custom Iscore software tools with real-time on-line visibility for customer access. The Company procures material from major manufacturers and distributors of electronic parts all over the world.

The Company relies on numerous third-party suppliers for components used in the Company’s production process. Certain of these components are available only from single-sources or a limited number of suppliers. In addition, a customer’s specifications may require the Company to obtain components from a single-source or a small number of suppliers. The loss of any such suppliers could have a material impact on the Company’s results of operations. Further, the Company could operate at a cost disadvantage compared to competitors who have greater direct buying power from suppliers. The Company orders material from its suppliers consistent with the purchase orders and binding forecasts it receives from its customers. See “Item 1A. Risk Factors – Raw material price increases and supply shortages could adversely affect results”.

Warehousing and Distribution: The Company provides both in-house and third-party warehousing, shipping, and customs brokerage for certain border crossings as part of its service offering. This includes international shipping, drop shipments to the end customer as well as support of inventory optimization activities such as kanban and consignment.

Government Compliance, Green, Sustainability, and Social Responsible Initiatives: The Company supports initiatives that promote sustainability, green environment and social responsibility. The Company helps its customers in achieving effective compliance. Those include, but are not limited to, Restrictions of Hazardous Substances (“RoHS”), Restriction of Chemicals (“REACH”) and Conflict Minerals regulations.

Manufacturing Locations and Certifications: The Company’s manufacturing locations are strategically located to support our customers with locations in Elk Grove Village, Illinois U.S.; Union City, California U.S.; Acuna, Chihuahua and Tijuana, Mexico; Suzhou, China; and Bien Hoa City, Vietnam. The Company’s ability to transition manufacturing to lower cost regions without jeopardizing flexibility and service differentiates it from many competitors. Manufacturing certifications and registrations are location specific,

7


and include ISO 9001:2015, ISO 14001:2004, ISO 14001:2015, IATF 16949:2016, Medical ISO 13485:2016 and FDB Certification Aerospace AS9100D and International Traffic in Arms Regulations (“ITAR”) certifications.

In addition, the Company providesprovided products, supplies design and manufacturing services to the pet technology market through its previously wholly owned subsidiary, Wagz. Wagz is believed to be the first Pet Tech company to develop a broad based, integrated family of smart products that truly enable pet owners to interact with, and manage the daily needs of their pets, from anywhere. The Company offersoffered electronic products such as the Freedom Smart Dog Collar,Collar™, a wireless, geo-mapped fence, and wellness system, and apparel and accessories. It also sellssold its products online. The Company sold a majority of the stock of Wagz on April 28, 2023, effective as of April 1, 2023. The Company still owns 19 percent of Wagz common stock as a passive investment as of April 30, 2023.

8


Markets and Customers

The Company’s customers are in the industrial electronics, consumer electronics and medical/life sciences industries. As of April 30, 2022,2023, the Company had approximately 215160 active customers ranging from Fortune 500 companies to small, privately held enterprises.

The following table shows, for the periods indicated, the percentage of net sales to the principal end-user markets the Company serves.

Percent of Net Sales

Percent of Net Sales

Markets

Typical OEM Application

Fiscal 2022%

Fiscal 2021%

Typical OEM Application

Fiscal 2023%

Fiscal 2022%

Industrial Electronics

Gaming, controls, smart grid connectivity, IOT connectivity

55.2

54.0

Gaming, controls, smart grid connectivity, IOT connectivity

67.0

55.2

Consumer Electronics

Appliances/white goods, automotive vision systems, carbon monoxide detectors, pet technology

38.7

40.8

Appliances/white goods, automotive vision systems, carbon monoxide detectors, pet technology

26.6

38.7

Medical/Life Sciences

Operating tables, battery packs, dental equipment, sterilizers, dialysis

6.1

5.2

Operating tables, battery packs, dental equipment, sterilizers, dialysis

6.4

6.1

Total

100%

100%

For the fiscal year ended April 30, 2022,2023, the Company’s largest two customers, Electrolux and Whirlpool,customer accounted for 21.8% and 11.7%, respectively,13.4% of the Company’s net sales. For the fiscal year ended April 30, 2021, Whirlpool and Electrolux2022, the Company’s largest customer accounted for 17.9% and 16.2%, respectively,21.8% of the Company’s net sales. The Company believes that Electrolux and Whirlpool will continue to account for a significant percentage of the Company’s net sales, although the percentage of net sales may vary from period to period.

The majority of sales are made to U.S. based customers and denominated in USD. The following geographic data includes net sales based on the country location of the Company’s operation providing the electronic manufacturing service for the year ended April 30, 20222023 and 2021:2022:

Location

Net Sales Fiscal 2022

Net Sales Fiscal 2021

Net Sales Fiscal 2023

Net Sales Fiscal 2022

United States

$

89,669,649

$

69,125,385

$

117,389,877

$

89,119,720

Mexico

228,867,962

158,779,276

236,938,519

228,867,962

China

46,347,260

36,030,112

48,584,165

46,347,260

Vietnam

13,981,553

13,783,899

11,523,284

13,981,553

Total

$

378,866,424

$

277,718,672

$

414,435,845

$

378,316,495

As of April 30, 2022,2023, approximately 35%37% of the total assets of the Company are located in foreign jurisdictions outside the United States, 20%25% and 12%10% of the total assets were located in Mexico and China, respectively, and 3%2% in other foreign locations. As of April 30, 2021,2022, approximately 39%35% of the total assets were located in foreign jurisdictions, 21%20% and 15%12% were located in China and Mexico, respectively, and 3% in other foreign locations.

8


Sales and Marketing

Many of the members of the Company’s senior management are actively involved in sales and marketing efforts, and the Company has direct sales employees. The Company also markets its services through independent manufacturers’ representative organizations that employ sales personnel in the United States and Canada. Independent manufacturers’ representative organizations receive variable commissions based on orders received by the Company and are assigned specific accounts, not territories. In addition, the Company markets itself through its website and tradeshows. Wagz sellssold its products primarily online.

9


Mexico, China, Vietnam and Taiwan Operations

The Company’s wholly-owned subsidiary, Standard Components de Mexico, S.A, a Mexican entity, is located in Acuna, Coahuila, Mexico, a border town across the Rio Grande River from Del Rio, Texas, U.S. and is 155 miles west of San Antonio. Standard Components de Mexico, S.A. was incorporated and commenced operations in 1968 and had 965854 employees at April 30, 2022.2023. The Company’s wholly-owned subsidiary, AbleMex S.A. de C.V., a Mexican entity, is located in Tijuana, Baja California, Mexico, a border town south of San Diego, California, U.S..U.S. AbleMex S.A. de C.V. was incorporated and commenced operations in 2000. The operation had 446436 employees at April 30, 2022.2023. The Company’s wholly-owned subsidiary, Digital Appliance Controls de Mexico S.A., a Mexican entity, operates in Chihuahua, Chihuahua, Mexico, located approximately 235 miles from El Paso, Texas, U.S..U.S. Digital Appliance Controls de Mexico S.A. was incorporated and commenced operations in 1997. The operation had 482455 employees at April 30, 2022.2023. The Company believes that one of the key benefits to having operations in Mexico is its access to cost-effective labor resources while having geographic proximity to the United States.

The Company’s wholly-owned foreign enterprises, Wujiang SigmaTron Electronics Co., Ltd. and Wujiang SigmaTron Electronic Technology Co., Ltd., are located in Suzhou, China. The Company has entered into an agreement with governmental authorities in the economic development zone of Wujiang, Jiangsu Province, Peoples Republic of China, pursuant to which the Company became the lessee of a parcel of land of approximately 100 Chinese acres. The term of the land lease is 50 years. The Company built a manufacturing plant, office space and dormitories on this site during 2004. In fiscal year 2015, the China facility expanded and added 40,000 square feet in warehouse and manufacturing. The total square footage of the facility is 216,950 and the operation had 389349 employees as of April 30, 2022.2023. Both Wujiang SigmaTron Electronics Co., Ltd.

andLtd.and Wujiang SigmaTron Electronic Technology Co., Ltd. operate at this site.

The Company’s wholly-owned subsidiary, Spitfire Controls (Cayman) Co. Ltd., owns all of the equity of the subsidiary, Spitfire Controls (Vietnam) Co. Ltd., and does not conduct any other operations. Spitfire Controls (Vietnam) Co. Ltd. is located in Amata Industrial Park, Bien Hoa City, Dong Nai Province, Vietnam, and is 18 miles east of Bien Hoa City. Spitfire Controls (Vietnam) Co. Ltd. was incorporated and commenced operation in 2005 and had 324295 employees as of April 30, 2022.2023.

The Company maintains an IPOinternational procurement office (“IPO”) in Taipei, Taiwan which was incorporated in 1991. The total square footage of the office is 4,685 square feet. The Company has an information technology office in Taichung, Taiwan. The total square footage of the office is 1,650 square feet. The Company had 3538 employees located in the Taiwan offices as of April 30, 2022.2023.

The Company provides funds for manufacturing services such as salaries, wages, inventory purchases for certain locations, overhead and capital expenditure items as necessary to operate its wholly-owned Mexican, Vietnamese and Chinese subsidiaries and foreign enterprises and the IPO in Taiwan. The Company provides funding in U.S. Dollars, which are exchanged for Pesos, Dong, Renminbi, and New Taiwan dollars. The fluctuation of currencies from time to time, without an equal or greater increase in inflation, could have a material impact on the financial results of the Company. The impact of currency fluctuations for the fiscal year ended April 30, 2022,2023, resulted in net foreign currency transaction losses of approximately $412,218$892,642 compared to net foreign currency losses of $285,389$412,218 in the prior fiscal year. In fiscal year 2022,2023, the Company paid approximately $62,250,000$60,070,000 to its foreign subsidiaries for manufacturing services. All intercompany balances have been eliminated upon consolidation.

9


The consolidated financial statements as of April 30, 2022,2023, include the accounts and transactions of SigmaTron, its wholly-owned subsidiaries, Standard Components de Mexico, S.A., AbleMex S.A. de C.V., Digital Appliance Controls de Mexico, S.A. de C.V., Spitfire Controls (Vietnam) Co. Ltd., and Spitfire Controls (Cayman) Co. Ltd., and Wagz, Inc., wholly-owned foreign enterprises Wujiang SigmaTron Electronics Co., Ltd. and Wujiang SigmaTron Electronic Technology Co., Ltd., its IPO, SigmaTron International, Inc. Taiwan Branch, and international procurement office, SigmaTron Taiwan Branch.Wagz, Inc. (19 percent ownership as of April 1, 2023). The functional currency of the Company’s foreign subsidiaries operations is the U.S. Dollar. Intercompany transactions are eliminated in the consolidated financial statements.

10


Competition

The EMS industry is highly competitive and subject to rapid change. Furthermore, both large and small companies compete in the industry, and many have significantly greater financial resources, more extensive business experience and greater marketing and production capabilities than the Company. The significant competitive factors in this industry include price, quality, service, timeliness, reliability, the ability to source raw components, and manufacturing and technological capabilities. The Company believes it can compete on all of these factors.

Consolidation

As a result of consolidation and other transactions involving competitors and other companies in the Company’s markets, the Company occasionally reviews potential transactions relating to its business, products and technologies. Such transactions could include mergers, acquisitions, strategic alliances, joint ventures, licensing agreements, co-promotion agreements, financing arrangements or other types of transactions. In the future, the Company may choose to enter into these types of or other transactions at any time depending on available sources of financing, and such transactions could have a material impact on the Company’s business, financial condition or operations.

Governmental Regulations

The Company’s operations are subject to certain foreign government, U.S. federal, state and local regulatory requirements relating to, among others, environmental, waste management, consumer, labor and health and safety matters.  Management believes that the Company’s business is operated in compliance with all such regulations, which include European regulations known as Restriction of Hazardous Substances (“RoHS”) and Registration, Evaluation, Authorization and Restriction of Chemicals (“REACH”).  From time-to-time the Company's customers request REACH required information and certifications on the assemblies the Company manufactures for them.  These requests require the Company to gather information from component suppliers to verify the presence and level of mass of any substances of very high concerns (“SVHCs”) greater than 0.1% in the assemblies the Company manufactures based on customer specifications.  If any SVHCs are present at more than 0.1% of the mass of the item, the specific concentration and mass of the SVHC must be reported to proper authorities by the Company's customer.

The Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”) introduced reporting requirements for verification of whether the Company directly (or indirectly through suppliers of components) is purchasing the minerals or metals gold, columbite-tantalite, cassiterite, wolframite and their derivatives (tin, tungsten, and tantalum), that are being provided by sources in the conflict region of the Democratic Republic of Congo (“DRC”) and contributing conflict.  Consistent with recent prior years, in May 2022, the Company filed Form SD with the Securities and Exchange Commission stating the Company’s supply chain remains DRC conflict undeterminable.

Backlog

The Company relies on binding forecasted orders and purchase orders (firm orders) from its customers to estimate backlog. The Company’s backlog of firm orders as of April 30, 2022,2023, and April 30, 2021,2022, was approximately $485,670,000$387,350,000 and $307,130,000,$485,670,000, respectively. The Company believes a significant portion of the backlog at April 30, 2022,2023, will ship in fiscal year 2023.2024. Because customers may cancel or reschedule deliveries, backlog may not be a meaningful indicator of future revenue. Variations in the magnitude and duration of contracts, forecasts and purchase orders received by the Company and delivery requirements generally may result in substantial fluctuations in backlog from period to period.

Human Capital Resources

The Company employed approximately 3,1002,950 full-time employees of which approximately 500 were located in the U.S. as of April 30, 2022.2023. There were approximately 250 engaged in engineering or engineering-related services, 2,4502,300 in manufacturing and 400 in administrative functions, including supply chain, accounting, management and sales and marketing.

1110


The Company makes a considerable effort to maintain a qualified and engaged work force. The Company makes a concerted effort to engage its employees and provide opportunities for growth and the Company believes that its employee relations are good. The Company considers the health and safety of its employees a key priority, and even more so sinceduring the COVID-19 pandemic started.pandemic. The Company has adopted various safety, cleaning and social distancing protocols consistent with the requirements of each jurisdiction. The Company is committed to removing conditions that may cause personal injury or occupational illness.

SigmaTron has a labor contract with Chemical & Production Workers Union Local No. 30, AFL-CIO, covering the Company’s workers in Elk Grove Village, Illinois which expires on November 30, 2024. The Company’s Mexican subsidiary, Standard Components de Mexico S.A., has a labor contract with Sindicato De Trabajadores de la Industra Electronica, Similares y Conexos del Estado de Coahuila, C.T.M. covering the Company’s workers in Acuna, Mexico which expires on February 7, 2024. The Company’s subsidiary located in Tijuana, Mexico has a labor contract with Sindicato Mexico Moderno De Trabajadores De La, Baja California, C.R.O.C. The contract does not have an expiration date. The Company’s subsidiary located in Bien Hoa City, Vietnam, has a labor contract with CONG DOAN CO SO CONG TY TNHH Spitfire Controls Vietnam. The contract expires on April 30, 2025.

Since the time the Company commenced operations, it has not experienced any union-related work stoppages.

Available Information

The Company’s website address is www.sigmatronintl.com. The Company announces material information, including press releases and financial information regarding the Company, through a variety of means, including the Company’s website, the Investors subpage of its website (www.sigmatronintl.com/investors/), press releases, filings with the SEC and social media, in order to achieve broad, non-exclusionary distribution of information to the public. The Investors subpage is accessible by clicking on the tab labeled “Investors” on the Company’s website home page. The Company also uses these channels to expedite public access to time-critical information regarding the Company in advance of or in lieu of distributing a press release or a filing with the SEC disclosing the same information. Therefore, investors should look to these channels for important and time-critical information. In addition, the Company is subject to the informational requirements of the Exchange Act and files or furnishes reports, proxy statements, and other information with the SEC. Such reports and other information filed by the Company with the SEC are available free of charge on its website when such reports are simultaneously available on the SEC’s website at http://www.sec.gov.www.sec.gov. The Company encourages investors, the media and others interested in the Company to review the information it posts on these various channels, as such information could be deemed to be material information.

The contents of the websites referred to above are not incorporated into this filing. Further, the Company’s references to the URLs for these websites are intended to be inactive textual references only.

1211


Information about our Executive Officers

Name

Age

Position

Gary R. Fairhead

7071

Chief Executive Officer and Chairman of the Board of Directors. Gary R. Fairhead has been the Chief Executive Officer of the Company and a director since January 1990 and Chairman of the Board of Directors of the Company since August 2011. He was also President from January 1990 until October 2021.2021 and then from August 2022 until January 2023. Gary R. Fairhead is the brother of Gregory A. Fairhead.

James E. BarnesJohn P. Sheehan

4062

President since October 2021. ExecutiveJanuary 2023. Vice President, Operations and Global Accounts from 2018 to 2021. Vice President of Operations from 2014 to 2018. Director of OperationsSupply Chain, and Assistant Secretary from 2011 to 2014. Senior Program Manager from 2010 to 2011. Program Manager from 2005 to 2010. Inventory Analyst from 2004 to 2005.February 1994 until January 2023.

James J. Reiman

5960

Chief Financial Officer, Vice President of Finance, Treasurer and Secretary since November 2021. Corporate Controller at Chroma Color Corporation from August 2019 to October 2021. Corporate Controller at Methode Electronics, Inc. from April 2007 to December 2018.

Gregory A. Fairhead

6667

Executive Vice President and Assistant Secretary. Gregory A. Fairhead has been the Executive Vice President since February 2000 and Assistant Secretary since 1994. Mr. Fairhead was Vice President - Acuna Operations for the Company from February 1990 to February 2000. Gregory A. Fairhead is the brother of Gary R. Fairhead.

John P. Sheehan

61

Vice President, Director of Supply Chain and Assistant Secretary since February 1994.

Daniel P. Camp

73

Vice President, Acuna Operations since 2007. Vice President - China Operations from 2003 to 2007. General Manager / Vice President of Acuna Operations from 1994 to 2003.

Rajesh B. Upadhyaya

6768

Executive Vice President, West Coast Operations since 2005. Mr. Upadhyaya was the Vice President of the Fremont Operations from 2001 until 2005.

Hom-Ming Chang

6263

Vice President, China Operations since 2007. Vice President - Hayward Materials / Test / IT from 2005 - 2007. Vice President of Engineering Fremont Operation from 2001 to 2005.

1312


ITEM 1A. RISK FACTORS

The following risk factors should be read carefully in connection with evaluating our business and the forward-looking information contained in this Annual Report on Form 10-K. Any of the following risks could materially adversely affect our business, operations, industry or financial position or our future financial performance. While the Company believes it has identified and discussed below the key risk factors affecting its business, there may be additional risks and uncertainties that are not presently known or that are not currently believed to be significant that may adversely affect its business, operations, industry, financial position and financial performance in the future.

Business and Operational Risks

Our financial conditionThe Company’s inventory levels have been adversely impacted by the global supply chain crisis, with an unprecedented impact on working capital requirements.

The impact of component shortages on sales of finished goods and the resulting increase in inventory levels have been unprecedented. Accordingly, we have been actively working with our suppliers to acquire scarce resources and with our customers to share the burden of these factors, while investing in systems to increase visibility into long-term supply and demand. Nevertheless, resulting improvements on the results of the Company’s operations are not certain and may continue to be elusive. The continued impact of increased inventory levels on working capital requirements materially increases our operating costs and if it continues unabated, could materially and adversely affect our business and results of operations have been impacted and may in the future be adversely affected by the ongoing COVID-19 pandemic.

We continue to closely monitor the impact of the global COVID-19 pandemic on all aspects of our operations and regions, including its effect on our operations, employees, trade customers, suppliers and distribution channels. Since 2020, the pandemic has created significant business disruption and economic uncertainty which adversely impacted our manufacturing operations, supply chain, and distribution channels and we continue to face unique challenges caused by COVID-19 pandemic in 2022. While the immediate impacts of the COVID-19 pandemic have been assessed, the long-term magnitude and duration of the disruption, including supply chain disruption, and resulting impact on global business activity remain uncertain. Many factors have impacted us and they, and others, may continue to impact us in the future, including timing and availability of effective treatments and vaccines, as well as vaccination rates among the population in the United States and many of the countries in which we operate. The adverse impact of the pandemic is expected to continue and may materially affect our results of operations and financial condition in future periods..

Raw material price increases and supply shortages could adversely affect results.

The supply of raw materials to the Company and to its component parts suppliers could be interrupted for a variety of reasons, including availability and pricing. The Company has experiencedIn particular, inflation, changes in trade policies, the imposition of duties and tariffs, potential retaliatory countermeasures, public health crises (such as the COVID-19 pandemic), and geopolitical conflicts (including involving Russia, Belarus, or the Ukraine, which supply chain disruptions relatedraw materials, such as neon, palladium and nickel, to the COVID-19 pandemic, and continued disruptions to the supply chainsemiconductor industry) could adversely affectimpact the Company's ability to meet commitments to customers. price or availability of raw materials. Prices for raw materials necessary for production have fluctuated significantly in the past and the Company is currently experiencing upward pricing pressure on raw materials. SignificantHistorically, it has been difficult to pass increased prices for components and raw materials through to our customers in the form of price increases could adversely affect the Company's results of operations and operating margins. In particular, inflation, changes in trade policies, the imposition of duties and tariffs, potential retaliatory countermeasures, public health crises (such as the COVID-19 pandemic), Russia’s invasion of Ukraine and geopolitical conflicts could adversely impact the price or availability of raw materials.increases. The Company may not be able to pass along increased raw material and components parts prices to its customers in the form of price increases or its ability to do so could be delayed. Significant price increases for components and raw materials could adversely affect the Company's results of operations and operating margins. Consequently, its results of operations and financial condition may be adversely affected.

The Company experiences variable operating results.

The Company’s results of operations have varied and may continue to fluctuate significantly from period to period, including on a quarterly basis. Consequently, results of operations in any period should not be considered indicative of the results for any future period, and fluctuations in operating results may also result in fluctuations in the price of the Company’s common stock.

The Company’s quarterly and annual results may vary significantly depending on numerous factors, many of which are beyond the Company’s control. Some of these factors include:

-          changes in sales mix to customersavailability and rising component costs

-          changes in availability and rising component costssales mix to customers

-          volume of customer orders relative to capacity

-          market demand and acceptance of our customers’ products

14


-          price erosion within the EMS marketplace

-          capital equipment requirements needed to remain technologically competitive

-          volatility in the U.S. and international economic and financial markets

13


The volume and timing of sales to the Company’s customers may vary due to:

-          component availability

-          customers’ attempts to manage their inventory

-          variation in demand for the Company’s customers’ products

-          customers’ attempts to manage their inventory

-          design changes

-          acquisitions of or consolidation among customers

Most of the Company’s customers’ production schedules are volatile, which makes it difficult to schedule production and achieve maximum efficiency at the Company’s manufacturing facilities and manage inventory levels.

The Company’s inability to forecast the level of customer orders with certainty can make it difficult to schedule production and maximize utilization of manufacturing capacity and manage inventory levels. The Company could be required to increase or decrease staffing and more closely manage other expenses in order to meet the anticipated demand of its customers. Orders from the Company’s customers could be cancelled or delivery schedules could be deferred as a result of changes in our customers’ demand, thereby adversely affecting the Company’s results of operations in any given period.

The price ofWe have, and may in the Company’s stock is volatile.future, encounter complications with acquisitions, which could potentially harm our business.

The priceTo integrate acquired businesses, we must implement our management information systems, operating systems and internal controls, and assimilate and manage the personnel of the Company’s common stock historically has experiencedacquired operations. The integration of acquired businesses may be further complicated by difficulties managing operations in geographically dispersed locations. The integration of acquired businesses may not be successful and could result in disruption by diverting management’s attention from the core business. Also the acquired business’s products or services may not be accepted by the market. In addition, the integration of acquired businesses may require that we incur significant volatility due to fluctuationsrestructuring charges or other increases in our expenses and working capital requirements, which reduce our return on invested capital. Acquisitions may involve numerous other risks and challenges including but not limited to: potential loss of key employees and customers of the acquired companies; the potential for deficiencies in internal controls at acquired companies; lack of experience operating in the Company’s revenuegeographic market or industry sector of the acquired business; constraints on available liquidity, and earnings, other factors relatingexposure to the Company’s operations, the market’s changing expectations for the Company’s growth, overall equity market conditionsunanticipated liabilities of acquired companies. These and other factors unrelatedcould harm our ability to the Company’s operations. In addition, the limited floatachieve anticipated levels of the Company’s common stockprofitability at acquired operations or realize other anticipated benefits of an acquisition, and the limited number of market makers alsocould adversely affect the volatility of the Company’s common stock. Such fluctuations are expected to continue in the future.our consolidated business and operating results.

Market Risks

Persistent inflation could have a material adverse impact on our business, operating results and financial condition.

Inflation has risen globally to levels not experienced in years. Inflation directly and indirectly increases the costs of operating expenses such as fuel, energy, transportation, materials, and labor. We may not be able to increase our product prices enough to offset these increased costs, and any increase in our product prices may reduce our future customer orders and profitability. Inflation may further erode consumer confidence, and negatively impact the market for our customers’ products. Persistent inflation could exacerbate other risk factors discussed in this Annual Report on Form 10-K.

Our customers have competitive challenges, including rapid technological changes, pricing pressures andthat could include decreasing demand from their customers, rapid technological changes, and pricing pressures, which could adversely affect their business and the Company’s business.

Factors affecting the industries that utilize our customers’ products could negatively impact our customers and the Company. These factors include:

-          recessionary periods in our customers’ markets

14


-          increased competition among our customers and their competitors

-          the inability of our customers to develop and market their products

-          the inability of our customers to obtain all necessary material to manufacture their products

-          recessionary periods in our customers’ markets

-          the potential that our customers’ products become obsolete

-          our customers’ inability to react to rapidly changing technology

Any such factor or a combination of factors could negatively impact our customers’ need for or ability to pay for our products, which could, in turn, affect the Company’s results of operations.

Adverse market conditions could reduce our future sales and earnings per share.

Uncertainty over the erosion of global consumer confidence amidst concerns about volatile energy costs, geopolitical issues, the availability and cost of credit, declining asset values, inflation, unemployment, and the stability and solvency of financial institutions, financial markets, businesses, and sovereign nations has slowed global economic growth. The economic recovery of recent years is fragile. The Company’s sales and gross margins depend significantly on market demand for its customers’ products. The uncertainty in the U.S. and international economic and political environments could result in a decline in demand for our customers’ products in any industry. Further, any adverse changes in tax rates and laws or trade policies affecting our customers could result in decreasing gross margins. Any of these potential negative economic conditions may reduce demand for the Company’s customers’ products and adversely affect the Company’s sales. Consequently, the Company’s past operating results, earnings and cash flows may not be indicative of the Company’s future operating results, earnings and cash flows.

Our exposure to financially troubled customers or suppliers may adversely affect the Company’s financial results.

On occasion, we provide services to customers, and rely upon suppliers that have in the past and may in the future experience financial difficulty. If any of the Company’s customers have financial difficulties, the Company could encounter delays or defaults in the payment of amounts owed for accounts receivable and

15


inventory obligations. Additionally, if our suppliers experience financial difficulties, we could have difficulty sourcing supplies necessary for production requirements. These risks may be heightened by the effects of the COVID-19 pandemic and recent economic volatility. Any financially troubled customer or supplier could have a significant adverse impact on the Company’s results of operations and financial condition.

The Company’s customer base is concentrated.

Sales to the Company’s five largest customers accounted for 55.3%47.4% and 57.8%55.3% of net sales for the fiscal years ended April 30, 2022,2023, and April 30, 2021,2022, respectively. For the fiscal year ended April 30, 2023, two customers accounted for 13.4% and 12.2% of net sales of the Company, and 6.8% and 4.6%, respectively, of accounts receivable. For the fiscal year ended April 30, 2022, two customers accounted for 21.8% and 11.7% of net sales of the Company, and 4.0% and 3.2%, respectively, of accounts receivable. For the fiscal year ended April 30, 2021, two customers accounted for 17.9% and 16.2% of net sales of the Company, and 3.8% and 5.6%, respectively, of accounts receivable. Significant reductions in sales to any of the Company’s major customers or the loss of a major customer could have a material impact on the Company’s operations. If the Company cannot replace cancelled or reduced orders, sales will decline, which could have a material adverse impact on the results of operations. There can be no assurance that the Company will retain any or all of its largest customers. This risk may be further complicated by pricing pressures and intense competition prevalent in our industry.

The Company faces intense industry competition and downward pricing pressures.

The EMS industry is highly fragmented and characterized by intense competition. Many of the Company’s competitors have greater experience, as well as greater manufacturing, purchasing, marketing and financial resources than the Company. Competition from existing or potential new competitors may have a material adverse impact on the Company’s business, financial condition or results of operations. The introduction of lower priced competitive products, significant price reductions by the Company’s competitors or significant pricing pressures from its customers could adversely affect the Company’s business, financial condition, and results of operations.

Adverse market conditions could reduce our future sales and earnings per share.

Uncertainty over the erosion of global consumer confidence amidst concerns about volatile energy costs, geopolitical issues, the availability and cost of credit, declining asset values, inflation, rising unemployment, and the stability and solvency of financial institutions, financial markets, businesses, and sovereign nations has slowed global economic growth. The economic recovery of recent years is fragile and recessionary conditions have returned. Any of these potential negative economic conditions may reduce demand for the Company’s customers’ products and adversely affect the Company’s sales. Consequently, the Company’s past operating results, earnings and cash flows may not be indicative of the Company’s future operating results, earnings and cash flows.15


Customer relationships with start-up companies present more risk.

A small portion of the Company’s current customer base is comprised of start-up companies.  Customer relationships with start-up companies may present heightened risk due to the lack of product history.  Slow market acceptance of their products could result in demand fluctuations causing inventory levels to rise.  Further, the current economic environment could make it difficult for such emerging companies to obtain additional funding.  This may result in additional credit risk including, but not limited to, the collection of trade account receivables and payment for their inventory.  If the Company does not have adequate allowances recorded, the results of operations may be negatively affected.

Capital and FinancingInternational Operations Risks

WeThe Company has significant foreign operations that may fail to secure or maintain necessarypose additional financing or capital.risks.

AlthoughThe Company manufactures product in facilities located in Mexico, China, Vietnam and the United States. These operations may be subject to a number of risks, including:

-the political climate and relations with the United States, including the impact of trade wars, tariffs and trade barriers (including quotas)

-political and economic instability (including acts of terrorism, territorial disputes, pandemics, civil unrest, forms of violence, and outbreaks of war), which could impact our ability to ship, manufacture, or receive product

-the instability of the foreign economies

-burdens of complying with a wide variety of foreign laws and labor practices

-unexpected changes in regulatory requirements and laws

-difficulties in staffing, turnover and managing onshore and offshore operations

-export duties, import controls

-legal authority of the Company to operate and expand its business in foreign countries

-impact of physical and operational risks from natural disasters, severe weather events, and climate change

-impact of future temporary closures and labor constraints as a result of COVID-19.

The Company obtains many of its materials and components through its IPO in Taipei, Taiwan. The Company’s access to these materials and components is dependent on the continued viability of its Asian suppliers.

Approximately 37% of the total assets of the Company are located in foreign jurisdictions outside the United States as of April 30, 2023; 25% and 10% of the total assets were located in Mexico and China, respectively, and 2% in other foreign locations. As of April 30, 2022, approximately 35% of the total assets were located in foreign jurisdictions; 20% and 12% were located in China and Mexico, respectively and 3% in other foreign locations.

There is a risk of fluctuation of various currencies integral to the Company’s operations.

The Company purchases some of its material components and funds some of its operations in foreign currencies. From time to time the currencies fluctuate against the U.S. Dollar. Such fluctuations could have a material impact on the Company’s results of operations and performance. The impact of currency fluctuations for the fiscal year ended April 30, 2023, resulted in net foreign currency transaction losses of $892,642 compared to net foreign currency losses of $412,218 in the prior year. These fluctuations are expected to continue and could have a negative impact on the Company’s results of operations. The Company has not, and is not expected to, utilize derivatives or hedge foreign currencies to reduce the risk of such fluctuations.

Unanticipated changes in our tax position, the adoption of new tax legislation or exposure to additional tax liabilities could adversely affect our financial results.

We base our tax position upon our understanding of the current tax laws of the various countries in which we have credit facilities, weassets or conduct activities. Our tax position, however, is subject to review and possible challenge by

16


taxing authorities and to possible changes in law. We cannot be certain thatdetermine in advance the extent to which some jurisdictions may assess additional tax or interest and penalties on such additional taxes. Given the scope of our existing creditinternational operations and our international tax arrangements, will provide all ofchanges to the financing capacity that we will needmanner in which U.S. based multinational companies are taxed in the U.S. could have a material impact on our financial results and competitiveness. Based on current and future tax policy in Washington D.C., our effective tax rates and overall cash taxes may change in the future and could have an impact on our financial results.

Financing and Capital Risks

If we fail to comply with our credit agreements in future periods, we may be unable to secure any required waivers or amendments from the lenders and repayment obligations on our outstanding indebtedness may be accelerated.

Our credit agreements contain numerous financial and operating covenants with which we must comply. In the fourth quarter of fiscal year 2023, the Company was able to negotiate amendments and waivers with both J.P. Morgan Chase and TCW Asset Management Company as a result of our failure to maintain certain covenants as of January 31, 2023. As of April 30, 2023, we were in compliance with these covenants. However, our continued compliance with our obligations in general and these financial covenants in particular is dependent on our financial results, which are subject to fluctuation as described elsewhere in the risk factors discussed in this Annual Report on Form 10-K. If we fail to comply with the covenants in the future and if our lenders do not agree to waive any future non-compliance, we may be unable to borrow funds and any outstanding indebtedness could become immediately due and payable, which could materially harm our business.

The Company’s current credit facilities may become unavailable.

We cannot be certain that we will be able to changeamend the credit facilities or revise covenants, if necessary, to accommodate changes or developments in our business and operations and/or

16


increased working capital needs. If we do not comply with the covenants under any of our credit facilities, our ability to borrow would be adversely affected. In addition, itoperations. It is possible that counterparties to our financial agreements, including our credit facilities and receivables factoring programs, may not be willing or able to meet their obligations, either due to instability in the global financial markets or otherwise, which could, among other impacts, increase the duration of our cash collection cycle. While we currently believe we have ample liquidity to manage the financial impact of the COVID-19 pandemic or global supply chain disruptions, we can give no assurance that this will continue to be the case if the impact of those conditions is prolonged or if there is an extended impact on us or the economy in general.

Our future success may depend on our ability to obtain additional financing and capital to support possible future growth and future initiatives. Many of our borrowings are at variable interest rates and therefore our interest expense is subject to increase if rates increase.

We may seek to raise additional capital by issuing additional common stock, other equity securities or debt securities, modifying our existing credit facilities or obtaining new facilities, or through a combination of these methods. We may not be able to obtain capital when we want or need it, and capital may not be available on satisfactory terms. If we issue additional equity securities or convertible securities to raise capital, it may be dilutive to shareholders’ ownership interests; we may not be able to offer our securities on attractive or acceptable terms in the event of volatility or weakness in our stock price. Furthermore, any additional financing may have terms and conditions that adversely affect our business, such as restrictive financial or operating covenants, and our ability to meet any current or future financing covenants will largely depend on our financial performance, which in turn will be subject to general economic conditions and financial, business and other factors. The cessation of any of our current credit facilities could cause a material adverse effect on the Company’s business, results of operations and financial condition.

We may fail to secure or maintain necessary additional financing or capital.

While we currently believe we have ample liquidity to finance our business and manage the financial impact of current economic challenges, we can give no assurance that our existing credit arrangements will provide all of the financing capacity that we will need in the future. If the current credit facilities are not adequate, we may seek to raise additional capital by issuing additional equity, modifying our existing or obtaining new credit facilities, or through a combination of these methods. Our ability to issue additional common stock, other equity securities or debt securities may be hampered by any actual or perceived weakness or volatility in our stock price. Any such securities also likely will be dilutive to stockholders’ ownership interests. We may not be able to obtain capital when we want or need it, or on satisfactory terms. The failure to have access to sufficient capital could adversely materially affect the Company’s business, results of operations and financial condition.

Increasing interest rates for our borrowings could adversely affect our results of operations.

The Company pays interest on outstanding borrowings under its secured credit facilities and certain other long-term debt obligations at interest rates that fluctuate. In recent months, global inflation and other factors have resulted in a substantial increase in interest rates, and future borrowing costs may rise further. Adverse changes in the Company’s interest rates could have a material adverse effect on its financial condition and results of operations.

17


The price of the Company’s stock is volatile.

The price of the Company’s common stock historically has experienced significant volatility due to fluctuations in the Company’s revenue and earnings, other factors relating to the Company’s operations, the market’s changing expectations for the Company’s growth, overall equity market conditions and other factors unrelated to the Company’s operations. In addition, the limited float of the Company’s common stock also affects the volatility of the Company’s common stock. Such fluctuations are expected to continue in the future.

Although forgiven, the Company’s Paycheck Protection Program Loan (“PPP Loan”) remains subject to audit.

On April 23, 2020, the Company received proceeds ofa $6,282,973 from a PPP Loan under the CARES Act, which it used to retain current U.S. employees, maintain payroll and make lease and utility payments. The PPP Loan was forgiven on July 9, 2021. However, due to the size of the PPP Loan, it is subject to audit by the SBA for up to six years after forgiveness, which introduces an additional layer of uncertainty. In order to apply for the PPP Loan, the Company was required to certify, that the then current economic uncertainty, including, among other factors, the short term customer demand reduction, made the PPP Loan request necessary to support its ongoing operations. The Company made this certification in good faith after analyzing, among other things, the continued employment of its entire U.S. workforce, certain obvious “work-from-home” limitations associated with the nature of its business, and its ability to meet fixed cost obligations, in light of customer concerns. Furthermore, the Company considered its classification as a “smaller reporting company” under SEC rules and its need for additional funding to continue operations, and its lack of ability to currently access alternative forms of capital in the market environment to fund working capital requirements. Based on this analysis,forgiveness. While the Company believes that it satisfied all eligibility criteria for the PPP Loan, andthere is a risk that on audit, the receipt of the PPP Loan is consistent with the broad objectives of the CARES Act. If, despite the Company’s actions and certification that it satisfied all eligibility requirements for the PPP Loan, it is laterCompany will be determined that it violated applicable laws or was otherwiseto have been ineligible to receive the PPP Loan, it mayLoan. In that case, the Company could be required to repay the PPP Loan in its entirety in a lump sum orand be subject to additional penalties and interest which could also result inand adverse publicity and damage to the Company’s reputation. If these events were to transpire, they could have a material adverse effect on the Company’s business, results of operations and financial condition.

Tax/Regulatory and Legal and Regulatory Risks

Uncertainty related to environmental regulation and industry standards, as well as physical risks of climate change, could impact the Company's results of operations and financial position.

Increased public awareness and concern regarding environmental risks, including global climate change, may result in more international, regional and/or federal requirements or industry standards to reduce or mitigate climate change and other environmental risks. These regulations or standards could mandate even more restrictive requirements, such as stricter limits on greenhouse gas emissions. There continues to be a lack of consistent climate legislation, which creates economic and regulatory uncertainty. In addition, the physical risks

17


of climate change may impact the availability and cost of materials and natural resources, sources and supply of energy, product demand and manufacturing and could increase insurance and other operating costs, including, potentially, to repair damage incurred as a result of extreme weather events or to renovate or retrofit facilities to better withstand extreme weather events. If environmental laws or regulations or industry standards are either changed or adopted and impose significant operational restrictions and compliance requirements upon the Company or its products, or the Company's operations are disrupted due to physical impacts of climate change, the Company's business, capital expenditures, results of operations, financial condition and competitive position could be negatively impacted.

Changes in U.S. trade policy, including the imposition of tariffs and the resulting consequences, may have a material adverse impact on our business and results of operations.

The U.S. government has indicated its intent to adopt a new approach to trade policy and in some cases to renegotiate, or potentially terminate, certain existing bilateral or multi-lateral trade agreements.  It has also initiated tariffs on certain foreign goods, including raw materials utilized by the Company.  Changes in U.S. trade policy could result in one or more of the U.S.’ trading partners adopting responsive trade policy making it more difficult or costly for the Company to import our productscomponents from those countries.  This in turn could require us to increase prices to our customers which may reduce demand, or, if we are unable to increase prices, result in a lower margin on products sold.

China and the European Union havehas imposed tariffs on U.S. products in retaliation for U.S. tariffs. Additional tariffs could be imposed by China and the European Union in response to proposed increased tariffs on products imported from China and the European Union.China.  There is also a concern that the imposition of additional tariffs by the United States could result in the adoption of additional tariffs by other countries.  The resulting trade war could have a significant adverse effect on world trade and the world economy.  To the extent that trade tariffs and other restrictions imposed by the United States increase the price of or limit the amount of certain raw materials utilized by the Company imported into the United States, the costs of our raw materials may be adversely affected and the demand from our customers for products and services may be diminished, which could adversely affect our revenues and profitability.

We cannot predict future trade policy or the terms of any renegotiated trade agreements and their impact on our business.  The adoption and expansion of trade restrictions, the occurrence of a trade war, or other governmental action related to tariffs or trade agreements or policies has the potential to adversely impact demand for our products, our costs, our customers, our suppliers, and the U.S. economy, which in turn could adversely impact our business, financial condition and results of operations.

An adverse changeChanges in securities laws and regulations may increase the interest rates for our borrowings could adversely affect our results of operations.Company’s compliance efforts and costs.

The Company pays interest on outstanding borrowings under its senior secured credit facilitySarbanes-Oxley Act of 2002, as well as rules subsequently implemented by the SEC and certain other long-term debt obligations at interest rates that fluctuate. In recent months, global inflationlisting requirements subsequently adopted by Nasdaq in response to Sarbanes-Oxley, have required changes in corporate governance practices, internal control policies and other factors have resulted in an increase in interest rates generally,securities disclosure and future borrowing costs may rise. An adverse change incompliance practices of public companies. More recently the Dodd-Frank Act has required changes to our corporate governance, compliance practices and securities disclosures, and the SEC recently approved pay versus performance disclosures and Nasdaq’s board diversity proposal, immediately increasing the Company’s interest rates could have a material adverse effect on its financial condition and results of operations.

Adverse changes in the economy or political conditions could negatively impact the Company’s business, results of operations and financial condition.

The Company’s sales and gross margins depend significantly on market demand for its customers’ products. The uncertainty in the U.S. and international economic and political environments could result in a decline in demand for our customers’ products in any industry. Further, any adverse changes in tax rates and laws or trade policies affecting our customers could result in decreasing gross margins. Any of these factors could negatively impact the Company’s business, results of operations and financial condition.

disclosure

18


Failurerequirements. Proposed regulations by the SEC mandating new disclosures of environmental, social and governance information, including climate-related risks, targets and goals and their financial impact, could be adopted in the future. Compliance with these rules has increased our legal, financial and accounting costs, and those costs will increase if additional requirements are imposed. These legal developments may result in the Company having difficulty in attracting and retaining qualified directors or officers. The Company’s failure to comply with environmentalpresent or future regulations could subjectresult in the SEC or Nasdaq levying sanctions against the Company or even moving to liability.

The Company is subject to a variety of environmental regulations relating to the use, storage, discharge and disposal of hazardous chemicals used duringdelist its manufacturing process. To date, the cost to the Company of such compliance has not had a material impact on the Company’s business, financial condition or results of operations. However, there can be no assurance that violations will not occur in the future as a result of human error, equipment failure or other causes. Further, the Company cannot predict the nature, scope or effect of environmental legislation or regulatory requirements that could be imposed or how existing or future laws or regulations will be administered or interpreted. Compliance with more stringent laws or regulations,stock. Such consequences, as well as more vigorous enforcement policies of regulatory agencies, could require substantial expenditures by the Company andcompliance costs, could have a material impact on the Company’s business, financial condition and results of operations. Any failure by the Company to comply with present or future regulations could subject it to future liabilities or the suspension of production which could have a material negative impact on the Company’s results of operations.

Conflict mineralsMinerals regulations may cause the Company to incur additional expenses and could increase the cost of components contained in its products and adversely affect its inventory supply chain.

The Dodd-Frank Act, and the rules promulgated by the Securities and Exchange Commission (“SEC”) thereunder, require the Company to attempt to determine and report annually whether any conflict mineralsConflict Minerals contained in our products originated from the DRC or an adjoining country. The Dodd-Frank Act and these rules could affect our ability to source components that contain conflict mineralsConflict Minerals at acceptable prices and could impact the availability of conflict minerals,Conflict Minerals, since there may be only a limited number of suppliers of conflict-free conflict minerals.Conflict Minerals. Our customers may require that our products contain only conflict-free conflict minerals,Conflict Minerals, and our revenues and margins may be negatively impacted if we are unable to meet this requirement at a reasonable price or are unable to pass through any increased costs associated with meeting this requirement. Additionally, the Company may suffer reputational harm with our customers and other stakeholders if our products are not conflict-free. The Company could incur significant costs in the event we are unable to manufacture products that contain only conflict-free conflict mineralsConflict Minerals or to the extent that we are required to make changes to products, processes, or sources of supply due to the foregoing requirements or pressures.

Changes in securities lawsThe Company’s operations are subject to numerous other regulations and failure to comply with all applicable regulations may increase costs.could subject the Company to liability.

The Sarbanes-OxleyCompany is subject to a variety of regulations, including environmental regulation of the use, storage, discharge and disposal of hazardous chemicals used during its manufacturing process; disclosures relating to cancer-causing substances in drinking water as required under California Proposition 65; and compliance with the European Union’s requirements relating to certain chemical and hazardous substances including under the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) Act and the Restriction of 2002,Hazardous Substances (RoHS-2) Directive. To date, the cost to the Company of such compliance has not had a material impact on the Company’s business, financial condition or results of operations. However, federal, state and local legislation and regulation are constantly evolving. Further, increased public awareness and concern regarding environmental risks, including global climate change, may result in more international, federal, state or local requirements or industry standards to reduce or mitigate climate change and other environmental risks. The Company cannot predict the nature, scope or effect of regulatory legislation or requirements that could be imposed or how existing or future laws or regulations will be administered or interpreted. Any failure by the Company to comply with present or future regulations, whether as a result of human error, equipment failure or other causes, could subject it to future liabilities to customers or governmental agencies, the suspension of production, increased costs or reputational harm with our customers and other stakeholders. Compliance with more stringent laws or regulations, as well as rules subsequently implementedmore vigorous enforcement policies of regulatory agencies, could require substantial expenditures by the SECCompany and listing requirements subsequently adopted by NASDAQ in response to Sarbanes-Oxley, have required changes in corporate governance practices, internal control policies and securities disclosure and compliance practices of public companies. More recently the Dodd-Frank Act has required changes to our corporate governance, compliance practices and securities disclosures , and the SEC recently approved Nasdaq’s board diversity proposal, immediately increasing the Company’s disclosure requirements. Compliance following the implementation of these rules has increased our legal, financial and accounting costs. The Company expects increased costs related to these new regulations to continue, including, but not limited to, legal, financial and accounting costs. These developments may result in the Company having difficulty in attracting and retaining qualified members of the board or qualified officers. Further, the costs associated with the compliance with and implementation of procedures under these laws and related rules could have a material impact on the Company’s business, financial condition and results of operations.

Any litigation, even where a claim is without merit, could result in substantial costs and diversion of resources.

In the past, the Company has been notified of claims relating to various matters including contractual matters, product liability, labor issues or other matters arising in the ordinary course of business. In the event of any such claim, the Company may be required to spend a significant amount of money and resources, even where the claim is without merit or covered by insurance. Accordingly, the resolution of such disputes, even those encountered in the ordinary course of business, could have a material adverse effect on the Company’s business, consolidated financial conditions and results of operations.

19


Strategic TransactionTechnology Risks

The Company may not be ableIt is increasingly difficult to achieveprotect the expected benefits of the business combination between the Company and Wagz, Inc. (the “Wagz acquisition”Company’s Information Technology (“IT”), including anticipated revenue and cost synergies, and costs associated with achieving synergies.systems.

TheWith the increased use of technologies to conduct business, a company is susceptible to operational, information security and related risks. In general, cyber incidents can result from deliberate attacks or unintentional events. Cyberattacks include gaining unauthorized access to digital systems (e.g., through “hacking” or malicious software coding) for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption (e.g., ransomware attacks). Cyberattacks may also be carried out in a manner that does not require gaining unauthorized access, such as causing denial-of-service attacks on websites (i.e., efforts to make network services unavailable to intended users). Cyber incidents affecting the Company or its service providers have the ability to cause disruptions and impact business operations, potentially resulting in financial losses, interference with the Company’s ability to conduct business in the ordinary course, violations of applicable privacy and other laws, regulatory fines, penalties, reputational damage, reimbursement or other compensation costs, additional compliance costs and, in extreme cases, have caused companies to cease doing business. Cyber events also can affect counterparties or entities with which the Company does business, governmental and other regulatory authorities, banks, insurance companies and other financial institutions, among others. In addition, substantial costs may not be ableincurred in order to achieveprevent any cyber incidents in the expected benefits offuture. While the Wagz acquisition,Company has established risk management systems designed to prevent such cyber incidents, there are inherent limitations in such systems including anticipated revenue. There can be no assurance that a robust market for Wagz’s products will materialize andthe possibility that the Wagz acquisition will be beneficialCompany has not prepared for certain risks that have not been or are not possible to the Company. Moreover, it is likely that Wagz will not be able to achieve success without the Company continuing to invest significant funds in Wagz. Although Wagz is a stand-alone operation of the Company, and should benefit from the broader manufacturing and supply support that may be provided by the Company, the integration process may be complex, costly and time-consuming. Accordingly, the benefits from the Wagz acquisition may be offset by costs incurred or delays in Wagz’s product launches. Any unexpected costs or delays incurred in connection with Wagz could have an adverse effect on the Company’s business, results of operations, financial condition and prospects, as well as the market price of its common stock. In addition, even if Wagz’s business succeeds,been identified. Further, the Company may not realizehave limited ability to influence, and cannot control, the full benefits ofcyber security plans and systems put in place by its service providers or any other third parties whose operations may affect the Wagz acquisition, including the sales or growth opportunities that it expects. These benefits may not be achieved within the anticipated time frame, or at all.

Company. The Company has significant goodwill and other intangible assets, and future impairment of these assets could have a material adverse impact on the Company's financial results.

The Company has recorded significant goodwill and other identifiable intangible assets on its balance sheetbe negatively impacted as a result of acquisitions, including the acquisition of the Wagz in fiscal 2022. A number of factors may result in impairments to goodwill and other intangible assets, including significant negative industry or economic trends, disruptions to our business, increased competition and significant changes in the use of the assets. Impairment charges could adversely affect the Company's financial condition or results of operations in the periods recognized. See Note F, Acquisitions of Item 15(a) Exhibits and Financial Statement Schedules, for a discussion related to impairment testing of goodwill for the year ended April 30, 2022. We concluded no impairment of long-lived assets as of April 30, 2022.

Technology Risksresult.

If the security of the Company’sInformation Technology (“IT”) IT systems is breached or otherwise subjected to unauthorized access, the Company’s reputation may be severely harmed and it may be exposed to liability.

The Company’s IT system storessystems store confidential information which includes its financial information, its customers’ proprietary information, product information, supplier information, and other critical data.  Any accidental or willful security breach or other unauthorized access could expose the Company to liability for the loss of such information, adverse regulatory action by federal, state and statelocal governments, time-consuming and expensive litigation and other possible liabilities as well as negative publicity, which could severely damage the Company’s reputation.  If security measures are breached because of third-party action, employee action or error, malfeasance or otherwise, or if design flaws in its software are exposed and exploited, and, as a result, a third party obtains unauthorized access to any of the Company’s customer data, its relationships with its customers may be severely damaged, and the Company could incur significant liability.  Because techniques used to obtain unauthorized access or to sabotage systems change frequently and generally are not recognized until they are launched against a target, the Company and its third-party hosting facilities may be unable to anticipate these techniques or to implement adequate preventive measures.  In addition, many states have enacted laws requiring companies to notify customers of data security breaches involving their data.  These mandatory disclosures regarding a security breach often lead to widespread negative publicity, which may cause the Company’s customers to lose confidence in the effectiveness of its data security measures.  Any security breach whether actual or perceived, could harm the Company’s reputation, could cause it to lose customers and may negatively impact its ability to acquire new customers.

20


With the increased use of technologies such as the Internet to conduct business, a company is susceptible to operational, information security and related risks. In general, cyber incidents can result from deliberate attacks or unintentional events. Cyberattacks include, but are not limited to, gaining unauthorized access to digital systems (e.g., through “hacking” or malicious software coding) for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption (e.g., ransomware attacks). Cyberattacks may also be carried out in a manner that does not require gaining unauthorized access, such as causing denial-of-service attacks on websites (i.e., efforts to make network services unavailable to intended users). Cyber incidents affecting the Company or its service providers have the ability to cause disruptions and impact business operations, potentially resulting in financial losses, interference with the Company’s ability to conduct business in the ordinary course, violations of applicable privacy and other laws, regulatory fines, penalties, reputational damage, reimbursement or other compensation costs, additional compliance costs and, in extreme cases, have caused companies to cease doing business. Cyber events also can affect counterparties or entities with which the Company does business, governmental and other regulatory authorities, banks, insurance companies and other financial institutions, among others. In addition, substantial costs may be incurred in order to prevent any cyber incidents in the future. While the Company has established risk management systems to prevent such cyber incidents, there are inherent limitations in such systems including the possibility that the Company has not prepared for certain risks that have not been or are not possible to have been identified. Further, the Company may be able to influence, but cannot control, the cyber security plans and systems put in place by its service providers or any other third parties whose operations may affect the Company. The Company could be negatively impacted as a result.

The Company and its customers may be unable to keep current with the industry’s technological changes.

The market for the Company’s manufacturing services is characterized by rapidly changing technology and continuing product development. The future success of the Company’s business will depend in large part upon our customers’ ability to maintain and enhance their technological capabilities, and our ability to develop and market manufacturing services which meet changing customer needs and successfully anticipate or respond to technological changes in manufacturing processes on a cost-effective and timely basis.

International Operations Risks

There is a risk of fluctuation of various currencies integral to the Company’s operations.

The Company purchases some of its material components and funds some of its operations in foreign currencies. From time to time the currencies fluctuate against the U.S. Dollar. Such fluctuations could have a material impact on the Company’s results of operations and performance. The impact of currency fluctuations for the fiscal year ended April 30, 2022, resulted in net foreign currency transaction losses of $412,218 compared to net foreign currency losses of approximately $285,000 in the prior year. These fluctuations are expected to continue and could have a negative impact on the Company’s results of operations. The Company did not, and is not expected to, utilize derivatives or hedge foreign currencies to reduce the risk of such fluctuations.

The Company has foreign operations that may pose additional risks.

The Company has substantial manufacturing operations in multiple countries. Therefore, the Company’s foreign businesses and results of operations are dependent upon numerous related factors, including the stability of the foreign economies, the political climate, relations with the United States, prevailing worker wages, the legal authority of the Company to operate and expand its business in a foreign country, the ability to identify, hire, train and retain qualified personnel and operating management in Mexico, China and Vietnam, and the Company’s ability to manage disruptions resulting from foreign government lockdowns and other actions taken in response to the COVID-19 pandemic.

The Company obtains many of its materials and components through its IPO in Taipei, Taiwan. The Company’s access to these materials and components is dependent on the continued viability of its Asian suppliers.

2120


Approximately 35% of the total assets of the Company are located in foreign jurisdictions outside the United States as of April 30, 2022, 20% and 12% of the total assets were located in Mexico and China, respectively, and 3% in other foreign locations. As of April 30, 2021, approximately 39% of the total assets were located in foreign jurisdictions, 21% and 15% were located in China and Mexico, respectively and 3% in other foreign locations.

The Russian Conflict in the Ukraine and the resulting political, social and economic impacts may adversely affect our business.

Generally, the Company does not purchase components from Russia, Belarus, or the Ukraine. However, the semiconductor industry, and purchasers of semiconductors, use raw materials that are sourced from these regions, such as neon, palladium and nickel. If the Company, or its direct or indirect customers, are unable to obtain the requisite raw materials or components needed to manufacture products, the Company’s ability to manufacture products, or demand for our products, may be adversely impacted. This could have a material adverse effect on its business, results of operations or financial condition. While there has been an adverse impact on the world’s palladium and neon supply chains, at this time, our palladium and neon supply chains have been able to meet our needs. While sales of the Company’s products into the regions, and to customers that sell into these regions, have been negatively impacted by the Russian invasion of the Ukraine, at this time, the Company has not experienced a material impact on our business, results of operations or financial conditions.

GeneralHuman Capital Risks

The Company depends on management and skilled personnel.

The Company depends significantly on its Chief Executive Officer and Chairman of the Board, President and other executive officers. The Company’s employees generally are not bound by employment agreements and the Company cannot assure that it will retain its executive officers or skilled personnel. The loss of the services of any of these key employees could have a material impact on the Company’s business and results of operations. In addition, due to significant competition in the labor market, continued growth and expansion of the Company’s EMS business will require that the Company attract, motivate and retain additional skilled and experienced personnel. The Company’s future growth depends on the contributions and abilities of key executives and skilled, experienced employees. The Company’s future growth also depends on its ability to recruit and retain high-quality employees. A failure to obtain or retain the number of skilled employees necessary to support the Company’s efforts, a loss of key employees or a significant shortage of skilled, experienced employees could jeopardize its ability to meet its growth targets.

Favorable labor relations are important to the Company, and failures to comply with domestic or international employment laws could result in significant damages.

The Company currently has labor union contracts with its employees constituting approximately 51%48% and 49%51% of its workforce for fiscal years 20222023 and 2021,2022, respectively. Although the Company believes its labor relations are good, any labor disruptions, whether union-related or otherwise, could significantly impair the Company’s business, substantially increase the Company’s costs or otherwise have a material impact on the Company’s results of operations. The Company is also subject to a variety of domestic and foreign employment laws, including those related to safety, wages, discrimination, harassment, organizing, employee privacy and severance. Allegations of violations of these laws could result in defense costs, damages, settlements and fines, which could have a material impact on the Company’s results of operations.

Accounting Risks

The Company has intangible assets, and future impairment of these assets could have a material adverse impact on the Company's financial results.

The Company has recorded identifiable intangible assets on its balance sheet as a result of operations and acquisitions. A number of factors may result in impairments to intangible assets, including significant negative industry or economic trends, disruptions to our business, increased competition and significant changes in the use of the assets. For example, we concluded that our goodwill and long-lived assets as of April 30, 2023 were impaired and recorded asset impairment charges equal to a total of $23,096,771, which adversely impacted our results of operations. See Note F – Acquisition and Disposition, for a discussion related to impairment testing of goodwill and intangible assets for the year ended April 30, 2023. Any additional impairment charges could adversely affect the Company's financial condition or results of operations in the periods recognized.

Inadequate internal control over financial reporting could result in a reduction in the value of our common stock.

If the Company identifies and reports a material weakness in its internal control over financial reporting, stockholders and the Company’s lenders could lose confidence in the reliability of the Company’s financial statements. This could have a material adverse impact on the value of the Company’s stock and the Company’s liquidity.

22


Disclosure and internal controls may not detect all errors or fraud.

The Company’s disclosure controls and internal controls can provide only reasonable assurance that the procedures will meet the control objectives. Controls are limited in their effectiveness by human error, including faulty judgments in decision-making. Further, controls can be circumvented by collusion of two or more people or by management override of controls. Therefore, the Company’s management, including the

21


Chief Executive Officer and Chief Financial Officer, cannot conclude with certainty that the Company’s disclosure controls and internal controls will prevent all errors and all fraud.

Changes in financial accounting standards may affect our reported financial condition or results of operations as well as increase costs related to implementation of new standards and modifications to internal controls.

Our consolidated financial statements are prepared in conformity with accounting standards generally accepted in the United States, or U.S. GAAP. These principles are subject to amendments made primarily by the Financial Accounting Standards Board (FASB) and the SEC. A change in those policies can have a significant effect on our reported results and may affect our reporting of transactions which are completed before a change is announced. Changes to accounting rules or challenges to our interpretation or application of the rules by regulators may have a material adverse effect on our reported financial results or on the way we conduct business.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

23


ITEM 2. PROPERTIES

AtPrior to April 30, 2022,1, 2023, the Company, operatesoperated in two reportable segments as an independent provider of electronic EMS, and a provider of products to the Pet Tech market , hadmarket. The majority of the Pet Tech Segment was sold, effective as of April 1, 2023, and following such date, the Company operates in one reportable segment, the EMS segment. The Company has manufacturing facilities located in Elk Grove Village, Illinois U.S., Union City, California U.S.,; Acuna, Coahuila, Mexico, Chihuahua, Chihuahua, Mexico and Tijuana, Mexico,Baja California, Mexico; Bien Hoa City, Dong Nai Province, Vietnam and Suzhou, Jiangsu Province, China. In addition, the Company provides material procurement services through all its locations.maintains an IPO in Taipei, Taiwan. The Company provides design services in Elgin, Illinois, and Portsmouth, New Hampshire, U.S. The Company has an information technology office in Taichung, Taiwan.

Certain information about the Company’s manufacturing, warehouse, purchasing and design facilities is set forth below:

Location

Square Feet

Services Offered

Owned/Leased

Suzhou, China

216,950

Electronic and electromechanical manufacturing solutions

*
***

Acuna, Mexico

128,440

Electronic and electromechanical manufacturing solutions

Owned
**

Elk Grove Village, IL

124,300

Corporate headquarters, electronic and electromechanical manufacturing solutions and warehousing

Owned

Chihuahua, Mexico

121,000

Electronic and electromechanical manufacturing solutions

Leased

Union City, CA

117,000

Electronic and electromechanical manufacturing solutions

Leased

Tijuana, Mexico

112,100

Electronic and electromechanical manufacturing solutions

Leased

Elgin, IL

45,000

Design services

Owned

San Diego, CA

30,240

Warehousing and distribution

Leased

22


Del Rio, TX

28,000

Warehousing and distribution

Owned

Del Rio, TX

30,000

Warehousing and distribution

Leased

Bien Hoa City, Vietnam

24,475

Electronic and electromechanical manufacturing solutions

Leased

El Paso, TX

18,200

Warehousing and distribution

Leased

Del Rio, TX

16,000

Warehousing and distribution

Leased

Portsmouth, NH

4,876

Design services

Leased

Taipei, Taiwan

4,685

International procurement office

Leased

Taichung, Taiwan

1,650

Information technology office

Leased

*The Company’s Suzhou, China buildings are owned by the Company and the land is leased from the Chinese government for a 50 year term ending on July 15, 2053.

**A portion of the facility is leased and the Company has an option to purchase it.

***Total square footage includes 70,000 square feet of dormitories.

The Union City and San Diego, California, U.S., Portsmouth, New Hampshire, U.S., Tijuana, Baja California and Chihuahua, Chihuahua Mexico, Bien Hoa City, Dong Nai Province, Vietnam, and Del Rio and El Paso, Texas, U.S. properties are occupied pursuant to leases of the premises. The lease agreement for the El Paso, Texas, U.S. property expires January 2030. The lease agreement for the Del Rio, Texas, U.S. property expires November 2025. The lease agreement for the San Diego, California, U.S. property expires August 2024. The lease agreement for the Union City, California, U.S. property expires June 2026. The lease agreement for the Portsmouth, New Hampshire, U.S. property expires December 2026. TheChihuahua, Chihuahua, Mexico lease expires July 2023.April 2024. The Tijuana, Baja California, Mexico lease expires November 2023. The lease agreement for the Bien Hoa City, Dong Nai Province, Vietnam property expires June 2025. The Company’s manufacturing facilities located in Acuna, Coahuila, Mexico, Del Rio, Texas, U.S., Elgin, Illinois, U.S., and Elk Grove Village, Illinois, U.S., are owned by the Company, except for a portion of each facility in Acuna, Coahuila, Mexico and Del Rio, Texas, U.S., which are leased. The Company has an option to buy the leased portion of the facility in Acuna, Coahuila, Mexico. The properties in Del Rio, Texas, U.S., Elk Grove Village, Illinois, U.S., and Elgin, Illinois, U.S., are financed under separate mortgage loan agreements. The Company

24


leases the IPO office in Taipei, Taiwan to coordinate Far East purchasing activities. The Company leases the information technology office in Taichung, Taiwan. The Company believes its current facilities are adequate to meet its current needs. In addition, the Company believes it can find alternative facilities to meet its needs in the future, if required.

ITEM 3. LEGAL PROCEEDINGS

From time to time the Company is involved in legal proceedings, claims or investigations that are incidental to the conduct of the Company’s business. In future periods, the Company could be subjected to cash cost or non-cash charges to earnings if any of these matters are resolved on unfavorable terms. However, although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including management’s assessment of the merits of any particular claim, the Company does not expect that these legal proceedings or claims will have any material adverse impact on its future consolidated financial position or results of operations. See Note R – Litigation, for more information.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

23


PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

The Company’s common stock is traded on the NASDAQ Capital Market System under the symbol SGMA.

As of July 20, 2022,19, 2023, there were approximately 16070 holders of record of the Company’s common stock, which does not include stockholders whose stock is held through securities position listings. The Company estimates there to be approximately 1,4003,000 beneficial owners of the Company’s common stock.

25


Equity Compensation Plan Information

For information concerning securities authorized for issuance under our equity compensation plans, see Part III, Item 12 of this Annual Report, under the caption “Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters” as well as the Company’s audited financial statements and notes thereto, including Note N – Leases of Item 15(a) Exhibits and Financial Statement Schedules, filed herewith and all such information is incorporated herein by reference.

ITEM 6. RESERVED

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

AND RESULTS OF OPERATIONS

In addition to historical financial information, this discussion of the business of SigmaTron International, Inc. (“SigmaTron”), its wholly-owned subsidiaries Standard Components de Mexico S.A., AbleMex, S.A. de C.V., Digital Appliance Controls de Mexico, S.A. de C.V., Spitfire Controls (Vietnam) Co. Ltd., and Spitfire Controls (Cayman) Co. Ltd., Wagz, Inc., wholly-owned foreign enterprises Wujiang SigmaTron Electronics Co., Ltd. and Wujiang SigmaTron Electronic Technology Co., Ltd. and, its international procurement office SigmaTron International, Inc. Taiwan branch, and Wagz, Inc. (19 percent ownership as of April 1, 2023), (collectively, the “Company”) and other Items in this Annual Report on Form 10-K contain forward-looking statements concerning the Company’s business or results of operations. Words such as “continue,” “anticipate,” “will,” “expect,” “believe,” “plan,” and similar expressions identify forward-looking statements. These forward-looking statements are based on the current expectationsSee “Item 1. Business—Cautionary Note” for a discussion of the Company. Because these forward-looking statements involveand the associated risks and uncertainties, the Company’s plans, actions and actual results could differ materially. Such statements should be evaluated in the context of the direct and indirect risks and uncertainties inherent in the Company’s business including, but not necessarily limited to, the risks inherent in any merger, acquisition or business combination (including the December 2021 acquisition of Wagz,Inc.); the Company’s continued dependence on certain significant customers; the continued market acceptance of products and services offered by the Company and its customers; pricing pressures from the Company’s customers, suppliers and the market; the activities of competitors, some of which may have greater financial or other resources than the Company; the variability of the Company’s operating results; the results of long-lived assets impairment testing; the ability to achieve the expected benefits of acquisitions as well as the expenses of acquisitions; the collection of aged account receivables; the variability of the Company’s customers’ requirements; the impact of inflation on the Company’s operating results; the availability and cost of necessary components and materials; the impact acts of war may have to the supply chain; the ability of the Company and its customers to keep current with technological changeswithin its industries; regulatory compliance, including conflict minerals; the continued availability and sufficiency of the Company’s credit arrangements; the costs of borrowing under the Company’s senior and subordinated credit facilities, including under the rate indices that replaced LIBOR; the ability to meet the Company’s financial and restrictive covenants under its loan agreements; changes in U.S., Mexican, Chinese, Vietnamese or Taiwanese regulations affecting the Company’s business; the turmoil in the global economy and financial markets; the spread of COVID-19 and variants (commonly known as “COVID-19”) which has threatened the Company’s financial stability by causing a disruption to the Company’s global supply chain, caused plant closings or reduced operations thus reducing output at those facilities; the continued availability of scarce raw materials, exacerbated by global supply chain disruptions, necessary for the manufacture of products by the Company; the stability of the U.S., Mexican, Chinese, Vietnamese and Taiwanese economic, labor and political systems and conditions; global business disruption caused by the Russia invasion of Ukraine and related sanctions; currency exchange fluctuations; and the ability of the Company to manage its growth. These and other factors which may affect the Company’s future business and results of operations are identified throughout this Annual Report on Form 10-K, and as risk factors, may be detailed from time to time in the Company’s filings with the Securities and Exchange Commission. These statements speak as of the date of such filings, and the Company undertakes no obligation to update such statements in light of future events or otherwise unless otherwise required by law.uncertainties.

26


Overview

ThePrior to April 1, 2023, the Company operatesoperated in two reportable segments as an independent provider of EMS, and as a provider of products to the Pet Tech market. A majority of the Pet Tech Segment was sold on April 28, 2023, effective as of April 1, 2023, and following such date, the Company operates in one reportable segment, the EMS segment. The EMS segment includes printed circuit board assemblies, electro-mechanical subassemblies and completely assembled (box-build) electronic products. The Pet Tech reportable segment offersoffered electronic products such as the Freedom Smart Dog Collar,Collar™, a wireless, geo-mapped fence, and wellness system, and apparel and accessories.

The Company relies on numerous third-party suppliers for components used in the Company’s production process. Certain of these components are available only from single-sources or a limited number of suppliers. In addition, a customer’s specifications may require the Company to obtain components from a single-source or a small number of suppliers. The loss of any such suppliers could have a material impact on the Company’s results of operations. Further, the Company could operate at a cost disadvantage compared to competitors who have greater direct buying power from suppliers. The Company does not enter into long-term purchase agreements with major or single-source suppliers. The Company believes that short-term purchase orders with its suppliers provides flexibility, given that the Company’s orders are based on the changing needs of its customers.

In connection with the production of assembled products, the Company provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; (6) assistance in obtaining product approval from governmental and other regulatory bodies and (7) compliance

24


reporting. The Company provides these manufacturing services through an international network of facilities located in the United States, Mexico, China, Vietnam and Taiwan.

The Company began its Pet Technology operations after the December 2021 acquisition of Wagz, Inc., discussed below under “RecentSee “Item 1. Business—Recent Developments”. for additional information.

Sales can be a misleading indicator of the Company’s financial performance. Sales levels can vary considerably among customers and products depending on the type of services (turnkey versus consignment) rendered by the Company and the demand by customers. Consignment orders require the Company to perform manufacturing services on components and other materials supplied by a customer, and the Company charges only for its labor, overhead and manufacturing costs, plus a profit. In the case of turnkey orders, the Company provides, in addition to manufacturing services, the components and other materials used in assembly. Turnkey contracts, in general, have a higher dollar volume of sales for each given assembly, owing to inclusion of the cost of components and other materials in net sales and cost of goods sold. Variations in the number of turnkey orders compared to consignment orders can lead to significant fluctuations in the Company’s revenue and gross margin levels. Consignment orders accounted for less than 1% of the Company’s revenues for each of the fiscal years ended April 30, 20222023 and April 30, 2021.2022.

The Company’s international footprint provides our customers with flexibility within the Company to manufacture in China, Mexico, Vietnam or the U.S. We believe this strategy will continue to serve the Company well as its customers continuously evaluate their supply chain strategies.

Factors Affecting Results

Supply Chain Component Shortages and COVID-19.Shortages. The Company’s business, results of operations, and financial condition werecontinue to be adversely affected by the COVID-19 pandemic since the fourth quarter of fiscal year 2020. The impact of COVID continued in fiscal 2022 and is expected to continue to impact the Company in future periods. The Company has experienced some plant closures in fiscal 2022 and has experienced significant supply chain issues due to world-wide component shortages. The COVID-19 pandemic and both public and private measures taken to contain it have negatively affected the Company’s business, results of operations, financial condition, and liquidity, all of which may continue to worsen.Company anticipates continuing supply chain issues in fiscal 2024.

For more informationImpairment of Goodwill and Long-Lived Assets. During the third quarter of fiscal 2023, the Company determined its goodwill and long-lived asset group was fully impaired and an impairment charge of $23,096,771 was recorded. This non-cash charge was recorded to impairment of goodwill and intangible assets on the potential impactunaudited condensed consolidated statements of the COVID-19 pandemic on the Company, see “Item 1A. Risk Factorsoperations. See Note HOur financial condition and results of operations have been impacted and may in the future be adversely affected by the ongoing COVID-19 outbreak.”Intangible Assets, for more information.

27


PPP Loan and CARES Act. During the fourth fiscal quarter of 2020 the Company received a $6,282,973 PPP Loan. The Company received the PPP Loan under the CARES Act. The Company believes it met the requirements for eligibility. During the fourth fiscal quarter of 2020 and continuing inthrough fiscal year 2022, the Company had operational interruptions and incurred significant expenses related to the COVID-19 pandemic at all of its operations.  In some locations the interruptions and expenses were worse than others.

The Company was notified of the forgiveness of the PPP Loan by the SBA on July 9, 2021 and all principal and accrued interest were forgiven. The accounting for the forgiveness is reflected in the Company’s Statement of Operations of Item 15(a) Exhibits and Financial Statement Schedulesas a non-cash gain upon extinguishment of long-term debt.

Recent Developments

OnThe Company began its Pet Technology operations after the December 31, 2021 theacquisition of Wagz, Inc. The Company acquired 100%sold a majority of the stockbusiness on April 28, 2023, effective as of Wagz under the terms of the Agreement and Plan of Merger dated July 19, 2021, as amended by the First Amendment to Agreement and Plan of Merger dated December 7, 2021 (the “Merger Agreement”).April 1, 2023. Wagz has developed and brought to market a high tech pet collar and has multiple other products in development. Wagz is an IoT company which both owns intellectual property and secures recurring revenue through subscriptions for its services.

Prior to During the acquisition,fourth quarter of fiscal year 2023, the Company had an investmentexited its active involvement in the Pet Tech business that is conducted by Wagz through the sale by the Company of a majority stake in Wagz, of $600,000, Convertible Secured Promissory Notes issued by Wagz of $12,000,000 and Secured Promissory Notes issued by Wagz of $1,380,705. Pursuant to the Merger Agreement, prior to the acquisition, the Convertible Secured Promissory Notes converted to 12,000,000 shares of Wagz common stock, resulting in a 25.5% ownership in Wagz. As described in Note F – Acquisition of Item 15(a) Exhibits and Financial Statement Schedules, the Company’s 25.5% equity interest in Wagz common stock was remeasured to fair value of $6,299,765, resulting in a non-cash impairment charge of $6,300,235.

Pursuant to the Merger Agreement, 2,443,870 shares of common stock of the Company were issued in the merger for a value of $25,245,177, of which 1,546,592 shares are allocated to Wagz shareholders (excluding the Company) for a total value of $15,976,295, and 897,278 shares are allocated to the Company and treated as treasury stock for a total value of $9,268,881 and were recorded in the Statements of Changes in Stockholders’ Equity under Issuance of stock for acquisition, respectively. The treasury shares were retiredeffective as of April 30, 2022.1, 2023. See “Item 1. Business—Recent Developments” for additional information.

On July 18, 2022, SigmaTron, Wagz and JPMorgan Chase Bank, N.A. (“Lender”) amended the Credit Agreement dated as of January 29, 2021, by entering into the Amended and Restated Credit Agreement (the “Facility” or “Credit Agreement”). The Facility, as amended, allowsMarch2,2023, the Company to borrow on a revolving basis up to received the lesser of (i) $70,000,000 or (ii) an amount equal to a percentage of the eligible receivable borrowing base plus a percentage of the inventory borrowing base minus any reserves established by Lender. The Facility bears interest at the adjusted REVSOFR30 rate (as defined in the Credit Agreement). The interest rate per annum applicable to the Facility will be the Adjusted Term SOFR Rate (“SOFR”), plusJPMNoticeand the Applicable MarginTCW Notice. The Notices indicated the occurrence of 2.0%. The maturity datecertain events of the Facility was extended to July 18, 2027.

In connection with the closing of the Credit Agreement, Lender and The Private Credit Group of TCW Asset Management Company LLC, as administrative agent (the “Agent”)default under the Term Loan Agreement (as defined below), entered into the Intercreditor Agreement, dated July 18, 2022, and acknowledged by SigmaTron and Wagz (the “ICA”), to set forth and govern the lenders’ respective lien priorities, rights and remedies under theJPM Credit Agreement and the Term Loan Agreement. See Note I – Long-term Debt, for more information.

The Facility is secured by: (a) a first priority security interest in SigmaTron’s and Wagz’s: (i) accounts and inventory (excluding Term Priority Mexican Inventory (as defined in the Intercreditor Agreement (“ICA”)) and certain inventory in transit, (ii) deposit accounts, (iii) proceeds of business interruption insurance that constitute ABL BI Insurance Share (as defined in the ICA), (iv) certain other property, including payment intangibles, instruments, equipment, software and hardware and similar systems, books and records, to the extent related to the foregoing, and (v) all proceeds of the foregoing, in each case, now owned or hereafter acquired (collectively, the “ABL Priority Collateral”); and (b) a second priority security interest in Term Priority Collateral (as defined below) other than (i) real estate and (ii) unless Lender requests a pledge thereof following July 18, 2022, the equity interests of SigmaTron’s foreign subsidiaries.

2825


On

On July 18, 2022, SigmaTron, WagzApril28,2023,theCompanyenteredinto(i) the JPMWaiver withWagzandJPM,aslender, which waived certain events of default under and The Private Credit Groupamended certain terms of theJPMCreditAgreementand(ii) the TCW Asset Management Company LLC, as administrative agent (the “Agent”), Waiver withWagz,theTCWLendersand other Lenders party thereto (collectively, “TCW”) entered into a Credit Agreement (the “Term Loan Agreement”) pursuant toAgent, which TCW made a term loan to the Company in the principal amountwaived certain events of $40,000,000 (the “TCW Term Loan”). The TCW Term Loan bears interest at a rate per annum applicable todefault under and amended certain terms of the Term Loan Facility based on the Adjusted Term SOFR Rate (“SOFR”), plus the Applicable Margin of 7.50% (as defined in the Term Loan Agreement). The Term Loan will have a SOFR floor of 1.00%. The maturity date of the TCW Term Loan is July 18, 2027.Agreement.See Note I – Long-term Debt and “Item 1. Business—Recent Developments”, for more information.

The TCW Term Loan is secured by: (a) a first priority security interestAs described in Note I – Long-term Debt, all property of SigmaTron and Wagz that does not constitute ABL Priority Collateral, which includes: (i) SigmaTron’s and Wagz’sthe real estate other than SigmaTron’s Del Rio, Texas, warehouses, (ii) SigmaTron’s and Wagz’sCompany machinery, equipmentexiteditsactiveinvolvementinthePet Techbusinessthatisconductedby Wagzthrough thesalebytheCompanyofamajoritystakein Wagz,effective as of April1,2023. Inconnectionwiththe Waivers and fixtures (but excluding ABL Priority Equipment (as defined insuch sale, the ICA)), (iii)Lender Parties agreed to release Wagz and its property from the Term Priority Mexican Inventory (as defined inlien of the ICA), (iv) SigmaTron’s stock in its direct and indirect subsidiaries, (v) SigmaTron’s and Wagz’s general intangibles (excluding any that constitute ABL Priority Collateral), goodwill and intellectual property, (vi)Lender Parties under the proceeds of business interruption insurance that constitute Term BI Insurance Share (as defined in the ICA), (vii) tax refunds, and (viii) all proceeds thereof, in each case, now owned or hereafter acquired (collectively, the “Term Priority Collateral”); and (b) a second priority security interest in all collateral that constitutes ABL Priority Collateral. Also, SigmaTron’s three Mexican subsidiaries pledged all of their assets as security for the TCW Term loan.Credit Agreements.

Critical Accounting Policies:Estimates:

Management Estimates and Uncertainties The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates made in preparing the consolidated financial statements include depreciation and amortization periods, the allowance for doubtful accounts, excess and obsolete reserves for inventory, deferred income, deferred taxes, uncertain tax positions, valuation allowance for deferred taxes and valuation of goodwill and long-lived assets. Actual results could materially differ from these estimates.

The potential impact of future disruptions and continued economic uncertainty over public health crises, including COVID-19 includingand variants, and the global supply chain may have a significant adverse impact on the timing of delivery of customer orders and the levels of future customer orders. It is possible that these potential adverse impacts may result in the recognition of material impairments of the Company’s long-lived assets or other related charges in future periods.

Revenue Recognition – The Company recognizes revenue when control of the promised goods or services are transferred to its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company’s primary performance obligation to its customers is the production of finished goods electronic assembly products pursuant to purchase orders. The Company has concluded that control of the products it sells and transfers to its customers and an enforceable right to receive payment is customarily established at the point in time when the finished goods are shipped to its customers, or in some cases delivered pursuant to the specified shipping terms of each customer arrangement. With respect to consignment arrangements, control transfers and revenue is recognized at the point in time when the goods are shipped to the customer from the consignment location or when delivered to the customer (pursuant to agreed upon shipping terms). In those limited instances where finished goods delivered to the customer location are stored in a segregated area which are not controlled by the customer (title transfer, etc.) until they are pulled from the segregated area and consumed by the Company’s customer, revenue is recognized upon consumption. For tooling services, the Company’s performance obligation is satisfied at the point in time when the customer takes possessionapproves the first article of dies or molds. For engineering, design, and testing services, the Company’s performance obligations are satisfied over time as the respective services are rendered as its customers simultaneously derive value from the Company’s performance. From the time that a customer purchase order is received and contract is established, the Company’s performance obligations are typically

29


fulfilled within a few weeks. The Company does not have any performance obligations that require more than one year to fulfill.

Each customer purchase order sets forth the transaction price for the products and services purchased under that arrangement. The Company evaluates the credit worthiness of its customers and exercises judgment to recognize revenue based upon the amount the Company expects to be paid for each sales transaction it enters into with its customers. Some customer arrangements include variable consideration, such as volume rebates, some of which depend upon the Company’s customers meeting specified performance criteria, such as a purchasing level over a period of time. The Company exercises judgment to estimate the most likely amount of variable consideration at each reporting date.

Inventories – Inventories are valued at cost. Cost is determined by an average cost method and the Company allocates labor and overhead to work-in-process and finished goods. In the event of an inventory write-down, the Company records expense to state the inventory at lower of cost or net realizable value. The

26


Company establishes inventory reserves for valuation shrinkage, and excess and obsolete inventory.inventory for which the customer is not obligated. The Company records provisions for inventory shrinkage based on historical experience to account for unmeasured usage or loss. Of the Company’s raw materials inventory, a substantial portion has been purchased to fulfill committed future orders or for which the Company is contractually entitled to recover its costs from its customers. For the remaining raw materials inventory, a provision for excess and obsolete inventories is recorded for the difference between the cost of inventory and its estimated realizable value based on assumptions about future product demand and market conditions. Upon a subsequent sale or disposal of the impaired inventory, the corresponding reserve is relieved to ensure the cost basis of the inventory reflects any reductions. Actual results differing from these estimates could significantly affect the Company’s inventories and cost of products sold as the inventory is sold or otherwise relieved.

Intangible Assets – Intangible assets are comprised of finite life intangible assets including customer relationships, trade names and patents. The fair value recorded as of April 30, 20222023 is based on significant inputs that are not observable in the market and thus represents a fair value measurement categorized within Level 3 of the fair value hierarchy. The fair value of the acquired trade names and patents was determined using the relief from royalty method, which is a risk-adjusted discounted cash flow approach. The relief from royalty method values an intangible asset by estimating the royalties saved through ownership of the asset. The relief from royalty method requires identifying the future revenue that would be generated by the intangible asset, multiplying it by a royalty rate deemed to be avoided through ownership of the asset and discounting the projected royalty savings amounts back to the acquisition date using the internal rate of return.

Impairment of Long-Lived Assets – The Company reviews long-lived assets, including amortizable intangible assets, for impairment. Property, machinery and equipment and finite life intangible assets are reviewed whenever events or changes in circumstances occur that indicate possible impairment. If events or changes in circumstances occur that indicate possible impairment, the Company first performs an impairment review based on an undiscounted cash flow analysis at the lowest level at which cash flows of the long-lived assets are largely independent of other groups of its assets and liabilities. This analysis requires management judgment with respect to changes in technology, the continued success of product lines, and future volume, revenue and expense growth rates. If the carrying value exceeds the undiscounted cash flows, the Company records an impairment, if any, for the difference between the estimated fair value of the asset group and its carrying value. The Company further conducts annual reviews for idle and underutilized equipment, and reviews business plans for possible impairment.

During the third quarter of fiscal 2023, the Company revised the financial outlook for the Pet Tech segment, resulting in lower projected sales and net income for future periods. The Company assessed the overall market acceptance of the current Wagz product offerings after the holiday season and determined that this constituted a triggering event for the Company’s long-lived asset groups, primarily consisting of patents, trade names and certain fixed assets. The Company reviewed the undiscounted future cash flows for the identified long-lived asset group, and the results of the analysis indicated the carrying amount for fiscal years 2022the long-lived group was not expected to be recovered.

The fair value of the identified intangible assets was estimated using the relief from royalty method, which is a risk-adjusted discounted cash flow approach. The relief from royalty method values an intangible asset by estimating the royalties saved through ownership of the asset. The relief from royalty method requires identifying the future revenue that would be generated by the intangible asset, multiplying it by a royalty rate deemed to be avoided through ownership of the asset and 2021 did not indicate that anydiscounting the projected royalty savings amounts back to the acquisition date using the internal rate of return.

The Company determined the fair value of the long-lived asset group was lower than its other long-livedcarrying value and recorded an intangible asset impairment charge of $9,527,773 during the three months ended January 31, 2023. This non-cash charge was recorded to impairment of goodwill and intangible assets were impaired.on the unaudited condensed consolidated statements of operations. As of April 30, 2023 this non-cash charge has been reported under discontinued operations. See Note H – Intangible Assets and Note P – Discontinued Operations, for more information.

Impairment of Goodwill Goodwill represents the cost of business acquisitions in excess of the fair value of identifiable net tangible and intangible assets acquired. On an annual basis, or more frequently if

27


triggering events occur, the Company compares the estimated fair value of its reporting units to the carrying value of each reporting unit to determine if a potential goodwill impairment exists. If the fair value of a reporting unit is less than its carrying value, a goodwill impairment loss is recorded for the difference. In calculating the fair value of the reporting units or specific intangible assets, management relies on a number of factors, including business plans, economic projections, anticipated future cash flows, comparable transactions and other market data. There are inherent uncertainties related to these factors and management's judgment in applying them in the impairment tests of goodwill and other intangible assets.

The Company observed during the third quarter of fiscal 2023, the overall lack of market acceptance of the current Wagz product offerings during the holiday season and determined this constituted a triggering event. Accordingly, the Company performed a quantitative goodwill impairment test and estimated the fair value of the Pet Tech segment based on a combination of an income approach (estimates of future discounted cash flows), a market approach (market multiples for similar companies) and a cost approach. Significant unobservable inputs and assumptions inherent in the valuation methodologies, which represented Level 3 inputs, under the fair value hierarchy, were employed and included, but were not limited to, prospective financial information, terminal value assumptions, discount rates, and multiples from comparable publicly traded companies in the Pet Tech industry.

30The cost approach is based on upon the concept of replacement cost as an indicator of value. Stated another way, this approach is premised on the assumption that a prudent investor would pay no more for an asset than the amount for which the asset could be replaced. The cost approach establishes value based on the cost reproducing or replacing the property, less depreciation from physical deterioration and functional obsolescence, if present and measurable.


During the third quarter of fiscal 2023, the Company determined its goodwill was fully impaired as the fair value was lower than the carrying value and recorded an impairment charge of $13,320,534. This non-cash charge was recorded to impairment of goodwill and intangible assets as of January 31, 2023.

Income TaxThe Company’s income tax expense, deferred tax assets and liabilities and reserves for unrecognized tax benefits reflect management’s best assessment of estimated future taxes to be paid. The Company is subject to income taxes in both the U.S. and several foreign jurisdictions. Significant judgments and estimates by management are required in determining the consolidated income tax expense assessment.

Deferred income tax assets and liabilities are determined based on differences between financial reporting and tax basis of assets and liabilities, and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. In evaluating the Company’s ability to recover its deferred tax assets within the jurisdiction from which they arise, the Company considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial operations. In projecting future taxable income, the Company begins with historical results and changes in accounting policies, and incorporates assumptions including the amount of future state, federal and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment and estimates by management about the forecasts of future taxable income and are consistent with the plans and estimates the Company uses to manage the underlying businesses. In evaluating the objective evidence that historical results provide, the Company considers three years of cumulative operating income and/or loss. Valuation allowances are established when necessary to reduce deferred income tax assets to an amount more likely than not to be realized. SigmaTron and Wagz willfiled or are expected to file U.S. tax returns on a consolidated basis for periods ending after the merger.during which Wagz was wholly owned. Therefore, a valuation allowance was previously established on the group’s U.S. deferred tax assets during fiscal year 2022. After the sale of Wagz, SigmaTron expects to file on a standalone basis and utilize its U.S. deferred tax assets with the exception of the capital loss on sale and certain foreign tax credits. The Company has established a valuation allowance of $4,146,208$7,260,628 on its federalU.S. capital loss and state NOLforeign tax credit carryforwards and other U.S. deferred tax assetsa valuation allowance of $442,889 on certain foreign loss carryforwards as of April 30, 2022.2023.

28


New Accounting Standards:

See Note B – Summary of Significant Accounting Policies of Item 15(a) Exhibits and Financial Statement Schedules.

31


Results of Operations:

FISCAL YEAR ENDED APRIL 30, 20222023 COMPARED

TO FISCAL YEAR ENDED APRIL 30, 20212022

The following table sets forth the percentage relationships of gross profit and expense items to net sales for the years indicated:

 

Fiscal Years Ended

Fiscal Years Ended

April 30,

April 30,

2022

2021

2023

2022

Net sales

$

378,866,424 

$

277,718,672 

$

414,435,845

$

378,316,495

Costs of products sold

334,434,553 

252,766,475 

362,982,248

333,925,226

As a percent of net sales

87.6%

88.3%

Gross profit

44,431,871 

24,952,197 

51,453,597

44,391,269

As a percent of net sales

12.4%

11.7%

Selling and administrative expenses

28,902,071 

21,562,413 

26,495,951

25,981,794

Impairment of notes receivable
and investment

6,300,235 

-

Operating income

9,229,565 

3,389,784 

As a percent of net sales

6.4%

6.9%

Operating income from continuing operations

24,957,646

18,409,475

Gain on extinguishment of long-term debt

(6,282,973)

-

-

6,282,973

Other (income) expense

(153,614)

81,000 

Other income

632,223

153,614

Interest expense, net

1,500,294 

1,210,024 

(8,403,904)

(1,500,140)

Income before income taxes

14,165,858 

2,179,760 

Income before income taxes from continuing operations

17,185,965

23,345,922

Income tax expense

4,301,690 

557,741 

(2,991,541)

(4,980,003)

Net income

$

9,864,168 

$

1,622,019 

Net income from continuing operations

$

14,194,424

$

18,365,919

Discontinued operations:

Loss before taxes from discontinued operations

$

(36,629,902)

(9,180,064)

Tax benefit for discontinued operations

1,860,093

678,313

Net loss from discontinued operations

$

(34,769,809)

$

(8,501,751)

Net (loss) income

$

(20,575,385)

$

9,864,168

Net sales

Net sales increased $101,147,752,$36,119,350, or 36.4%,9.5% to $378,866,424$414,435,845 in fiscal 2022,2023, compared to $277,718,672$378,316,495 in fiscal 2021. The Company’s sales increased in fiscal year 2022 in consumer electronics, industrial electronics and medical/life science compared to the prior year. The overall increase in net sales was primarily due to increasing demand from existing and new customers. In addition, net2022. Net sales were higher in fiscal 2022, due to higher sales volume and certain customer price increases implemented as a result of increased raw material and other operating costs that occurred during thefiscal 2023, as compared to last fiscal year. The Federal Reserve has raised interest rates several times during fiscal 2023, which has negatively affected customer demand in the consumer electronics markets, but has not had the same effect in the industrial electronics and medical/life science markets. As a result, the Company’s sales increased in fiscal 2023 in

29


industrial electronics and medical/life science compared to the prior fiscal year. The increase in sales was accompanied by a decrease in sales in consumer electronics.

Costs of products sold

Cost of products sold increased $81,668,078,$29,057,022, or 32.3%8.7%, to $334,434,553$362,982,248 (87.6% of net sales) in fiscal 2023, compared to $333,925,226 (88.3% of net sales) in the prior fiscal 2022, compared to $252,766,475 (91.0%year. The decrease in cost of net sales) in fiscal 2021. The increase wasproducts sold as a percentage of sales is primarily due to favorable sales mix, partially offset with higher material, logistics and other operating costs as a result of higher sales volumes and the impact of global supply chain disruptions that caused factory inefficiencies. Labor costs and other manufacturing costs were higher in fiscal 2023, compared to fiscal 2022, as fiscal 2021,primarily due to inflationary pressurespressures. The Company anticipates continuing supply chain issues in fiscal 2024.

Gross profit margin

Gross profit margin was 12.4% of net sales, in fiscal year 2023 compared to 11.7% of net sales in fiscal year 20222022. The increase in gross margins as a percentage of sales was primarily due to favorable sales mix, notwithstanding higher material, labor and other manufacturing costs during fiscal 2023, compared to 9.0%fiscal 2022.

Selling and administrative expenses

Selling and administrative expenses increased $514,157, or 2.0% to $26,495,951 (6.4% of net salessales) in fiscal 2021.2023, compared to $25,981,794 (6.9% of net sales) in the prior fiscal year. The increase in selling and administrative expenses primarily relates to inflationary pressures in fiscal 2023, compared to fiscal 2022.

Gain on the extinguishment of long-term debt

On April 23, 2020, the Company received proceeds of $6,282,973 from a PPP Loan under the CARES Act, which it used to retain current U.S. employees, maintain payroll and make lease and utility payments. The PPP Loan was forgiven on July 9, 2021 and was recorded as a gain on the extinguishment of debt in fiscal 2022.

Other Income

Other income increased to $632,223 in fiscal 2023, compared to $153,614 in fiscal 2022. The increase primarily relates to insurance proceeds received related to fire damage in one of our manufacturing locations.

Interest expense, net

Interest expense, net, increased to $8,403,904 in fiscal 2023 compared to $1,500,140 in fiscal 2022. The increase primarily relates to higher average debt levels as well as increased interest rates during fiscal 2023.

Income tax expense

Income tax expense decreased $1,988,462 to $2,991,541 in fiscal 2023, compared to $4,980,003 in fiscal 2022. The effective tax rate decreased to 17.4% in fiscal 2023, compared to 21.3% in fiscal 2022, primarily due to a decrease in the valuation allowance in the current year. The decrease in income tax expense in fiscal 2023 compared to fiscal 2022 is primarily due to decreased taxable income recognized in the current fiscal year compared to the previous fiscal year.

Net income from continuing operations

Net income from continuing operations decreased $4,171,495, to a net income of $14,194,424 in fiscal 2023, compared to a net income of $18,365,919 in fiscal 2022. Net income in fiscal 2022 included the one-time extinguishment of the PPP Loan in the amount of $6,282,973 that was recorded as a gain on the extinguishment of debt.

30


Net loss from discontinued operations

Net loss from discontinued operations in fiscal 2023 from the Pet Tech Segment of $34,769,809 which includes an impairment of goodwill and long-lived assets of $23,096,771 and losses on the sale of a business of $3,742,709. The fiscal 2023 discontinued losses include a tax benefit of $1,860,093. The net loss from discontinued operations for fiscal 2022 consisted of operational losses from the Pet Tech Segment of $2,879,829 and an impairment of notes receivable and investment charge of $6,300,235. The fiscal 2022 discontinued losses include a tax benefit of $678,313.

EMS Segment

The following table sets forth the percentage relationships of gross profit and expense items to net sales for the years indicated:

Fiscal Years Ended

April 30,

2023

2022

Net sales

$

414,435,845

$

378,316,495

Costs of products sold

362,982,248

333,925,226

As a percent of net sales

87.6%

88.3%

Gross profit

51,453,597

44,391,269

As a percent of net sales

12.4%

11.7%

Selling and administrative expenses

26,495,951

25,981,794

As a percent of net sales

6.4%

6.9%

Operating income

$

24,957,646

$

18,409,475

Net sales

Net sales increased $36,119,350, or 9.5%, to $414,435,845 in fiscal 2023, compared to $378,316,495 in fiscal 2022. Net sales were higher primarily due to higher sales volume and certain customer price increases implemented as a result of increased raw material and other operating costs that occurred in fiscal 2023, compared to fiscal 2022. The Federal Reserve has raised interest rates several times during the fiscal year, which has negatively affected customer demand in the consumer electronics markets, but has not had the same effect in the industrial electronics and medical/life science markets. As a result, the Company’s sales increased in fiscal 2023 in industrial electronics and medical/life science compared to the prior fiscal year. The increase in sales was accompanied by a decrease in sales in consumer electronics.

Cost of products sold

Cost of products sold increased $29,057,022, or 8.7%, to $362,982,248 (87.6% of net sales) in fiscal 2023, compared to $333,925,226 (88.3% of net sales) in the prior fiscal year. The decrease in cost of products sold as a percentage of sales is primarily due to favorable sales mix, partially offset with higher material, logistics and other operating costs associated withas a result of higher sales volumes and the impact of global supply chain disruptions that caused factory inefficiencies. Labor costs and other manufacturing costs were higher in fiscal 2023, primarily due to inflationary pressures. The Company anticipates continuing supply chain issues in fiscal 2024.

Gross profit

Gross profit margin was 12.4% of net sales in fiscal 2023, compared to 11.7% of net sales in the prior fiscal year. The increase in gross margins as a percentage of sales was primarily due to favorable sales mix, partially offset with higher material, labor and other manufacturing costs in fiscal 2023, compared to fiscal 2022.

3231


Selling and administrative expenses

Selling and administrative expenses increased $7,339,658,$514,157, or 34.0%2.0%, to $28,902,071 (7.6%$26,495,951 (6.4% of net sales) in fiscal 2022,2023, compared to $21,562,413 (7.8%$25,981,794 (6.9% of net sales) in the prior fiscal year. Selling and administrative expenses increased in fiscal 2023 primarily due to increased wages and professional fees, partially offset by lower bonus expense, compared to fiscal 2022.

Operating income

Operating income increased $6,548,171, or 35.6%, to $24,957,646 (6.0% of net sales) in fiscal 2021. Of2023, compared to $18,409,475 (4.9% of net sales) in the $7,339,658prior fiscal year. The increase $2,861,211 relateswas primarily due to higher sales volume and favorable sales mix, notwithstanding higher material, logistics and other operating costs.

Pet Technology Segment

The Company sold a majority of the Wagz business,stock on April 28, 2023, effective as of April 1, 2023. The Company still owns 19 percent of Wagz common stock as a passive investment as of April 30, 2023. The activity for fiscal 2023 and fiscal 2022 have been classified as discontinued operations in the Consolidated Statements of Operations.

Wagz was acquired on December 31, 2021, and therefore were not includedonly reflects financial results for fiscal 2022 after the transaction date.

The following table sets forth the percentage relationships of gross profit and expense items to net sales for the years indicated:

Fiscal Years Ended

April 30,

2023

2022

Net sales

$

1,598,929

$

549,929

Costs of products sold

1,732,352

509,327

As a percent of net sales

108.3%

92.6%

Gross profit

(133,423)

40,602

As a percent of net sales

-(8.3)%

7.4%

Selling and administrative expenses

9,656,999

2,920,277

Impairment of notes receivable
and investment

-

6,300,235

Impairment of goodwill and other long-lived assets

23,096,771

-

Operating loss

$

(32,887,193)

$

(9,179,910)

Net sales

Net sales increased $1,049,000 to $1,598,929 in fiscal 2023, compared to $549,929 in fiscal 2022. Wagz was purchased on December 31, 2021 operations.and sales for fiscal 2022 only reflect four months of activity. Sales for the period are primarily comprised of hardware and accessories, as well as recurring subscription revenue. The Pet Tech segment experienced supply chain issues, causing certain inventory shortages during fiscal 2023, which negatively affected hardware sales. In addition, sellingthe products struggled to gain market acceptance during the fiscal year.

32


Cost of products sold

Cost of products sold increased $1,223,025 to $1,732,352 (108.3% of net sales) in fiscal 2023, compared to $509,327 (92.6% of net sales) in the prior fiscal year. Cost of products sold as a percentage of sales increased during the current period primarily due to material cost increases and lower sales volumes.

Gross profit margin

Gross profit margin was –(8.3)% of net sales in fiscal 2023, compared to a gross profit margin of 7.4% in the prior fiscal year. Gross profit margins were negative in the current period due to material cost increases and lower sales volumes.

Selling and administrative expenses

Selling and administrative expenses increased $6,736,722, to $9,656,999 in fiscal 2022 due2023, compared to transaction$2,920,277 in the prior fiscal year. Selling and administrative costs were primarily comprised of research and development costs for new products that were expected to launch in fiscal 2024, selling and marketing expenses, for the Wagz acquisition, higher Company performance bonus expenseas well as general and higher costs due to inflationary pressures.administrative expenses.

Impairment of notes receivable and investment

Prior to the acquisition on December 31, 2021, the Company had an investment in Wagz of $600,000, Convertible Secured Promissory Notes issued by Wagz of $12,000,000 and Secured Promissory Notes issued by Wagz of $1,380,705. Pursuant to the Merger Agreement, prior to the acquisition, the Convertible Secured Promissory Notes converted to 12,000,000 shares of Wagz common stock, resulting in a 25.5% ownership in Wagz. As described in Note F – Acquisition of Item 15(a) Exhibits and Financial Statement Schedules,Disposition, the Company’s 25.5% equity interest in Wagz common stock was remeasured to fair value of $6,299,765, resulting in a non-cash impairment charge of $6,300,235.

Interest expense, net

Interest expense, net, increased slightly to $1,500,294 in fiscal 2022 compared to $1,291,024 in fiscal year 2021. The increase relates to higher average borrowings, as well as increased interest rates$6,300,235 in fiscal 2022.

Income tax expenseImpairment of goodwill and other long-lived assets

Income tax expense increased $3,743,949In connection with the preparation and review of the financial statements for the quarter ended January 31, 2023, the Company revised the financial projections for its Pet Tech segment. The revised projections resulted in a triggering event for the Company’s goodwill and long-lived asset groups consisting of patents and trade names. As a result, the Company concluded that the carrying amount for goodwill and the long-lived asset groups was impaired and not expected to $4,301,690be recovered. Accordingly, a non-cash pre-tax goodwill impairment charge of $13,320,534 and a non-cash intangible assets impairment charge of $9,527,773, was recorded for the Company’s Pet Tech segment in fiscal 2022, compared2023. In addition, Pet Tech fixed assets of $248,464 were written off due to $557,741 in fiscal 2021. Thethe sale of Wagz effective tax rate increased to 30.4% in fiscal 2022, compared to 26.6% in fiscal 2021.April 1, 2023.

Net incomeOperating loss

Net incomeOperating loss increased $8,323,149, or 540.1%,$23,707,283, to $9,864,168$32,887,193 in fiscal 2022,2023, compared to $1,541,019$9,179,910 in fiscal 2021. Higher gross profit margins were partially offset with expenses related2022. The increased loss was primarily due to the Wagz acquisition, higher operatingimpairment of goodwill and other long-lived assets, lower than expected sales and increased selling and administrative expenses and higher income tax expense.in fiscal 2023.

EMS SegmentLiquidity and Capital Resources:

The following table sets forth the percentage relationships of expense itemsCompany’s liquidity requirements are primarily to net sales for the years indicated:

Fiscal Years Ended

April 30,

2022

2021

Net sales

$

378,303,749 

$

277,718,672 

Costs of products sold

334,081,928 

252,766,475 

Gross profit

44,221,821 

24,952,197 

Selling and administrative expenses

26,040,860 

21,562,413 

Operating income

$

18,180,961 

$

3,389,784 

Net sales

Net sales increased $100,585,077, or 36.2%,fund its business operations, including capital expenditures and working capital requirements, as well as to $378,303,749 in fiscal 2022, compared to $277,718,672 in fiscal 2021.fund debt service requirements. The Company’s sales increased in fiscal year 2022 in consumer electronics, industrial electronicsprimary sources of liquidity are cash flows from operations and borrowings under the revolving Facility credit agreement. The Company believes its liquidity position will be sufficient to fund its existing operations and current commitments for at least the next twelve months. However, if economic conditions remain impacted for longer than the Company expects due to inflationary pressure, supply chain disruptions, public health crises, including COVID-19 and variants, or other geopolitical risks, the Company’s liquidity position could be severely impacted. Due to availability being less than 10% of the Revolving Commitment,the Facility (as defined below) has been classified as a current liability on the Consolidated Balance Sheet as of April 30, 2023.

33


medical/life science compared to the prior year. The overall increase in net sales was primarily due to increasing demand from existing and new customers. In addition, net sales were higher in fiscal 2022, due to certain customer price increases implemented as a result of increased raw material and other operating costs that occurred during the fiscal year.

Cost of products sold

Cost of products sold increased $81,315,453, or 32.2%, to $334,081,928 (88.3% of net sales) in fiscal 2022, compared to $252,766,475 (91.0% of net sales) in fiscal 2021. The increase was primarily due to higher material, logistics and other operating costs as a result of higher sales volumes and the impact of global supply chain disruptions that caused factory inefficiencies. Labor costs and other manufacturing costs were higher in fiscal 2022 as fiscal 2021, due to inflationary pressures.

Gross profit

Gross profit margin was 11.7% of net sales in fiscal 2022, compared to 9.0% of net sales in fiscal 2021. The increase was due to higher customer price increases, partially offset with higher material, logistics and other operating costs associated with global supply chain disruptions that caused factory inefficiencies.

Selling and administrative expenses

Selling and administrative expenses increased $4,478,447, or 20.8%, to $26,040,860 (6.9% of net sales) in fiscal 2022, compared to $21,562,413 (7.8% of net sales) in fiscal 2021. Selling and administrative expenses increased in fiscal 2022 due to higher Company performance bonus expense and higher costs due to inflationary pressures.

Operating income

Operating income increased $14,791,177, or 436.3%, to $18,180,961 (4.8% of net sales) in fiscal 2022, compared to $3,389,784 (1.2% of net sales) in fiscal 2021. The increase was primarily due to higher sales, partially offset with higher material, logistics and other operating costs.

Pet Technology Segment

Wagz was acquired on December 31, 2021, and therefore does not have comparable financial results for fiscal 2021 and only reflects financial results for fiscal 2022 after the transaction date.

The following table sets forth the percentage relationships of expense items to net sales for the years indicated:

Fiscal Years Ended

April 30,

2022

2021

Net sales

$

562,675 

$

-

Costs of products sold

352,625 

-

Gross profit

210,050 

-

Selling and administrative expenses

2,861,211 

-

Impairment of notes receivable
and investment

6,300,235 

-

Operating loss

$

(8,951,396)

$

-

34


Net sales

Net sales were $562,675 in fiscal 2022. Sales for the period are primarily comprised of hardware and accessories, as well as recurring subscription revenue.

Cost of products sold

Cost of products was $352,625 (62.7% of net sales) in fiscal 2022.

Gross profit margin

Gross profit margin was $210,050 (37.3% of net sales) in fiscal 2022.‌ 

Selling and administrative expenses

Selling and administrative expenses were $2,861,211 in fiscal 2022.‌ Selling and administrative cost are primarily comprised of research and development costs, selling and marketing expenses, as well as general and administrative expenses.

Impairment of notes receivable and investment

Prior to the acquisition, the Company had an investment in Wagz of $600,000, Convertible Secured Promissory Notes issued by Wagz of $12,000,000 and Secured Promissory Notes issued by Wagz of $1,380,705. Pursuant to the Merger Agreement, prior to the acquisition, the Convertible Secured Promissory Notes converted to 12,000,000 shares of Wagz common stock, resulting in a 25.5% ownership in Wagz. As described in Note F – Acquisition of Item 15(a) Exhibits and Financial Statement Schedules, the Company’s 25.5% equity interest in Wagz common stock was remeasured to fair value of $6,299,765, resulting in a non-cash impairment charge of $6,300,235.

Operating loss

Operating loss for fiscal 2022 was $8,951,396.

Liquidity and Capital Resources:

Operating Activities

Cash flow used in operating activities was $20,227,399$13,256,804 for the fiscal year ended April 30, 2022,2023, compared to cash flow provided byused in operating activities of $8,098,946$14,381,723 for the prior fiscal year. Cash flow used in operating activities was primarily the result of an increase in accounts receivable in the amount of $5,328,740, a decrease in accounts payable in the amount of $20,702,026 and a decrease in deferred revenue in the amount of $3,179,709. Cash flow from operating activities was offset by a decrease in prepaid expenses and other assets in the amount of $5,954,202. The increase in accounts receivable is the result of an increase in net sales. The decrease in accounts payable is the result of the timing of vendor payments. The decrease in prepaid expenses and other assets is the result of a decrease in right-of-use assets.

Cash flow used in operating activities was $14,381,723 for the fiscal year ended April 30, 2022. Cash flow used in operating activities was primarily the result of an increase in both inventory and accounts receivable in the amount of $68,314,626$68,297,962 and $12,188,024,$12,288,539, respectively. Cash flow from operating activities was offset by an increase in accounts payable and deferred revenue in the amount of $32,824,474$33,299,432 and $10,487,828, respectively. The increase in inventory iswas the result of an increase in inventory purchases to satisfy customer orders. Further, capacity issues in the component industry made it difficult to obtain some components to complete assemblies for shipping. The increase in accounts payable iswas the result of more favorable payment terms with vendors and increased inventory purchases.

Cash flow provided by operating activities was $8,098,946 for the fiscal year ended April 30, 2021. Cash flow provided by operating activities was primarily the result of net income, and an increase in both accounts payable and accrued expenses and wages in the amount of $6,885,498 and $2,436,532, respectively. Cash flow from operating activities was offset by an increase in both inventory and prepaid expenses and other assets in the amount of $12,072,227 and $6,911,655, respectively. The increase in accounts payable was the result of more favorable payment terms with vendors. The increase in inventory was the result of an increase in purchases to satisfy customer orders. Further, capacity issues in the component industry made it difficult to obtain some components to complete assemblies for shipping.

35


Investing Activities

In fiscal year 2022,2023, cash used in investing activities was $9,703,258.$5,179,247. During fiscal year 20222023, the Company purchased $4,749,532$4,334,169 in machinery and equipment to be used in the ordinary course of business. The Company has received forecasts from current customers for increased business that would require additional investment in capital equipment and facilities. The Company anticipates purchases will be funded by lease transactions. However, there is no assurance that such increased business will be obtained or that the Company will be able to obtain funding for leases at acceptable terms, if at all, in the future. During fiscal year 2022the month of April 2023, the Company made advances of $5,512,000$900,000 to Wagz.Wagz as agreed upon under the SPA. On December 31, 2021,April 28, 2023, the sale of the majority interest in Wagz pursuant to the SPA was consummated effective as of April 1, 2023, and as a result, as of the closing, the Company consummatedholds a minority 19% ownership of the transactions contemplated byshares and Buyer holds a majority 81% of the Merger Agreement. Please refer to Note F – Acquisition of Item 15(a) Exhibits and Financial Statement Schedules, for more information.shares.

In fiscal year 2021,2022, cash used in investing activities was $10,228,816.$10,252,100. The Company purchased $4,747,316$4,740,100 in machinery and equipment used in the ordinary course of business. The Company purchases were funded by the bank line of credit and lease transactions. The Company made advances of $5,481,500$5,512,000 to Wagz. In June 2020, the Company announced a proposed business combination with Wagz. The advances were made in conjunction with the proposed business combination.

Financing Activities

Cash provided by financing activities was $24,155,387 for the fiscal year ended April 30, 2023. Cash provided by financing activities was primarily the result of net borrowings under the line of credit and term loan agreement.

Cash provided by financing activities was $29,476,071 for the fiscal year ended April 30, 2022. Cash used inprovided by financing activities was primarily the result of net borrowings under the line of credit.

Liquidity from Discontinued Operations

During fiscal 2023 cash used in discontinued operations from operating activities was $7,264,377, primarily related to Pet Tech Segment operations and transaction related expenses associated with the sale of the Wagz business. During fiscal 2022, cash used in operating activities of $5,843,456 relates to activity from the Pet Tech Segment. Cash used in financinginvesting activities for fiscal 2023 and fiscal 2022 was $1,140,346$134,419 and $9,432, respectively, primarily for the fiscal year ended April 30, 2021. Cash used in financing activities was primarily the result of net payments under finance leases and sale leaseback agreements.capital expenditures.

34


Financing Summary

Debt and finance lease obligations consisted of the following at April 30, 20222023 and April 30, 2021:2022:

2022

2021

2023

2022

Debt:

Notes Payable - Banks

$

56,830,377

$

32,137,919

$

90,968,000

$

56,830,377

Notes Payable - Buildings

6,459,340

6,937,763

417,143

6,459,340

Notes Payable - Equipment

4,202,292

3,923,639

3,524,115

4,202,292

Unamortized deferred financing costs

(401,040)

(353,438)

(1,608,558)

(401,040)

Total debt

67,090,969

42,645,883

93,300,700

67,090,969

Less current maturities

6,991,567

7,862,058

Less current maturities*

52,761,520

6,991,567

Long-term debt

$

60,099,402

$

34,783,825

$

40,539,180

$

60,099,402

Finance lease obligations

$

4,215,810

$

2,636,134

$

4,119,437

$

4,215,810

Less current maturities

1,410,675

1,455,638

1,523,259

1,410,675

Total finance lease obligations, less current portion

$

2,805,135

$

1,180,496

$

2,596,178

$

2,805,135

* Due to availability being less than 10% of the Revolving Commitment,the Facility (as defined below) has been classified as a current liability on the Consolidated Balance Sheet as of April 30, 2023.

Notes Payable – Banks

Prior to January 29, 2021, the Company had a senior secured credit facility with U.S. Bank National Association (“U.S. Bank”).  The revolving credit facility allowed the Company to borrow up to the lesser of (i) $45,000,000 (theSecured lenders“Revolving Line Cap”) less reserves or (ii) the Borrowing Base, but no more than 80% of the Company’s Revolving Line Cap. Prior to its payoff and termination, the U.S. Bank senior secured credit

36


facility was due to expire on March 31, 2022. On January 29, 2021, the Company paid the balance outstanding under the senior secured credit facility in the amount of $25,574,733. The unamortized deferred financing costs of $158,476 were expensed in fiscal year 2021 upon extinguishment of the debt.

On January 29, 2021, the Company entered into a Credit Agreement (the “Agreement”“JPM Agreement”) with JPMorgan Chase Bank, N.A. (“Lender”), pursuant to which Lender has agreed to provideprovided the Company with a secured credit facility maturing on January 29,2026,consisting of which (a) up to $50,000,000 is available on a revolving loan basis,facility and (b) an aggregate of $6,500,000 was borrowed pursuant to twoa term loans (theloan facility (collectively, the “Facility”). The Facility is secured by substantially all of SigmaTron’ assets including mortgages on its two Illinois properties.

On July 18, 2022, SigmaTron, Wagz and Lender amended and restated the JPM Agreement by entering into an Amended and Restated Credit Agreement (as so amended and restated, the “JPM Credit Agreement”). The Facility, as amended, allows the Company to choose among interest rates at which it may borrow funds foron a revolving loans:  “CBFR Loans,” the interest on which is based on (A) the “REVLIBOR30 Rate” (as defined in the Agreement) unless the REVLIBOR30 Rate is not available, in which case the interest is generally the rate of interest last quoted by The Wall Street Journal as the “Prime Rate” in the U.S., plus (B) an applicable margin of 2.0% (effectively 2.41% per annum at April 30, 2022); or “Eurodollar Loans,” the interest on which is based on (X) an interest rate per annum (rounded upwards, if necessary, to the next 1/16 of 1%) equal to the LIBO Rate (as defined in the Agreement) for any interest period multiplied by the Standard Reserve Rate (as defined in the Agreement) plus (Y) an applicable margin of 2.0%.  Under the revolving portion of the Facility, the Company may borrowbasis up to the lesser of (i) $50,000,000$70,000,000 or (ii) an amount equal to a percentage of the eligible receivable borrowing base plus a percentage of the inventory borrowing base.base minus any reserves established by Lender (the “Revolving Commitment”). The maturity date of the Facility is collateralized by a lien on substantially allJuly 18, 2027. Deferred financing costs of $332,139 and $128,733 were capitalized during the fiscal year ended April 30, 2023 and April 30, 2022, respectively, which are amortized over the term of the assetsJPM Credit Agreement. As of April 30, 2023, there was $51,134,699 outstanding and $11,539,183 of unused availability under the Company. revolving Facility compared to an outstanding balance of $51,392,158 and $5,691,855 of unused availability at April 30, 2022. As of April 30, 2023 and April 30, 2022, the unamortized amount offset against outstanding debt was $572,191 and $393,503, respectively.

Under the JPM Credit Agreement, a minimum Fixed Charge Coverage Ratio (“FCCR”) financial covenant of 1.10x is applicable only during an FCCR trigger period which occurs when (a) commencing on the Effective Date (as defined in the JPM Credit Agreement) and ending when the Term Loan Obligations (as defined in the JPM Credit Agreement) have been paid in full and (b) following the payment in full of the Term Loan Obligations, (i) an event of default (as defined in the JPM Credit Agreement) has occurred and is continuing, and Lender has elected to impose a FCCR trigger period upon notice to the Company or (ii) availability falls below the greater of (a) 10% of the revolving commitmentRevolving Commitment and (b) the outstanding principal amount of the term loans. TheIn addition, prior to the amendment to the JPM Credit Agreement pursuant to the JPM Waiver (as discussed below under “Waiver, Consent and Amendment to Credit Agreements”),the JPM Credit Agreement imposed a financial covenant that required the Company wasto maintain a leverage ratio of Total Debt to EBITDA (each as defined in the JPM Credit Agreement) for any twelve month period ending on the last day of a fiscal quarter through the maturity of the revolving Facility not to exceed a certain amount, which ratio (a) ranged from 5.00-to-1 for fiscal quarters beginning with the fiscal quarter ending on January 31, 2023 to 3.00-to-1 for the fiscal quarter ending on July 31, 2026 (if the Term Loan Borrowing Base Coverage Ratio (as defined in the JPM Credit Agreement) as of the end of the applicable fiscal quarter is less than or equal to 1.50-to-1) and (b) ranged from 5.50-to-1 for the fiscal quarter ending on January 31, 2023 to 4.00-to-1 for the fiscal quarters

35


beginning with the fiscal quarter ending on July 31, 2026 (if the Term Loan Borrowing Base Coverage Ratio as of the end of the applicable fiscal quarter is greater than 1.50-to-1).

In addition, the JPM Credit Agreement imposes a FCCR triggercash dominion period if there is an event of default or if availability is less than 10% of the Revolving Commitment, and such requirement continues until there is no event of default and availability is greater than 10% of the Revolving Commitment, in each case for 30 consecutive days. Based on this criteria, the total debt balances for the Facility must be classified as a current liability on the Consolidated Balance Sheet as of April 30, 2022. Deferred financing costs of $128,733 and $361,734 were capitalized during the fiscal year ended April 30, 2022 and April 30, 2021, respectively, which are amortized over the term of the Agreement. As of April 30, 2022, there was $51,392,158 outstanding and $5,691,855 of unused availability under the revolving Facility compared to an outstanding balance of $24,967,668 and $15,947,990 unused availability at April 30, 2021. As of April 30, 2022 and April 30, 2021, the unamortized amount offset against outstanding debt was $393,503 and $343,890, respectively.2023.

On November 17, 2021,In connection with the entry into the JPM Credit Agreement, Lender and TCW Asset Management Company and LenderLLC, as administrative agent under the Term Loan Agreement (as defined below), entered into an amendment of the Facility. The amended Facility allowsIntercreditor Agreement, dated July 18, 2022, and acknowledged by SigmaTron and Wagz (the “ICA”), to set forth and govern the Company to borrowlenders’ respective lien priorities, rights and remedies under the revolving portion ofJPM Credit Agreement and the Facility up to the lesser of (i) $53,000,000 or (ii) an amount equal to a percentage of the eligible receivable borrowing base plus a percentage of the inventory borrowing base minus any reserves established by Lender. Further, the Facility was amended to allow in some circumstances customer deposits to be deemed eligible for collateral purposes.Term Loan Agreement.

Effective as of December 31, 2021, Wagz joinedThe Facility under the Facility asJPM Credit Agreement is secured by: (a) a loan guarantor, and granted to the Lender afirst priority security interest in SigmaTron’s and Wagz’s (i) accounts receivable and inventory (excluding Term Priority Mexican Inventory (as defined in the ICA) and certain inventory in transit, (ii) deposit accounts, (iii) proceeds of business interruption insurance that constitute ABL BI Insurance Share (as defined in the ICA), (iv) certain other property, including payment intangibles, instruments, equipment, software and hardware and similar systems, books and records, to the extent related to the foregoing, and (v) all of its assets, including its intellectual property.

On March 17, 2022, the Company and Lender entered into an amendmentproceeds of the Facility. The amended Facility allowsforegoing, in each case, now owned or hereafter acquired (collectively, the Company to borrow under“ABL Priority Collateral”); and (b) a second priority security interest in Term Priority Collateral (as defined below) other than (i) real estate and (ii) the revolving portionequity interests of the Facility up to the lesser of (i) $60,000,000 or (ii) an amount equal toSigmaTron’s foreign subsidiaries (unless such a percentage of the eligible receivable borrowing base plus a percentage of the inventory borrowing base minus any reserves establishedpledge is requested by Lender. Further, the Facility was amended to allow in some circumstances accounts arising from sales of inventory subject to bill and hold arrangements to be deemed eligible for collateral purposes. The interest rates based on LIBOR were changed under the Facility as follows:

Lender).

On April 25, 2022, the Company and Lender, entered into an amendment of the Facility. Under the amended Facility, Lender extended a term loan to the Company in the principal amount of $5,000,000 (the “FILO Term Loan”), the interest on which is based on (i) the “Adjusted Term SOFR Rate” for a one-month Interest Period (each, as defined in the Agreement), plus (ii) an applicable margin of 4.0% (effectively 4.41% per annum at April 30, 2022). The FILO Term Loan will mature within 120 days from the date of the amendment. The amount outstanding as of April 30, 2022 was $5,000,000. There were no issuance costs associated with the FILO Term Loan. On July 18, 2022, a portion of the proceeds of the Term Loan Agreement (as defined below) was used to pay in full the FILO Term Loan extended by Lender.

37


On July 18, 2022, SigmaTron, Wagz and JPMorgan Chase Bank, N.A. (“Lender”) amended the Credit Agreement dated as of January 29, 2021, by entering into the Amended and Restated Credit Agreement (the “Facility” or “Credit Agreement”). The Facility, as amended, allows the Company to borrow on a revolving basis up to the lesser of (i) $70,000,000 or (ii) an amount equal to a percentage of the eligible receivable borrowing base plus a percentage of the inventory borrowing base minus any reserves established by Lender. The Facility bears interest at the adjusted REVSOFR30 rate (as defined in the Credit Agreement). The interest rate per annum applicable to the Facility will be the Adjusted Term SOFR Rate (“SOFR”), plusthe Applicable Margin of 2.0%. The maturity date of the Facility was extended to July 18, 2027.

In connection with the closing of the Credit Agreement, Lender and The Private Credit Group of TCW Asset Management Company LLC, as administrative agent (the “Agent”) under the Term Loan Agreement (as defined below), entered into the Intercreditor Agreement, dated July 18, 2022, and acknowledged by SigmaTron and Wagz (the “ICA”), to set forth and govern the lenders’ respective lien priorities, rights and remedies under the Credit Agreement and the Term Loan Agreement.

The Facility is secured by: (a) a first priority security interest in SigmaTron’s and Wagz’s: (i) accounts and inventory (excluding Term Priority Mexican Inventory (as defined in the Intercreditor Agreement (“ICA”)) and certain inventory in transit, (ii) deposit accounts, (iii) proceeds of business interruption insurance that constitute ABL BI Insurance Share (as defined in the ICA), (iv) certain other property, including payment intangibles, instruments, equipment, software and hardware and similar systems, books and records, to the extent related to the foregoing, and (v) all proceeds of the foregoing, in each case, now owned or hereafter acquired (collectively, the “ABL Priority Collateral”); and (b) a second priority security interest in Term Priority Collateral (as defined below) other than (i) real estate and (ii) unless Lender requests a pledge thereof following July 18, 2022, the equity interests of SigmaTron’s foreign subsidiaries.

On July 18, 2022, SigmaTron, Wagz and The Private Credit Group of TCW Asset Management Company LLC, as administrative agent, (the “Agent”), and other Lenders party thereto (collectively, “TCW”) entered into a Credit Agreement (the “Term Loan Agreement”) pursuant to which TCW made a term loan to the Company in the principal amount of $40,000,000 (the “TCW Term Loan”). The TCW Term Loan bears interest at a rate per annum applicable to the Term Loan Facility based on the Adjusted Term SOFR, Rate (“SOFR”), plus the Applicable Margin of 7.50% (as(each as defined in the Term Loan Agreement). The TCW Term Loan will havehas a SOFR floor of 1.00%. The maturity date of the TCW Term Loan is July 18, 2027. The amount outstanding as of April 30, 2023, was $39,833,301. Deferred financing costs of $1,233,894 were capitalized during the fiscal year ended April 30, 2023. As of April 30, 2023, the unamortized amount offset against outstanding debt was $1,036,367.

The Term Loan Agreement imposes financial covenants, including covenants requiring the Company to maintain a minimum Fixed Charge Coverage Ratio (as defined in the Term Loan Agreement) of 1.10-to-1 and maintain the same leverage ratio of Total Debt to EBITDA as described above under the JPM Credit Agreement. The Company is required to make quarterly repayments of the principal amount of the TCW Term Loan in amounts equal to $250,000 per fiscal quarter for the quarters beginning October 31, 2022 and $500,000 per fiscal quarter for quarters beginning October 31, 2024. The Term Loan Agreement also requires mandatory annual repayments equal to 50% of Excess Cash Flow (as defined in the Term Loan Agreement).

The TCW Term Loan is secured by: (a) a first priority security interest in all property of SigmaTron and Wagz that does not constitute ABL Priority Collateral, which includes: (i) SigmaTron’s and Wagz’s real estate other than SigmaTron’s Del Rio, Texas, warehouses, (ii) SigmaTron’s and Wagz’s machinery, equipment and fixtures (but excluding ABL Priority Equipment (as defined in the ICA)), (iii) the Term Priority Mexican

36


Inventory (as defined in the ICA), (iv) SigmaTron’s stock in its direct and indirect subsidiaries, (v) SigmaTron’s and Wagz’s general intangibles (excluding any that constitute ABL Priority Collateral), goodwill and intellectual property, (vi) the proceeds of business interruption insurance that constitute Term BI Insurance Share (as defined in the ICA), (vii) tax refunds, and (viii) all proceeds thereof, in each case, now owned or hereafter acquired (collectively, the “Term Priority Collateral”); and (b) a second priority security interest in all collateral that constitutes ABL Priority Collateral. Also, SigmaTron’s three Mexican subsidiaries pledged all of their assets as security for the TCW Term Loan.

Waiver, Consent and Amendment to Credit Agreements

OnMarch2,2023, the Company received notices of default from both JPM and TCW. The Notices indicated the occurrence of certain events of default under the JPM Credit Agreement and the Term Loan Agreement. Inaddition,theCompanyreceivedadelinquencynotificationletterfromNasdaqindicatingthat theCompanywasnotincompliancewiththecontinuedlistingrequirementsofNasdaqforfailingtotimelyfiletheCompanysForm10-Qforthefiscal quarterendedJanuary31,2023.ThisnotificationalsoconstitutedadefaultundertheCreditAgreements. The delinquency was remedied on May 19, 2023.

The JPM Notice indicated that the Lender was informed of the occurrence of events of defaults and the continuation thereof under the JPM Credit Agreement as a result of the Company’s failure to maintain a FCCR for the twelve month period ending January 31, 2023 of at least 1.10x as required under the JPM Credit Agreement (the “JPM Covenant Defaults”).

The TCW Notice indicated that Agent and TCW Lenders were informed of the occurrence of events of default and the continuation thereof under the Term Loan Agreement (described below) as a result of the Company permitting the Total Debt to EBITDA Ratio for the twelve month period ending January 31, 2023 to be greater than 5.00:1.00 in violation of the Term Loan Agreement and the Company’s failure to maintain FCCR as required under the JPM Credit Agreement (the “TCW Covenant Defaults” and together with the JPM Covenant Defaults, the “Defaults”).

As a result of the Defaults, the Company was not in compliance with its financial covenants under the Credit Agreements as of January 31, 2023. Due to theNotices received on March 2, 2023, fromeachofJPMandtheTCWLendersandAgent, the total debt balances for both the Facility and the TCW Term Loan had been classified as a current liability on the Condensed Consolidated Balance Sheet on January 31, 2023.

OnApril28,2023,theCompanyenteredinto(i)a Waiver,ConsentandAmendment No.1tothe JPM CreditAgreementwith WagzandJPM,aslender, which waived certain events of default under and amended certain terms of theJPMCreditAgreementand(ii)a Waiver,Consent andAmendmentNo.1totheCreditAgreementwithWagz,thefinancialinstitutionsidentifiedthereinand TCWAssetManagementCompanyLLCasadministrativeagentfortheTCWLenders(insuchcapacity,the“Agent”and collectivelywiththeTCWLendersandJPM,the“LenderParties”), which waived certain events of default under and amended certain terms ofthe Credit Agreements.TheCompanyenteredintotheJPM Waiverand TCW Waiver(together,theWaivers”)afterreceivingonMarch2,2023,the NoticesfromeachofJPMandtheTCWLendersandAgent.

Pursuanttothe Waivers,theCompanyhasagreed,amongotherthings,to (i)ifrequestedbytheAgent,effectacorporaterestructuringthatwouldcreateanewholdingcompanystructuretoownalloftheCompanysstock throughamergerpursuanttoSection251(g)oftheGeneralCorporationLawoftheStateofDelaware,afterwhichtheholdingcompanywouldcontinue asthepubliccompany,becomeaguarantorundertheCreditAgreementsandpledgetotheLenderPartiesalloftheequityoftheCompany (the “Corporate Restructuring”),(ii)engagea financialadvisortoreviewcertainoftheCompanysfinancialreportingtoJPMandtheAgentandparticipateinweeklyconferencecallswiththe advisor,JPMandtheAgenttodiscussandprovideupdatesontheCompanysliquidityandoperations,(iii)extendthe WagzLoan,(iv) paytoJPManamendmentfeeintheamountof$70,000,paidincash,and(v)paytotheTCWLendersanamendmentfeeof$395,000andadefaultrate feeof$188,301,bothofwhichwerepaidinkindbybeingaddedtotheprincipalofthe TCW TermLoan.The WaiversalsoamendedtheCreditAgreementsto,amongotherthings,(x)requirethattheCompanymaintainaminimumof$2.5millioninrevolver availabilityundertheJPMCredit

37


Agreement,(y)modifythedefinitionofEBITDAtoallowadjustmentstoaccountfor Wagzoperatinglosses, impairmentchargesrelatingtothewrite-downofthe Wagzbusiness,the Wagz LoanandnetassetsoftheCompanyand Wagz,and expensesrelatingtothe Waivers,the WagzsaleandSPA,and(z)modifytheexistingTotalDebttoEBITDARatios(asdefinedinthe CreditAgreements)asfollows:

Fiscal Quarter

Total Debt to EBITDA Ratio* (as amended)

Total Debt to EBITDA Ratio* (prior to amendment)

October 31,2023

4.50:1.0

4.25:1.0

January 31, 2024

4.50:1.0

4.00:1.0

April 30, 2024

4.50:1.0

4.00:1.0

July 31, 2024

4.25:1.0

3.75:1.0

October 31, 2024

4.00:1.0

3.75:1.0

* Assumesthe TermLoanBorrowingBaseCoverageRatio(asdefinedintheCreditAgreements)islessthanorequalto1.50:1.0.

In addition, pursuant to the TCW Waiver, if the Total Debt to EBITDA Ratio for the trailing twelve monthperiodasoftheendofthethird quarter of fiscal 2023exceedstheratiosthatwereineffectpriortotheamendment(assetforthinthefarrightcolumnofthetableabove)fora fiscal quarterduringthePIKPeriod(defined in the Term Loan Agreement),thentheApplicableMarginundertheTerm LoanAgreement inrespectoftheoutstanding TCW TermLoanwouldincreasebyanamountequalto1.0%perannumforthefiscalquarter,withsuch interestbeingpaidinkind.Furthermore,theJPM WaivermodifiedthedefinitionofApplicableMarginfromafixedamountequalto2.00%toanamount thatvariesfrom2.00%(forrevolveravailabilitygreaterthanorequalto$20.0million),to2.50%(forrevolveravailabilitygreaterthanorequalto$10.0 million),to3.00%(forrevolveravailabilitylessthan$10.0million),andfixedtheApplicableMarginat3.00%forsixmonthsstartingApril1,2023.

Inexchangeforsuchagreements,theLenderPartieshaveagreedtowaivealloftheexistingeventsofdefaultundertheCreditAgreements throughMarch31,2023,consenttothesaleof WagzandreleaseWagzanditspropertyandtheCompanys81%interestin Wagz thatwassoldtoBuyer(asdisclosedbelow)fromthelienoftheLenderParties.

Inconnectionwiththe Waivers,theCompanyexiteditsactiveinvolvementinthePet Techbusinessthatisconductedby Wagzthrough thesalebytheCompanyofamajoritystakein Wagz,effective as of April1,2023.

On June 15, 2023, the Company entered into (i) Amendment No. 2 to the Credit Agreement (the “JPM Amendment No. 2”) by and among the Company and Lender, with respect to the JPM Credit Agreement and (ii) Amendment No. 2 to the Credit Agreement (“TCW Amendment No. 2”) by and among the Company, the TCW Lenders and the Agent with respect to the Term Loan Agreement. The JPM Amendment No. 2 and TCW Amendment No. 2 (together, the “Amendments”) amend the Credit Agreements to extend the date, from May 31, 2023 to July 31, 2023, after which the Agent may request that the Company effect the Corporate Restructuring.

On April 23, 2020, the Company received a PPP Loan from U.S. Bank, as lender, pursuant to the Paycheck Protection Program of the CARES Act, as administered by the U.S. Small Business Administration (the “SBA”) in the amount of $6,282,973 (the “PPP Loan”). The PPP Loan was scheduled to mature on April 23, 2022. The Company was notified of the forgiveness of the PPP Loan by the SBA on July 9, 2021 and all principal and accrued interest were forgiven. The accounting for the forgiveness is reflected in the Company’s Statement of Operations of Item 15(a) Exhibits and Financial Statement Schedulesfor fiscal 2022 as a non-cash gain upon extinguishment of long-term debt.

On March 15, 2019, the Company’s wholly-owned subsidiary,foreign enterprise, Wujiang SigmaTron Electronic Technology Co., Ltd., entered into a credit facility with China Construction Bank. On January 26, 2021, the agreement was amended and terminatedexpired in accordance with its terms on January 6, 2022. On January 17, 2022, the agreement was renewed, and is scheduled to expire on December 23, 2022. Under the agreement SigmaTron Electronic Technology Co., Ltd. can borrow up

38


agreement was renewed, and expired in accordance with its terms on December 23, 2022. On February 17, 2023, the agreement was renewed, and is scheduled to 9,000,000expire on February 7, 2024. Under the agreement Wujiang SigmaTron Electronic Technology Co., Ltd. can borrow up to 10,000,000 Renminbi, approximately $1,359,989$1,444,252 as of April 30, 2022,2023, and the facility is collateralized by Wujiang SigmaTron Electronics Co., Ltd.’s manufacturing building. Interest is payable monthly and the facility bears a fixed interest rate of 3.8%. The term of the facility extends to December 23, 2022.3.35% per annum. There was $438,219no outstanding balance under the facility at April 30, 20222023 compared to an outstanding balance of $824,159$438,219 at April 30, 2021.2022.

Notes Payable - Buildings

The Company entered into a mortgage agreement on December 21, 2017, in the amount of $5,200,000, with U.S. Bank to refinance the property that serves as the Company’s corporate headquarters and its Illinois manufacturing facility in Elk Grove Village, Illinois. The note required the Company to pay monthly principal payments in the amount of $17,333, bore interest at a fixed rate of 4.0% per year and was payable over a fifty one month period. Deferred financing costs of $74,066 were capitalized in fiscal year 2018 which were amortized over the term of the agreement. On January 29, 2021, the Company repaid its U.S. Bank mortgage in the amount outstanding of $4,576,000, using proceeds from the Facility extended by Lender. The Company recorded a prepayment penalty of $120,842 in fiscal year 2021. The remaining deferred financing costs of $21,365 were expensed in fiscal year 2021.

The Company entered into a mortgage agreement on December 21, 2017, in the amount of $1,800,000, with U.S. Bank to refinance the property that serves as the Company’s engineering and design center in Elgin, Illinois. The note required the Company to pay monthly principal payments in the amount of $6,000, bore interest at a fixed rate of 4.0% per year and was payable over a fifty one month period. Deferred financing costs of $65,381 were capitalized in the fiscal year 2018 which were amortized over the term of the agreement. On January 29, 2021, the Company repaid its U.S. Bank mortgage in the amount outstanding of $1,584,000, using proceeds from the Facility extended by Lender. The Company recorded a prepayment penalty of $41,830 in fiscal year 2021. The remaining deferred financing costs of $18,859 were expensed in fiscal year 2021.

The Company’s Facility with Lender, entered into on January 29, 2021, also included two term loans, in the aggregate principal amount of $6,500,000. The loans require the Company to pay aggregate principal payments in the amount of $36,111 per month for 60 months, plus monthly payments of interest thereon at (A) the REVSOFR30 Rate, (as defined in the Agreement), plus (B) an applicable margin of 2.5%; (effectively 2.91% per annum at April 30, 2022). Deferred financing costs of $10,050 were capitalized during fiscal year 2021 which are amortized over the term of the agreement. As of April 30, 2022, the unamortized amount included as a reduction to long-term debt was $7,537. A final aggregate payment of approximately $4,368,444 iswas due on or before January 29, 2026. The outstanding balance was $5,994,445 at April 30, 2022 compared to an outstanding balance of $6,427,778 at April 30, 2021. On July 18, 2022, a portion of the proceeds of the TCW Term Loan Agreement was used to pay in full both term loans extended by Lender.There was no outstanding balance at April 30, 2023 compared to an outstanding balance of $5,994,445 at April 30, 2022.

The Company entered into a mortgage agreement on March 3, 2020, in the amount of $556,000, with The Bank &and Trust SSB to finance the purchase of the property that serves as the Company’s warehousing and distribution center in Del Rio, Texas. The note requires the Company to pay monthly installment payments in the amount of $6,103. Interest accrues at a fixed rate of 5.75% per year until March 3, 2025, and adjusts thereafter, on an annual basis, equal to 1.0% over the Prime Rate as published by The Wall Street Journal. The note is payable over a 120 month period. The outstanding balance was $464,895$417,143 and $509,985$464,895 at April 30, 20222023 and April 30, 2021,2022, respectively.

Notes Payable - Equipment

The Company routinely entersentered into secured note agreements with Engencap Fin S.A. DE C.V. to finance the purchase of equipment. The terms of the outstanding secured note agreementsagreement mature from November 2022 throughon May 1, 2023, with a final quarterly installment payments ranging from $10,041 to $16,198payment of $9,310 and a fixed interest rate ranging from 7.35% toof 8.00% per annum.

The Company routinely enters into secured note agreements with FGI Equipment Finance LLC to finance the purchase of equipment. The terms of the outstanding secured note agreements mature from March 2025 through MayOctober 2027, with quarterly installment payments ranging from $10,723 to $69,439 and a fixed interest rate ofranging from 8.25% to 9.25% per annum.

39


Finance Lease and Sales Leaseback Obligations

The Company enters into various finance lease and sales leaseback agreements. The terms of the outstanding lease agreements mature through February 2026,April 1, 2027, with monthly installment payments ranging from $2,874 to $33,706 and a fixed interest rate ranging from 4.90%7.09% to 12.73% per annum.

Other

The Company provides funds for administration and manufacturing services such as salaries, wages, overhead and capital expenditure items as necessary to operate its wholly-owned Mexican, Vietnamese and Chinese subsidiaries and the international procurement office in Taiwan. The Company provides funding in U.S. Dollars, which are exchanged for Pesos, Dong, Renminbi, and New Taiwan dollars. The fluctuation of currencies from time to time, without an equal or greater increase in inflation, could have a material impact on the financial results of the Company. The impact of currency fluctuations for the fiscal year ended April 30, 2022,2023, resulted in net foreign currency transaction losses of $412,218$892,642 compared to net foreign currency losses of approximately $285,000$412,218 in the prior year. In fiscal year 2022,2023, the Company paid approximately $62,250,000$60,070,000 to its foreign subsidiaries for manufacturing services. All intercompany balances have been eliminated upon consolidation.

The Company expectshas not changed its plans to indefinitely reinvest the earnings of the Company’s foreign subsidiaries. The cumulative amount of unremitted earnings for which U.S. income taxes have not been recorded is $11,822,000 as of April 30, 2023.

39


The Company anticipates that its credit facilities, expected future cash flow from operations and leasing resources are adequate to meet its working capital requirements and fund capital expenditures for the next 12 months. However, in the event customers delay orders or future payments are not made timely, the Company desires to expand its operations, its business grows more rapidly than expected, or the current economic climate deteriorates, additional financing resources may be necessary. There is no assurance that the significant disruptionCompany will be able to obtain equity or debt financing at acceptable terms, or at all, in business activity and the financial markets created by the COVID-19 will impact several sources of its liquidity, andfuture.  There is therefore continuously and critically reviewing its liquidity and anticipated capital requirements. For more information on the potential impact of the COVID-19 pandemic onno assurance that the Company see “Item 1A. Risk Factors – Our financial condition and results of operations have been impacted and maywill be able to retain or renew its credit agreements in the future, or that any retention or renewal will be adversely affected byon the ongoing COVID-19 outbreak.”same terms as currently exist.

The impact of inflation onand the Company’s net sales, revenues and income from operationscontinuing global supply chain disruptions in the electronic component marketplace have been challenging. Prices for raw materials necessary for production have fluctuated significantly in the past two fiscal years has been minimal.

Off-balance Sheet Transactions:

and the Company is currently experiencing upward pricing pressure on raw materials. The Company has no off-balance sheet transactions.anticipates supply chain and raw material price volatility will continue during fiscal 2024.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISKS

As a smaller reporting company, as defined in Rule 10(f)(1) of Regulation S-K under the Exchange Act, the Company is not required to provide the information required by this item.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The response to this item is included in Item 15(a) of this Report.

ITEM 9. CHANGES AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING

AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures:

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in its reports under the Securities Exchange Act of 1934 (the “Exchange Act”), is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. The Company’s management, including its Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of itsthe Company’s disclosure controls and procedures (as defined under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Rules 13a-15(e) and 15(d)-15(e) thereunder) as of April 30, 2022. The2023. Based on such evaluation, the Company’s disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives and its Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective at the reasonable assurance level as of April 30, 2022.2023.

40


Management, including our Chief Executive Officer and Chief Financial Officer, believes the consolidated financial statements included in this Annual Report on Form 10-K fairly represent in all material respects our financial condition, results of operations and cash flows at and for the periods presented in accordance with GAAP.

There has been no change in the Company’s internal control over financial reporting during the fiscal year ended April 30, 2023, that has materially affected or is reasonably likely to materially affect its internal control over financial reporting.

40


Management’s Report on Internal Control Over Financial Reporting:

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Exchange Act Rules 13a-15(f) and 15d-15(f). The Company’s internal controls over financial reporting are designed to provide reasonable assurance regarding the reliability of financial reporting and preparation of financial statements for external purposes in accordance with U.S. GAAP. Under the supervision and with the participation of the Company’s management, including its Chief Executive Officer and Chief Financial Officer, the Company conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our assessment, management believes that, as of April 30, 2022,2023, our internal control over financial reporting was effective.

This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to the rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this annual report.

Changes in Internal Control over Financial Reporting

There has been no change in the Company’s internal control over financial reporting during the quarter ended April 30, 2022,2023, that has materially affected or is reasonably likely to materially affect its internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

Not Applicable.

ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTION

Not Applicable.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

The information required under this item is incorporated herein by reference to the Company’s definitive proxy statement, to be filed with the Securities and Exchange Commission not later than 120 days after the close of the Company’s fiscal year ended April 30, 2022.2023.

ITEM 11. EXECUTIVE COMPENSATION

The information required under this item is incorporated herein by reference to the Company’s definitive proxy statement, to be filed with the Securities and Exchange Commission not later than 120 days after the close of the Company’s fiscal year ended April 30, 2022.2023.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

AND RELATED STOCKHOLDER MATTERS

41


The information required under this item is incorporated herein by reference to the Company’s definitive proxy statement, to be filed with the Securities and Exchange Commission not later than 120 days after the close of the Company’s fiscal year ended April 30, 2022.2023.

41


ITEM 13. CERTAIN RELATIONSHIPS, RELATED TRANSACTIONS AND DIRECTOR

INDEPENDENCE

The information required under this item is incorporated herein by reference to the Company’s definitive proxy statement, to be filed with the Securities and Exchange Commission not later than 120 days after the close of the Company’s fiscal year ended April 30, 2022.2023.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information required under this item is incorporated herein by reference to the Company’s definitive proxy statement, to be filed with the Securities and Exchange Commission not later than 120 days after the close of the Company’s fiscal year ended April 30, 2022.

42


2023.

PART IV

ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)(1) 

The financial statements are listed in the Index to Financial Statements filed as part of this Annual Report on Form 10-K beginning on Page F-1.

(a)(2)

Financial statement schedules are omitted because they are not applicable or required.

(a)(3) and (b)

The exhibits required by Item 601 of Regulations S-K are listed in the Index to Exhibits filed as part of this Annual Report on Form 10-K beginning on Page 43.

ITEM 16. FORM 10-K SUMMARY

None.


4342


Index to Exhibits

3.1 

Restated Certificate of Incorporation of the Company, incorporated herein by reference to Exhibit 3.13.2 to Registration Statementthe Company’s Form 8-K filed on Form S-1, File No. 33-72100, dated February 9, 1994. (P)(Rule 311)July 13, 2023.

3.2 

Amended and Restated By-laws of the Company, adopted on September 24, 1999, incorporated herein by reference to Exhibit 3.2 to the Company’s Form 10-K for the fiscal year ended April 30, 2000.

3.2

3.3

Amended and Restated By-laws of the Company, adopted on October 13, 2021, incorporated herein by reference to Exhibit 3.1 to the Company’s Form 8-K filed on October 15, 2021.

3.3

Second Amended and Restated By-laws of the Company, adopted on July 11, 2023 and effective July 31, 2023, incorporated herein by reference to Exhibit 3.1 to the Company’s Form 8-K filed on July 13, 2023.

10.1 

Form of 1993 Stock Option Plan, incorporated herein by reference to Exhibit 10.4 to the Company’s Registration Statement on Form S-1, File No. 33-72100.* (P)(Rule 311)

10.2 

2004 Employee Stock Option Plan, incorporated herein by reference to Appendix B to the Company’s 2004 Proxy Statement filed on August 16, 2004. *

10.3 

SigmaTron International, Inc. 2011 Employee Stock Option Plan dated September 16, 2011, incorporated herein by reference to Exhibit 10.14 to the Company’s Registration Statement on Form S-8 filed on December 14, 2011.*

10.4

Mortgage and Assignment of Rents and Leases executed as of October 24, 2013, by SigmaTron International, Inc., to Wells Fargo Bank, National Association, incorporated herein by reference to Exhibit 10.18 to the Company’s Form 10-Q filed on December 13, 2013.

10.5

SigmaTron International, Inc. Amended and Restated Change in Control Severance Payment Plan dated March 11, 2014, incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K/A filed on March 14, 2014.*

10.6

First Amendment to Third Amended and Restated Credit Agreement entered into as of March 7, 2015, by and between SigmaTron International, Inc. and Wells Fargo Bank, National Association, incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed on March 12, 2015.

10.7

Loan and Security Agreement between SigmaTron International, Inc. and U.S. Bank National Association dated March 31, 2017, incorporated herein by reference to Exhibit 10.32 to the Company’ Form 10-K filed on July 24, 2017.

10.8

Real Property mortgage (Cook County, Illinois) made as of the 21st day of December, 2017, is made and executed by SigmaTron International, Inc. (“Mortgagor”) and U.S. Bank National Association (“Lender”), incorporated herein by reference to Exhibit 10.1 to the Company’s Form 10-Q filed on March 14, 2018.

10.9

Real Property mortgage (Kane County, Illinois) made as of the 21st day of December, 2017, is made and executed by SigmaTron International, Inc. (“Mortgagor”) and U.S. Bank National Association (“Lender”), incorporated herein by reference to Exhibit 10.2 to the Company’s Form 10-Q filed on March 14, 2018.

10.1010.5

Asset Purchase Agreement effective as of April 30, 2018 between SigmaTron International, Inc. and Wagz, Inc., incorporated herein by reference to Exhibit 99.1 to the Company’s Form 8-K/A filed on May 4, 2018.

44


10.1110.12

Amendment No.1 to Amended and Restated Loan and Security Agreement entered into as of July 16, 2018, by and between SigmaTron International, Inc., and U.S. Bank National Association incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed on July 17, 2018.

10.12

SigmaTron International, Inc. 2019 Employee Stock Option Plan dated September 13, 2019, incorporated herein by reference to Exhibit 10.1 to the Company’ Form 8-K filed on September 17, 2019.*

10.13

U.S. Bank SBA Payroll Loan Agreement dated April 23, 2020 by and between SigmaTron International, Incorporation, incorporated here by reference to Exhibit 10.1 to the Company’s Form 8-K filed on April 24, 2020.

10.14

Amendment No. 6 to Amended and Restated Loan and Security Agreement entered into as of July 15, 2020, by and between SigmaTron International, Inc., and U.S. Bank National Association incorporated herein by reference to Exhibit 10.l to the Company’s Form 8-K filed on September 9, 2020.

10.15

Amendment No. 7 to Amended and Restated Loan and Security Agreement entered into as of August 7, 2020, by and between SigmaTron International, Inc., and U.S. Bank National Association incorporated herein by reference to Exhibit 10.2 to the Company’s Form 8-K filed on September 9, 2020.

10.16

Amendment No. 8 to Amended and Restated Loan and Security Agreement entered into as of September 8, 2020, by and between SigmaTron International, Inc., and U.S. Bank National Association incorporated herein by reference to Exhibit 10.3 to the Company’s Form 8-K filed on September 9, 2020.

10.17

Credit Agreement dated as of January 29, 2021 between SigmaTron International, Inc., and JPMorgan Chase Bank, N.A. incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed on February 4, 2021.

10.18

First Amendment to Credit Agreement entered into as of April 20, 2021, by and between SigmaTron International, Inc., and JPMorgan Chase Bank, N.A. incorporated herein by reference to Exhibit 10.72 to the Company’s Form 10-K filed on July 23, 2021.

10.19

Second Amendment to Credit Agreement entered into as of June 21, 2021, by and between SigmaTron International, Inc., and JPMorgan Chase Bank, N.A. incorporated herein by reference to Exhibit 10.73 to the Company’ Form 10-K filed on July 23, 2021.

10.2010.6

SigmaTron International, Inc., Employee Bonus Plan for Fiscal Year 2022 dated May 25, 2021, incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed on July 9, 2021.*

10.2110.7

Agreement and Plan of Merger, dated July 19, 2021, by and among SigmaTron International, Inc., Remy Pom, Inc., Wagz, Inc., and Terry B. Anderton incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed on July 21, 2021.

10.2210.8

SigmaTron International, Inc. 2021 Employee Stock Option Plan dated July 13, 2021, incorporated herein by reference to Exhibit B to the definitive proxy statement for the Special Meeting of Stockholders filed with the Securities and Exchange Commission on September 8, 2021.*

10.2310.9

SigmaTron International, Inc. 2021 Non-Employee Director Restricted Stock Plan dated September 15, 2021, incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed on September 16, 2021.*

45


10.2410.10

Third Amendment to Credit Agreement entered into as of September 30, 2021, by and between SigmaTron International, Inc., and JPMorgan Chase Bank, N.A. incorporated herein by reference to Exhibit 10.1 to the Company’s Form 10-Q filed on December 13, 2021.

43


10.2510.11

Fourth Amendment to Credit Agreement entered into as of November 17, 2021, by and between SigmaTron International, Inc., and JPMorgan Chase Bank, N.A. incorporated herein by reference to Exhibit 10.2 to the Company’s Form 10-Q filed on December 13, 2021.

10.2610.12

Fifth Amendment to Credit Agreement entered into as of March 17, 2022, by and between SigmaTron International, Inc., and JPMorgan Chase Bank, N.A. incorporated herein by reference to Exhibit 10.1 to the Company’s Form 10-Q filed on March 22, 2022.

10.2710.13

First Amendment to Agreement and Plan of Merger, dated December 7, 2021, by and among SigmaTron International, Inc., Remy Pom, Inc., Wagz, Inc., and Terry B. Anderton incorporated herein by reference to Exhibit 10.2 to the Company’s Form 8-K filed on December 10, 2021.

10.2810.14

Sixth Amendment to Credit Agreement entered into as of April 25, 2022, by and between SigmaTron International, Inc., and JPMorgan Chase Bank, N.A. incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed on April 27, 2022.

10.2910.15

Amended and Restated Credit Agreement dated July 18, 2022, by and among SigmaTron International, Inc., Wagz, Inc., and JPMorgan Chase Bank, N.A. incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed on July 22, 2022.

10.3010.16

Credit Agreement dated July 18, 2022, by and among SigmaTron International, Inc., Wagz, Inc., TCW Asset Management Company LLC, as Administrative Agent, and the Lenders parties thereto incorporated herein by reference to Exhibit 10.2 to the Company’s Form 8-K filed on July 22, 2022.

10.17

SigmaTron International, Inc., Employee Bonus Plan for Fiscal Year 2023 dated September 16, 2022, incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed on September 19, 2022.*

10.18

Waiver, Consent and Amendment No. 1 to the Credit Agreement dated April 28, 2023, by and among SigmaTron International, Inc., Wagz, Inc. and JPMorgan Chase Bank, N.A.incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed on May 4, 2023.

10.19

Waiver, Consent and Amendment No. 1 to the Credit Agreement dated April 28, 2023, by and among SigmaTron International, Inc., Wagz, Inc. and TCW Asset Management Company LLC, as Administrative Agent, and the Lenders parties thereto,incorporated herein by reference to Exhibit 10.2 to the Company’s Form 8-K filed on May 4, 2023.

10.20

Stock Purchase Agreement, dated April 28, 2023, by and among SigmaTron International, Inc. Wagz, Inc., Vynetic LLC, and Terry B. Anderton incorporated herein by reference to Exhibit 10.3 to the Company’s Form 8-K filed on May 4, 2023.

10.21

Promissory Note dated April 1, 2023, issued by Wagz, Inc. to SigmaTron International, Inc.incorporated herein by reference to Exhibit 10.4 to the Company’s Form 8-K filed on May 4, 2023.

10.22

Amendment No. 2 to the Credit Agreement dated June 15, 2023, by and among SigmaTron International, Inc., and JPMorgan Chase Bank, N.A.incorporated herein by reference to Exhibit 10.1 to the Company’s Form 8-K filed on June 23, 2023.

10.23

Amendment No. 2 to the Credit Agreement dated June 15, 2023, by and among SigmaTron International, Inc., and TCW Asset Management Company LLC, as Administrative Agent, and the Lenders parties thereto,incorporated herein by reference to Exhibit 10.2 to the Company’s Form 8-K filed on June 23, 2023.

21.0

Subsidiaries of the Registrant.**

44


23.1

Consent of BDO USA, LLP.P.A.**

24.0

Power of Attorney of Directors and Executive Officers (included on the signature page of this Form 10-K for the fiscal year ended April 30, 2022)2023).**

31.1

Certification of Principal Executive Officer of the Company Pursuant to Rule 13a-14(a) under the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.**

31.2

Certification of Principal Financial Officer of the Company Pursuant to Rule 13a-14(a) under the Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.**

32.1

Certification by the Principal Executive Officer of SigmaTron International, Inc. Pursuant to Rule 13a-14(b) under the Exchange Act and Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).***

32.2

Certification by the Principal Financial Officer of SigmaTron International, Inc. Pursuant to Rule 13a-14(b) under the Exchange Act and Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350).***

46


101.INS 

Inline XBRL Instance Document (the instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document)

101.SCH

Inline XBRL Taxonomy Extension Schema Document **

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document **

101.DEF 

Inline XBRL Taxonomy Extension Definition Linkbase Document **

101.LAB 

Inline XBRL Taxonomy Extension Label Linkbase Document **

101.PRE 

Inline XBRL Taxonomy Extension Presentation Linkbase Document **

104

Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101)

* Indicates management contract or compensatory plan.

** Filed herewith.

*** Furnished herewith.

(c) Exhibits

The Company hereby files as exhibits to this Report the exhibits listed in Item 15(a)(3) above, which are

attached hereto or incorporated herein.

4745


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

SIGMATRON INTERNATIONAL, INC.

By: /s/ Gary R. Fairhead

Gary R. Fairhead, Chief Executive Officer,

Principal Executive Officer and Director

Dated: July 27, 202221, 2023

 KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned directors and officers of SigmaTron International, Inc., a Delaware corporation, which is filing an Annual Report on Form 10-K with the Securities and Exchange Commission under the provisions of the Securities Exchange Act of 1934 as amended, hereby constitute and appoint Gary R. Fairhead and James J. Reiman, and each of them, each of their true and lawful attorneys-in fact and agents, with full power of substitution and resubstitution, for him/her and in his/her name, place and stead, in all capacities, to sign any or all amendments to the report to be filed with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as each of them might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities, and on the dates indicated.

Signature

Title

Date

/s/ Gary R. Fairhead

Chairman of the Board of Directors,

July 27, 202221, 2023

Gary R. Fairhead

Chief Executive Officer,

(Principal Executive Officer) and Director

/s/ James J. Reiman

Chief Financial Officer, Vice President Finance,

July 27, 202221, 2023

James J. Reiman

Secretary and Treasurer (Principal Financial and Accounting Officer)

/s/Linda K. Frauendorfer

Director

July 27, 202221, 2023

Linda K. Frauendorfer

/s/ Thomas W. Rieck

Director

July 27, 202221, 2023

Thomas W. Rieck

/s/ Dilip S. Vyas

Director

July 27, 202221, 2023

Dilip S. Vyas

/s/ Paul J. Plante

Director

July 27, 202221, 2023

Paul J. Plante

/s/ Barry R. Horek

Director

July 27, 2022

Barry R. Horek

/s/ Bruce J. Mantia

Director

July 27, 202221, 2023

Bruce J. Mantia

4846


SigmaTron International, Inc. and Subsidiaries

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

April 30, 20222023 and 20212022

INDEX TO FINANCIAL STATEMENTS

Page

SigmaTron International, Inc. and Subsidiaries

 

F-1


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Shareholders and Board of Directors

SigmaTron International, Inc.

Elk Grove Village, Illinois

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of SigmaTron International, Inc. (the “Company”) as of April 30, 20222023 and 2021,2022, the related consolidated statements of operations, stockholders’ equity, and cash flows for each of the two years in the periodthen ended, April 30, 2022, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at April 30, 20222023 and 2021,2022, and the results of its operations and its cash flows for each of the two years in the periodthen ended, April 30, 2022, in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit MattersMatter

The critical audit mattersmatter communicated below are mattersis a matter arising from the current period audit of the consolidated financial statements that werewas communicated or is required to be communicated to the audit committee and that: (1) relaterelates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit mattersmatter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit mattersmatter below, providing separate opinions on the critical audit matter or on the accounts or disclosures to which they relate.it relates.

Inventory Obsolescence Reserve

As described in NoteNotes B and D to the consolidated financial statements, as of April 30, 2022,2023, the Company recorded an inventory obsolescence reserve of $3,236,347$4,566,061 on raw materials inventory of $140,118,156.$142,612,325. A substantial portion of the Company’s raw materials inventory has been purchased to fulfill committed future orders or relates to raw materials inventory for which the Company is contractually entitled to recover its costs from its customers. For the remaining raw materials inventory (“value over stock raw material inventory”), the Company records provisions for

F-2


excess and obsolete inventories for the difference between the cost of inventory and its estimated realizable value based on assumptions about future product demand and market conditions.

F-2


We identified the valuation of the value over stock raw material inventory as a critical audit matter. In determining the obsolescence reserve for value over stock raw material inventory, critical inputs are used over the rates applied to historical usage and future forecasts by inventory item to identify items for specific management review. The evaluation over the need for a reserve requires assumptions overabout the expected future ability to use the raw material inventory items based on an assessment of current market conditions, future industry trends, and customer demand. Auditing the assumptions used by management in determining the inventory obsolescence reserve involved especially challenging auditor judgment due to the nature and extent of audit effort needed to evaluate the reasonableness of the assumptions and judgments made by management.management.

The primary procedures we performed to address this critical audit matter included:

Testing the completeness and accuracy of the underlying historical usage and future forecastsforecast reports used as inputs through the examination of relevant source documents.

Testing the existence of raw material inventory items through the attendance of physical inventory observations at selected locations.

Evaluating management's conclusion by testing selected value over stock raw material inventory items, examining relevant source documents,sources of information, both internal and external, to corroborate the expected future use of the identified raw material and the extent of any reserve required.

Evaluating the reasonableness of management’s prior period estimates for inventory reserves by performing a retrospective comparison of prior estimates to current period sales, write-offs, and inventory consumptions as well as evaluating the current period reserve estimate for items that were slow moving in the current period.

Valuation of Definite Lived Intangible Assets

As described in Note F to the consolidated financial statements, as of April 30, 2022, the Company acquired 100% of Wagz, Inc., a pet technology company. As part of the purchase price allocation, the Company identified definite lived intangible assets for trade names and patents with a fair value of $10,960,000 as of the acquisition date. The fair value of these definite lived intangible assets was determined using the relief from royalty method, which values an intangible asset by estimating the royalties saved through ownership of the asset.

We identified the determination of the acquisition date fair value of the acquired definite lived intangibles assets for certain trade names as a critical audit matter. In determining the fair value of these acquired identified definite lived intangible assets, critical inputs include the determination of the appropriate valuation methodology and the key valuation assumptions used, specifically as it relates to the royalty rate and the internal rate of return. Auditing these critical inputs used by management involved especially challenging auditor judgment due to the nature and extent of audit effort needed to evaluate the reasonableness of the assumptions and judgments made by management.

The primary procedures we performed to address this critical audit matter included:

Inspecting the merger agreements between the Company and Wagz, Inc. to identify relevant terms and conditions that impact the identification of acquired definite lived intangibles assets.

Testing the completeness and accuracy of the underlying data used in the fair value measurement calculations, and recalculating the recorded definite lived intangibles assets fair value.

Utilizing personnel with specialized knowledge and skills in valuation to evaluate the fair value methodology and the key valuation assumptions used in determining the royalty rate and internal rate of return.

/s/ BDO USA, LLPP.A.

We have served as the Company’s auditor since 2006.

Chicago, Illinois

July 27, 202221, 2023


F-3


SigmaTron International, Inc. and Subsidiaries

CONSOLIDATED BALANCE SHEETS

APRIL 30, 20222023 and 20212022

C

April 30,

April 30,

April 30,

April 30,

ASSETS

2022

2021

2023

2022

CURRENT ASSETS

Cash and cash equivalents

$

3,054,643

$

3,509,229

$

819,129

$

2,498,589

Accounts receivable, less allowance for doubtful accounts of

$100,000 at April 30, 2022 and April 30, 2021

41,153,248

28,783,161

$100,000 at April 30, 2023 and April 30, 2022

46,284,818

41,071,740

Inventories, net

164,965,216

98,078,601

165,555,199

164,664,965

Prepaid expenses and other assets

2,213,895

1,314,834

1,678,263

2,151,827

Refundable and prepaid income taxes

1,238,973

388,766

779,705

1,238,973

Note receivable

-

7,014,594

Other receivables

6,318,164

2,464,678

5,349,328

6,318,164

Current assets of discontinued operations

-

999,881

Total current assets

218,944,139

141,553,863

220,466,442

218,944,139

PROPERTY, MACHINERY AND EQUIPMENT, NET

35,973,215

34,186,918

35,788,357

35,778,106

OTHER LONG-TERM ASSETS

Intangible assets, net

12,409,478

1,996,749

1,311,030

1,650,163

Goodwill

13,320,534

-

Deferred income taxes

856,863

1,647,143

2,640,902

856,863

Right-of-use assets

10,946,764

13,015,986

7,225,423

10,946,764

Other assets

1,180,284

1,772,748

1,195,045

1,174,284

Assets of discontinued operations

-

24,280,958

Total other long-term assets

38,713,923

18,432,626

12,372,400

38,909,032

TOTAL ASSETS

$

293,631,277

$

194,173,407

$

268,627,199

$

293,631,277

The accompanying notes are an integral part of these statements.


F-4


SigmaTron International, Inc. and Subsidiaries

CONSOLIDATED BALANCE SHEETS CONTINUED

APRIL 30, 20222023 and 20212022

April 30,

April 30,

April 30,

April 30,

LIABILITIES AND STOCKHOLDERS’ EQUITY

2022

2021

2023

2022

CURRENT LIABILITIES

Trade accounts payable

$

96,039,209

$

62,656,451

$

75,159,716

$

95,953,429

Accrued expenses

3,172,922

2,457,882

2,933,430

2,753,102

Accrued wages

9,180,582

6,283,987

7,917,266

9,077,849

Income taxes payable

802,556

1,331,504

1,041,998

802,556

Deferred revenue

11,394,820

423,971

8,063,197

11,394,820

Current portion of long-term debt

6,991,567

7,862,058

52,761,520

6,991,567

Current portion of finance lease obligations

1,410,675

1,455,638

1,523,259

1,410,675

Current portion of operating lease obligations

3,508,864

2,843,758

2,908,213

3,508,864

Current liabilities of discontinued operations

-

608,333

Total current liabilities

132,501,195

85,315,249

152,308,599

132,501,195

Long-term debt, less current portion

60,099,402

34,783,825

40,539,180

60,099,402

Finance lease obligations, less current portion

2,805,135

1,180,496

2,596,178

2,805,135

Operating lease obligations, less current portion

7,903,898

10,474,601

4,723,867

7,903,898

Income taxes payable

357,331

404,975

267,998

357,331

Deferred income taxes

578,732

-

-

363,732

Other long-term liabilities

1,051,587

1,465,200

100,350

1,051,587

Long-term liabilities of discontinued operations

-

215,000

Total long-term liabilities

72,796,085

48,309,097

48,227,573

72,796,085

Total liabilities

205,297,280

133,624,346

200,536,172

205,297,280

Commitment and contingencies (See Note R - Litigation)

 

 

STOCKHOLDERS’ EQUITY

Preferred stock, $0.01 par value; 500,000 shares

authorized, NaN issued or outstanding

-

-

authorized, none issued or outstanding

-

-

Common stock, $0.01 par value; 12,000,000 shares

authorized, 6,026,788 and 4,269,508 shares issued and

outstanding at April 30, 2022 and April 30, 2021, respectively

60,379

42,560

authorized, 6,091,288 and 6,026,788 shares issued and

outstanding at April 30, 2023 and April 30, 2022, respectively

60,634

60,379

Capital in excess of par value

41,654,410

23,751,461

41,986,570

41,654,410

Retained earnings

46,619,208

36,755,040

26,043,823

46,619,208

Total stockholders’ equity

88,333,997

60,549,061

68,091,027

88,333,997

TOTAL LIABILITIES AND

STOCKHOLDERS’ EQUITY

$

293,631,277

$

194,173,407

$

268,627,199

$

293,631,277

The accompanying notes are an integral part of these statements.

F-5


SigmaTron International, Inc. and Subsidiaries

CONSOLIDATED STATEMENTS OF OPERATIONS

Years ended April 30, 20222023 and 20212022

2022

2021

2023

2022

Net sales

$

378,866,424 

$

277,718,672 

$

414,435,845

$

378,316,495

Cost of products sold

334,434,553 

252,766,475 

362,982,248

333,925,226

Gross profit

44,431,871 

24,952,197 

51,453,597

44,391,269

Selling and administrative expenses

28,902,071 

21,562,413 

26,495,951

25,981,794

Impairment of notes receivable and investment

6,300,235 

-

Operating income

9,229,565 

3,389,784 

24,957,646

18,409,475

Gain on extinguishment of long-term debt

(6,282,973)

-

-

6,282,973

Other (income) expense

(153,614)

81,000 

Other income

632,223

153,614

Interest expense, net

1,500,294 

1,210,024 

(8,403,904)

(1,500,140)

Income before income taxes

14,165,858 

2,098,760 

17,185,965

23,345,922

Income tax expense

4,301,690 

557,741 

(2,991,541)

(4,980,003)

NET INCOME

$

9,864,168 

$

1,541,019 

Net income from continuing operations

$

14,194,424

$

18,365,919

Earnings per common share

Basic

$

2.04 

$

0.36 

Discontinued operations:

Loss before tax from discontinued operations

(36,629,902)

(9,180,064)

Tax benefit from discontinued operations

1,860,093

678,313

Net loss from discontinued operations

$

(34,769,809)

$

(8,501,751)

Diluted

$

1.92 

$

0.36 

Net (loss) income

$

(20,575,385)

$

9,864,168

Basic (loss) earnings per common share:

Income from continuing operations

2.34

3.81

Loss from discontinued operations

(5.73)

(1.77)

Basic (loss) earnings per common share:

$

(3.39)

$

2.04

Diluted (loss) earnings per common share:

Income from continuing operations

2.34

3.58

Loss from discontinued operations

(5.73)

(1.66)

Diluted (loss) earnings per common share:

$

(3.39)

$

1.92

Weighted-average shares of common

stock outstanding

Basic

4,825,360

4,256,094

6,069,680

4,825,360

Diluted

5,129,234

4,301,981

6,069,680

5,129,234

The accompanying notes are an integral part of these statements.

F-6


The accompanying notes are an integral part of these statements.

SigmaTron International, Inc. and Subsidiaries

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

Years ended April 30, 20222023 and 20212022

Capital in

Total

Preferred

Common

excess of par

Retained

stockholders’

stock

stock

value

earnings

equity

Balance at May 1, 2020

$

-

42,265

23,619,513

35,214,021

$

58,875,799

Common stock awards

-

120

74,160

-

74,280

Restricted stock awards

-

175

57,788

-

57,963

Net income

-

-

-

1,541,019

1,541,019

Balance at April 30, 2021

-

42,560

23,751,461

36,755,040

60,549,061

Common stock awards

-

-

622,244

-

622,244

Exercise of stock options

-

1,857

915,735

-

917,592

Restricted stock awards

-

176

127,340

-

127,516

Issuance of stock

-

320

276,800

-

277,120

Issuance of stock for acquisition

-

24,439

25,220,738

-

25,245,177

Purchase of treasury stock related to acquisition

-

(8,973)

(9,259,908)

-

(9,268,881)

Net income

-

-

-

9,864,168

9,864,168

Balance at April 30, 2022

$

-

$

60,379

$

41,654,410

$

46,619,208

$

88,333,997

Capital in

Total

Preferred

Common

excess of par

Retained

stockholders’

stock

stock

value

earnings

equity

Balance at April 30, 2021

-

42,560

23,751,461

36,755,040

60,549,061

Recognition of stock-based compensation

-

-

622,244

-

622,244

Exercise of stock options

-

1,857

915,735

-

917,592

Restricted stock awards

-

176

127,340

-

127,516

Issuance of stock for settlement of
lease agreement

-

320

276,800

-

277,120

Issuance of stock for acquisition

-

24,439

25,220,738

-

25,245,177

Purchase of treasury stock related to
acquisition

-

(8,973)

(9,259,908)

-

(9,268,881)

Net loss from discontinued operations

-

-

-

(8,501,751)

(8,501,751)

Net income from continuing
operations

-

-

-

18,365,919

18,365,919

Balance at April 30, 2022

$

-

$

60,379

$

41,654,410

$

46,619,208

$

88,333,997

Recognition of stock-based compensation

-

-

184,343

-

184,343

Restricted stock awards

-

255

147,817

-

148,072

Net loss from discontinued operations

-

-

-

(34,769,809)

(34,769,809)

Net income from continuing
operations

-

-

-

14,194,424

14,194,424

Balance at April 30, 2023

$

-

$

60,634

$

41,986,570

$

26,043,823

$

68,091,027

The accompanying notes are an integral part of these statements.

F-7


SigmaTron International, Inc. and Subsidiaries

CONSOLIDATED STATEMENTS OF CASH FLOWS

Years ended April 30, 20222023 and 20212022

2022

2021

2023

2022

Cash flows from operating activities

Net income

$

9,864,168 

$

1,541,019 

Net income from continuing operations

$

14,194,424

$

18,365,919

Net loss from discontinued operations

(34,769,809)

(8,501,751)

Adjustments to reconcile net income to net

cash (used in) provided by operating activities

Depreciation and amortization of property, machinery and equipment

5,736,318 

5,124,121 

cash used in operating activities from continuing operations

Depreciation and amortization of property, machinery and
equipment

5,817,659

5,720,157

Stock-based compensation

622,244 

74,280 

184,343

622,244

Restricted stock expense

127,516 

57,963 

148,072

127,516

Impairment of notes receivable and investment

6,300,235 

-

-

6,300,235

Provision for inventory obsolescence

1,711,599 

1,172,995 

488,000

1,711,599

Deferred income tax expense (benefit)

1,154,012 

(1,550,914)

(2,362,771)

1,154,012

Gain on extinguishment of long-term debt

(6,282,973)

-

-

(6,282,973)

Amortization of intangible assets

547,271 

354,200 

339,133

346,586

Amortization of financing fees

81,130 

319,780 

358,515

81,130

Gain from involuntary conversion on non-monetary assets due to fire

(469,849)

-

Loss from disposal or sale of machinery and equipment

24,970 

209,260 

15,419

24,970

Changes in operating assets and liabilities, net of acquisition

Accounts receivable

(12,188,024)

2,021,815 

(5,328,740)

(12,288,539)

Inventories

(68,314,626)

(12,072,227)

(2,819,297)

(68,297,962)

Prepaid expenses and other assets

(1,584,175)

(6,911,655)

5,954,202

(1,784,499)

Refundable and prepaid income taxes

(850,207)

1,311,204 

468,790

(850,207)

Income taxes payable

(576,592)

814,717 

150,109

(576,592)

Trade accounts payable

32,824,474 

6,885,498 

(20,702,026)

33,299,432

Deferred revenue

10,487,828 

423,971 

(3,179,709)

10,487,828

Operating lease liabilities

(2,552,673)

5,886,387 

(3,780,682)

(2,552,673)

Accrued expenses and wages

2,640,106 

2,436,532 

(2,732,396)

10,094

Net cash (used in) provided by operating activities

(20,227,399)

8,098,946 

Cash flows from investing activities

Net cash used in operating activities from continuing operations

(13,256,804)

(14,381,723)

Cash flows from investing activities from continuing operations

Purchases of machinery and equipment

(4,749,532)

(4,747,316)

(4,334,169)

(4,740,100)

Cash assumed from acquisition

558,274 

-

Proceeds from the sale of business

1

-

Advances on notes receivable

(5,512,000)

(5,481,500)

(900,000)

(5,512,000)

Net cash used in investing activities

(9,703,258)

(10,228,816)

Proceeds from insurance settlement

54,921

-

Net cash used in investing activities from continuing operations

(5,179,247)

(10,252,100)

Cash flows from financing activities

Proceeds from the exercise of common stock options

917,592 

-

-

917,592

Proceeds under equipment note

1,412,005 

3,345,915 

416,728

1,412,005

Payments under finance lease and sale leaseback agreements

(1,855,822)

(1,988,106)

Payments under finance and sale leaseback agreements

(1,695,829)

(1,855,822)

Payments under equipment note

(1,133,352)

(722,554)

(1,094,905)

(1,133,352)

Proceeds under building notes payable

-

6,500,000 

Payments under building notes payable

(478,423)

(6,484,798)

(6,042,197)

(478,423)

Borrowings under term loan agreement

40,000,000

-

Payments under term loan agreement

(750,000)

-

Borrowings under revolving line of credit

450,182,580 

367,450,952

454,991,301

450,182,580

Payments under revolving line of credit

(418,758,090)

(369,127,270)

(460,103,679)

(418,758,090)

Payments of debt financing costs

(514,672)

(114,485)

(1,566,032)

(514,672)

Payments of debt

(295,747)

-

Net cash provided by (used in) financing activities

29,476,071 

(1,140,346)

Change in cash and cash equivalents

(454,586)

(3,270,216)

F-8


SigmaTron International, Inc. and Subsidiaries

CONSOLIDATED STATEMENTS OF CASH FLOWS CONTINUED

Years ended April 30, 20222023 and 20212022

Payments of debt

-

(295,747)

Net cash provided by financing activities

24,155,387

29,476,071

Cash flows from discontinued operations:

Net cash used in operating activities

(7,264,377)

(5,843,456)

Net cash used in investing activities

(134,419)

548,842

Net cash used in discontinued operations

(7,398,796)

(5,294,614)

Change in cash and cash equivalents

(1,679,460)

(452,366)

Cash and cash equivalents at beginning of year

3,509,229

6,779,445

2,498,589

2,950,955

Cash and cash equivalents at end of year

$

3,054,643 

$

3,509,229 

$

819,129

$

2,498,589

2022

2021

2023

2022

Supplementary disclosures of cash flow information

Cash paid for interest

$

1,470,789 

$

1,179,064 

$

7,765,467

$

1,470,789

Cash paid for income taxes

4,575,349 

474,931 

2,650,641

4,575,349

Purchase of machinery and equipment financed

under finance leases

3,435,498 

837,224 

1,599,456

3,435,498

Financing of insurance policy

201,226 

145,558 

391,437

201,226

Issuance of stock for settlement of lease agreement

277,120 

-

-

277,120

The accompanying notes are an integral part of these statements.

F-9


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

April 30, 20222023 and 20212022

NOTE A - DESCRIPTION OF THE BUSINESS

SigmaTron International, Inc., its subsidiaries, foreign enterprises and international procurement office (collectively, the “Company”) operates in 2 reportable segmentsoperated as an independent provider of electronic manufacturing services (“EMS”), and a provider of products to the Pet Tech market. The Pet Tech Segment was sold, effective as of April 1, 2023. The EMS segment includes printed circuit board assemblies, electro-mechanical subassemblies and completely assembled (box-build) electronic products. The Pet Tech reportable segment offersoffered electronic products such as the Freedom Smart Dog Collar,Collar™, a wireless geo-mapped fence and wellness system, andalong with apparel and accessories. In connection with the production of assembled products, the CompanyEMS segment also provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; (6) assistance in obtaining product approval from governmental and other regulatory bodies and (7) compliance reporting.

During the fourth quarter of fiscal 2023, the Company exited its active involvement in the Pet Tech business that is conducted by Wagz through the sale by the Company of a majority stake in Wagz, effective as of April 1, 2023. The Company entered into a Stock Purchase Agreement (“SPA”) by and among the Company, Wagz, Vynetic LLC, a Delaware limited liability company (“Buyer”), and Terry B. Anderton, co-founder of Wagz and principal of Buyer (“Anderton”), pursuant to which the Company sold to Buyer 81% of the issued and outstanding shares of common stock of Wagz (the “Shares”) for the purchase price of one dollar. Under the SPA, the Company also agreed to provide a $900,000 working capital term loan (the “Wagz Loan”) to Wagz during the month of April 2023. The Company agreed to work with Wagz as an EMS provider pursuant to a manufacturing agreement, but the Company did not commit to extending any further financial support beyond the Wagz Loan. On April 28, 2023, the sale of the majority interest in Wagz pursuant to the SPA was consummated effective as of April 1, 2023, and as a result, as of the closing, the Company holds a minority 19% ownership of the shares and Buyer holds a majority 81% of the shares.

As of April 30, 2022,2023, the Company provided these manufacturing services through an international network of facilities located in the United States, Mexico, China, Vietnam and Taiwan. Approximately 35%37% of the total assets of the Company are located in foreign jurisdictions outside the United States as of April 30, 2022, 20%2023; 25% and 12%10% of the total assets were located in Mexico and China, respectively, and 3%2% in other foreign locations. As of April 30, 2021,2022, approximately 39%35% of the total assets were located in foreign jurisdictions, 21%jurisdictions; 20% and 15%12% were located in China and Mexico, respectively, and 3% in other foreign locations.

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Consolidation Policy

The consolidated financial statements include the accounts and transactions of SigmaTron International, Inc. (“SigmaTron”), its wholly-owned subsidiaries, Standard Components de Mexico, S.A., AbleMex S.A. de C.V., Digital Appliance Controls de Mexico, S.A. de C.V., Spitfire Controls (Vietnam) Co. Ltd., and Spitfire Controls (Cayman) Co. Ltd., Wagz, Inc. and SigmaTron International Trading Co., wholly-owned foreign enterprises SuzhouWujiang SigmaTron Electronics Co. Ltd., and Wujiang SigmaTron Electronic Technology Co., Ltd. (collectively, “SigmaTron China”), and its international procurement office, SigmaTron Taiwan.International Inc. Taiwan Branch, and Wagz, Inc. (majority of business sold, effective as of April 1, 2023). The functional currency of the Mexican, Vietnamese and Chinese subsidiaries and procurement branch is the U.S. Dollar. Intercompany transactions are eliminated in the consolidated financial statements. The impact of currency fluctuations for the fiscal year ended April 30, 2022,2023, resulted in net foreign currency transaction losses of $412,218$892,642 compared to net foreign currency losses of $285,389$412,218 in the prior year.

F-10


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Discontinued Operations

On April 1, 2023, SigmaTron completed the sale of its Wagz, Inc. business. In accordance with the authoritative guidance for discontinued operations (Accounting Standards Codification (ASC) 205-20), the Company determined that the Wagz, Inc. business met discontinued operations accounting criteria at the end of the fourth quarter of fiscal year 2023. The results of the Wagz, Inc. business and the related cash flows have been reported as discontinued operations in the Consolidated Statements of Operations and Consolidated Statements of Cash Flows, respectively, through the date of sale. These changes have been applied to all periods presented. See Note P — Discontinued Operations, for additional information.

Use of Estimates

The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates made in preparing the consolidated financial statements include depreciation and amortization periods, the allowance for doubtful accounts, excess and obsolete reserves for inventory, deferred income, deferred taxes, valuation allowance for deferred taxes and valuation of goodwill and long-lived assets. Actual results could materially differ from these estimates.

Cash and Cash Equivalents

Cash and cash equivalents include cash and all highly liquid short-term investments with original maturities within three months of the purchase date.

F-10


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2022 and 2021

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Accounts Receivable

The majority of the Company’s accounts receivable are due from companies in the industrial electronics, consumer electronics and medical/life sciences industries. Credit is extended based on evaluation of a customer’s financial condition, and, generally, collateral is not required. Accounts receivable are due in accordance with agreed upon terms, and are stated at amounts due from customers net of an allowance for doubtful accounts. Accounts outstanding longer than the contractual payments terms are considered past due. The Company writes off accounts receivable when they are determined to be uncollectible.

Financing Receivables

The Company has arrangements with various financial institutions to sell certain eligible accounts receivable balances from specific customers without recourse. The accounts receivable balances sold are at the election of the Company. The Company incurred fees for such sales, which are reflected as selling and administrative expenses on the Company’s Consolidated Statements of Operations and were not material for the fiscal years ended April 30, 20222023 and 2021.2022.  The accounts receivable balances are derecognized at the time of sale, as the Company does not have continuing involvement after the point of sale. During the years ended April 30, 20222023 and April 30, 2021,2022, the Company sold without recourse trade receivables of approximately $121,000,000$94,000,000 and $78,000,000,$121,000,000, respectively. Cash proceeds from these agreements are reflected as operating activities included in the change in accounts receivable in the Company's Consolidated Statements of Cash Flows.

F-11


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Allowance for Doubtful Accounts

The Company’s allowance for doubtful accounts relates to receivables not expected to be collected from its customers. This allowance is based on management’s assessment of specific customer balances, considering the age of receivables and financial stability of the customer and a five yearfive-year average of prior uncollectible amounts. If there is an adverse change in the financial condition of the Company’s customers, or if actual defaults are higher than provided for, an addition to the allowance may be necessary.

Inventories

Inventories are valued at cost. Cost is determined by an average cost method and the Company allocates labor and overhead to work-in-process and finished goods. In the event of an inventory write-down, the Company records expense to state the inventory at lower of cost or net realizable value. The Company establishes inventory reserves for shrinkage and excess and obsolete inventory. The Company records provisions for inventory shrinkage based on historical experience to account for unmeasured usage or loss. Of the Company’s raw materials inventory, a substantial portion has been purchased to fulfill committed future orders or for which the Company is contractually entitled to recover its costs from its customers. For the remaining raw materials inventory, a provision for excess and obsolete inventories is recorded for the difference between the cost of inventory and its estimated realizable value based on assumptions about future product demand and market conditions. Upon a subsequent sale or disposal of the impaired inventory, the corresponding reserve is relieved to ensure the cost basis of the inventory reflects any reductions. Actual results differing from these estimates could significantly affect the Company’s inventories and cost of products sold as the inventory is sold or otherwise relieved.

F-11


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2022 and 2021

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Property, Machinery and Equipment

Property, machinery and equipment are valued at cost. The Company provides for depreciation and amortization using the straight-line method over the estimated useful life of the assets:

Buildings 

20 years

Machinery and equipment 

5-12 years

Office equipment and software

3-5 years

Tools and dies

12 months

Leasehold improvements

lesser of lease term or useful life

Expenses for repairs and maintenance are charged to selling and administrative expenses as incurred.

Deferred Financing Costs

Deferred financing costs consist of costs incurred to obtain the Company’s long-term debt and are amortized using the straight line method, which approximates the effective interest method, over the term of the related debt. Deferred financing fees of $401,040$1,608,558 and $353,438$401,040 net of accumulated amortization of $99,477$457,992 and $18,347,$99,477, respectively, as of April 30, 20222023 and 2021,2022, respectively, are deducted from long term debt on the Company’s Consolidated Balance Sheet.

Risks and Uncertainties

A pandemic of respiratory diseases, including variants (commonly known as "COVID-19") began to spread globally, including to the United States, in early 2020. The full impact of the COVID-19 outbreak is inherently uncertain at the time of this report. The COVID-19 outbreak has resulted in disruption to the Company’s global supply chain, caused by supplier plant closings or reduced operations thus reducing output at those facilities. The full extent to which COVID-19 impacts the Company’s business, results of operations and financial condition will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the outbreak within the U.S., China, Mexico, Vietnam and Taiwan, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume.

Even after COVID-19 has subsided, the Company may continue to experience materially adverse impacts to its business as a result of its global economic impact, including any recession that has occurred or may occur in the future. There are no comparable recent events which may provide guidance as to the effect of the spread of COVID-19, and, as a result, the ultimate impact of COVID-19, or a similar health epidemic or pandemic, is highly uncertain and subject to change. To date, the Company has been able to continue to meet the needs of its customers. Although the Company cannot estimate the length or gravity of the impact of the COVID-19 outbreak at this time, if the pandemic continues, it may have a material adverse effect on the Company’s results of future operations, financial position, and liquidity in fiscal year 2023.

F-12


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Risks and Uncertainties

Since 2020, the global COVID-19 pandemic has created significant business disruption and economic uncertainty which adversely impacted our manufacturing operations, supply chain, and distribution channels. While the immediate impacts of the COVID-19 pandemic have been assessed, the long-term effects of the disruption, including supply chain disruption, and resulting impact on the global economy and capital markets remain unpredictable, and depend on future developments such as the potential resurgence of the crisis, variant strains of the virus, vaccine availability and effectiveness, and future government actions in response to the crisis. This unpredictability could limit our ability to respond to future developments quickly.

Income Taxes

The Company’s income tax expense, deferred tax assets and liabilities and reserves for unrecognized tax benefits reflect management’s best assessment of estimated future taxes to be paid. The Company is subject to income taxes in both the U.S. and several foreign jurisdictions. Significant judgments and estimates by management are required in determining the consolidated income tax expense assessment.

Deferred income tax assets and liabilities are determined based on differences between financial reporting and tax basis of assets and liabilities, and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. In evaluating the Company’s ability to recover its deferred tax assets within the jurisdiction from which they arise, the Company considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial operations. In projecting future taxable income, the Company begins with historical results and changes in accounting policies, and incorporates assumptions including the amount of future state, federal and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment and estimates by management about the forecasts of future taxable income and are consistent with the plans and estimates the Company uses to manage the underlying businesses. In evaluating the objective evidence that historical results provide, the Company considers three years of cumulative operating income and/or loss. Valuation allowances are established when necessary to reduce deferred income tax assets to an amount more likely than not to be realized.

A tax benefit from an uncertain tax position may only be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits.

The calculation of the Company’s tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across its global operations. Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future. Except as noted below, management is not aware of any such changes that would have a material effect on the Company’s results of operations, cash flows or financial position.

The Company adjusts its tax liabilities when its judgment changes as a result of the evaluation of new information not previously available. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from its current estimate of the tax liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which they are determined.

F-13


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Earnings per Share

Basic earnings per share are computed by dividing net income (loss) (the numerator) by the weighted-average number of common shares outstanding (the denominator) for the period. The computation of diluted earnings per share is similar to the computation of basic earnings per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potentially dilutive common stock equivalents such as stock options and restricted stock, had been exercised or vested. There were 0105,286 anti-dilutive common stock equivalents and 167,910no anti-dilutive common stock equivalents at April 30, 20222023 and April 30, 2021,2022, respectively, which have been excluded from the calculation of diluted earnings per share.

Fiscal Years Ended

Fiscal Years Ended

April 30,

April 30,

2022

2021

2023

2022

Net income

$

9,864,168 

$

1,541,019 

Net income from continuing operations

$

14,194,424

$

18,365,919

Net loss from discontinued operations

(34,769,809)

(8,501,751)

Total net (loss) income

(20,575,385)

9,864,168

Weighted-average shares

Basic

4,825,360

4,256,094

6,069,680

4,825,360

Effect of dilutive stock options

303,874 

45,887 

-

303,874

Diluted

5,129,234 

4,301,981 

6,069,680

5,129,234

Basic earnings per share

$

2.04 

$

0.36 

Basic (loss) earnings per common share

Basic earnings per share from continuing operations

2.34

3.81

Basic loss per share from discontinued operations

(5.73)

(1.77)

Basic total (loss) earnings per share

$

(3.39)

$

2.04

Diluted earnings per share

$

1.92 

$

0.36 

Diluted (loss) earnings per common share

Diluted earnings per share from continuing operations

2.34

3.58

Diluted loss per share from discontinued operations

(5.73)

(1.66)

Diluted total (loss) earnings per share

$

(3.39)

$

1.92

Revenue Recognition

The Company recognizes revenue when control of the promised goods or services are transferred to its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company’s primary performance obligation to its customers is the production of finished goods electronic assembly products pursuant to purchase orders. The Company has concluded that control of the products it sells and transfers to its customers and an enforceable right to receive payment is customarily established at the point in time when the finished goods are shipped to its customers, or in some cases delivered pursuant to the specified shipping terms of each customer arrangement. With respect to consignment arrangements, control transfers and revenue is recognized at the point in time when the goods are shipped to the customer from the consignment location or when delivered to the customer (pursuant to agreed upon shipping terms). In those limited instances where finished goods delivered to the customer location are stored in a segregated area which are not controlled by the customer (title transfer) until they are pulled from the segregated area and consumed by the Company’s customer, revenue is recognized upon consumption. For tooling services, the Company’s performance obligation is satisfied at the point in time when the customer takes legal possession of dies or molds, which accounted for less than 1% of the Company’s

F-14


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Revenue Recognition - Continued

revenue. For engineering, design, and testing services, the Company’s performance obligations are satisfied over time as the respective services are rendered as its customers simultaneously derive value from the Company’s performance.

From the time that a customer purchase order is received and contract is established, the Company’s performance obligations are typically fulfilled within a few weeks after receipt of all material. The Company does not have any performance obligations that require more than 12 months to fulfill.

F-14


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2022 and 2021

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Revenue Recognition - Continued

Each customer purchase order sets forth the transaction price for the products and services purchased under that arrangement. The Company evaluates the credit worthiness of its customers and exercises judgment to recognize revenue based upon the amount the Company expects to be paid for each sales transaction it enters into with its customers. Some customer arrangements include variable consideration, such as volume rebates, some of which depend upon the Company’s customers meeting specified performance criteria, such as a purchasing level over a period of time. The Company exercises judgment to estimate the most likely amount of variable consideration at each reporting date.

The Company’s typical payment terms are 30 days and its sales arrangements do not contain any significant financing component for its customers. The Company’s customer arrangements do not generate contract assets or liabilities that are material to the consolidated financial statements.

Contract liabilities consist of payments received in advance of the transfer of control to the customer. As products are delivered and control transfers, the Company recognizes the deferred revenue in net sales in the Consolidated Statements of Operations. The following table summarizes the deferred revenue associated with payments received in advance of the transfer of control to the customer reported as deferred revenue in the Consolidated Balance Sheets and amounts recognized through net sales for each period presented.

Fiscal Years Ended

April 30,

2023

2022

Contract Liability (deferred revenue)

$

8,063,197

$

11,394,820

Revenue recognized in the period from
amounts included in the contact liability
at the beginning of the period

$

11,394,820

$

423,971

The Company generally provides a warranty for workmanship, unless the assembly was designed by the Company, in which case it warrants assembly/design. The Company assembles and tests assemblies based on customers’ specifications prior to shipment. Historically, the amount of returns for workmanship issues has been de minimis under the Company’s standard or extended warranties. The Company does not provide its customers the option to purchase additional warranties and, therefore, the Company’s warranties are not considered a separate service or performance obligation.

The Company utilizes the practical expedient to treat shipping and handling activities after the customer obtains control as fulfillment activities. The Company records shipping and handling costs as selling and administrative expenses and costs are accrued when revenue is recognized.

The Company pays sales commissions to its sales representatives which may be considered as incremental costs to obtain a contract. However, since the recoverability period is less than one year, the Company utilizes the practical expedient provided by the revenue recognition accounting standard that allows an entity to expense the costs of obtaining a contract as incurred.

F-15


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Revenue Recognition - Continued

During fiscal year 2022, 02023, no revenues were recognized from performance obligations satisfied or partially satisfied in previous periods and 0no amounts were allocated to performance obligations that remain unsatisfied or partially unsatisfied at April 30, 2022.2023. The Company is electing not to disclose the value of the remaining unsatisfied performance obligation with a duration of one year or less as permitted by the practical expedient in ASU 2014-09, “Revenue from Contracts with Customers.” The Company had no material remaining unsatisfied performance obligations as of April 30, 2022,2023, with an expected duration of greater than one year.

The majority of sales are made to U.S. based customers. The following table presents the Company’s revenue disaggregated by the principal end-user markets it serves:

Year Ended April 30,

Year Ended April 30,

Net sales by end-market

2022

2021

Industrial Electronics

$

209,405,083

$

149,861,832

Consumer Electronics

146,522,237

113,374,065

Medical / Life Sciences

22,939,104

14,482,775

Total Net Sales

$

378,866,424

$

277,718,672

Year Ended April 30,

Year Ended April 30,

Net sales by end-market

2023

2022

Industrial Electronics

$

278,844,264

$

209,405,083

Consumer Electronics

109,043,652

145,972,308

Medical / Life Sciences

26,547,929

22,939,104

Total Net Sales

$

414,435,845

$

378,316,495

F-15


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2022 and 2021

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Shipping and Handling Costs

The Company records shipping and handling costs for goods shipped to customers as selling and administrative expenses. Customers are typically invoiced for shipping costs and such amounts are included in net sales. Shipping and handling costs were not material to the financial statements for fiscal years 20222023 or 2021.2022.

Fair Value Measurements

Fair value measurements are determined based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs. The Company utilizes a fair value hierarchy based upon the observability of inputs used in valuation techniques as follows:

Level 1: Observable inputs such as quoted prices in active markets;

Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and

Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

Fair Value of Financial Instruments

The Company’s financial instruments include cash and cash equivalents, accounts receivable, note receivable, other receivables, accounts payable and accrued expenses which approximate fair value at April 30, 20222023 and April 30, 2021,2022, due to their short-term nature.nature and are considered Level 1.  The carrying amounts of the Company’s debt obligations approximate fair value based on future payments discounted at current interest rates for similar obligations or interest rates which fluctuate with the market.market and are considered Level 2.

Intangible Assets

Intangible assets are comprised of finite life intangible assets including customer relationships, trade names and patents. Finite life intangible assets are amortized on a straight line basis over their estimated useful lives of 20 years for trade names, 18 years for patents, except forand customer relationships which are amortized on an accelerated basis over their estimated useful life of 15 years.

F-16


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Impairment of Long-Lived Assets

The Company reviews long-lived assets, including amortizable intangible assets, for impairment in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 360: Property, Plant and Equipment. Property, machinery and equipment and finite life intangible assets are reviewed whenever events or changes in circumstances occur that indicate possible impairment. If events or changes in circumstances occur that indicate possible impairment, the Company first performs an impairment review based on an undiscounted cash flow analysis at the lowest level at which cash flows of the long-lived assets are largely independent of other groups of its assets and liabilities. This analysis requires management judgment with respect to changes in technology, the continued success of product lines, and future volume, revenue and expense growth rates. If the carrying value exceeds the undiscounted cash flows, the Company records an impairment, if any, for the difference between the estimated fair value of the asset group and its carrying value. The Company further conducts annual reviews of its long-lived asset groups for possible impairment.

During the third quarter of fiscal 2023, the Company revised the financial outlook for the Pet Tech segment, resulting in lower projected sales and net income for future periods. The Company assessed the overall market acceptance of the current Wagz product offerings after the holiday season and determined that this constituted a triggering event for the Company’s long-lived asset groups, primarily consisting of patents, trade names and certain fixed assets. The Company reviewed the undiscounted future cash flows for the identified long-lived asset group, and the results of the analysis indicated the carrying amount for the long-lived group was not expected to be recovered.

The fair value of the identified intangible assets was estimated using the relief from royalty method, which is a risk-adjusted discounted cash flow approach. The relief from royalty method values an intangible asset by estimating the royalties saved through ownership of the asset. The relief from royalty method requires identifying the future revenue that would be generated by the intangible asset, multiplying it by a royalty rate deemed to be avoided through ownership of the asset and discounting the projected royalty savings amounts back to the acquisition date using the internal rate of return.

The Company determined the fair value of the long-lived asset group was lower than its carrying value and recorded an intangible asset impairment charge of $9,527,773 during the third quarter of fiscal 2023. This non-cash charge was recorded to impairment of goodwill and intangible assets on the unaudited condensed consolidated statements of operations as of January 31, 2023. As of April 30, 2023 this non-cash charge has been reported under discontinued operations. See Note H – Intangible Assets and Note P – Discontinued Operations, for more information.

The Company’s analysis for 2022 and 20212023 did not indicate that any

F-16


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2022 and 2021

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Impairment of Long-Lived Assets- Continued

of its other long-lived assets were impaired. The Company has yet to experience significant cancellations of orders; however, the potential impact of future disruptions, continued economic uncertainty over COVID-19 may have a significant adverse impact on the timing of delivery of customer orders and the levels of future customer orders.

Goodwill

Goodwill represents the excess cost over fair value of the net assets of acquired businesses. The Company does not amortize goodwill and intangible assets that have indefinite lives. The Company performs an impairment assessment of goodwill and intangible assets with indefinite lives annually, or more frequently if triggering events occur, based on the estimated fair value of the related reporting unit or intangible asset. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. When performing its annual impairment assessment as of April 30, the Company evaluates the goodwill assigned to each of its reporting units for potential impairment by comparing the estimated fair value of the relevant reporting unit to the carrying value. The Company uses various Level 2 and Level 3 valuation techniques to determine the fair value of its reporting units, including discounting estimated future cash flows based on a cash flow forecast prepared by the relevant reporting unit and market multiples of relevant public companies. If the fair value of a reporting unit is less than its carrying value, a goodwill impairment loss is recorded for the difference. NaN impairment of goodwill was recorded for the year ended April 30, 2022.

Investment in Wagz

The Company had recorded an investment in Wagz, Inc. (“Wagz”), a privately held company whose equity did not have a readily determinable fair value. As permitted by ASC 321, Investments - Equity Securities, paragraph 321-35-2, the Company had elected to carry its investment in Wagz equity at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investments of the same issuer until the investment no longer qualified to be measured under paragraph 321-35-2. The recognized fair value of Wagz common stock was $600,000 at April 30, 2021 which was recorded within Other assets in the Consolidated Balance Sheet. On December 31, 2021, the Company acquired 100% of all outstanding Wagz stock.

On May 29, 2020, the Company and Wagz, a privately held company in the pet technology market, entered into a Convertible Secured Promissory Note in the principal sum of up to $4,052,478. Between January 27, 2021 and December 31, 2021, Wagz issued to the Company additional convertible secured promissory notes and secured notes aggregating to $7,947,522 and $1,380,705, respectively (collectively, the “Notes”) which were accounted for as Notes receivable in the Consolidated Balance Sheet. The Notes were due (the “Maturity Date”) on the earliest to occur of (a) December 31, 2021 or, if the closing of the Company’s proposed acquisition of Wagz (the “Closing”) does not occur due to the Company’s termination, that date which is twelve (12) months after the date of such termination, (b) upon the closing of a sale of all or substantially all of the assets or common stock of Wagz (other than the Closing), or (c) an Event of Default (as defined in the Notes). Interest was payable at the rate of four percent (4%) per annum and was payable on the Maturity Date. The Notes werecollateralized by substantially all assets of Wagz. The Notesdid notmeet the accounting definition of a security and were accounted for under ASC 310, Receivables, at amortized cost.

On December 31, 2021, the Company consummated the merger contemplated by the Agreement and Plan of Merger, dated July 19, 2021, as amended by the First Amendment to Agreement and Plan of Merger dated December 7, 2021 (the “Merger Agreement”). Please refer to Note F – Acquisition, for more information.

F-17


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Investment in WagzGoodwill - Continued

The Company observed during the third quarter of fiscal 2023, the overall lack of market acceptance of the current Wagz product offerings during the holiday season and determined this constituted a triggering event. Accordingly, the Company performed a quantitative goodwill impairment test and estimated the fair value of the Pet Tech segment based on a combination of an income approach (estimates of future discounted cash flows), a market approach (market multiples for similar companies) and a cost approach. Significant unobservable inputs and assumptions inherent in the valuation methodologies, which represented Level 3 inputs, under the fair value hierarchy, were employed and included, but were not limited to, prospective financial information, terminal value assumptions, discount rates, and multiples from comparable publicly traded companies in the Pet Tech industry.

The cost approach is based on upon the concept of replacement cost as an indicator of value. Stated another way, this approach is premised on the assumption that a prudent investor would pay no more for an asset than the amount for which the asset could be replaced. The cost approach establishes value based on the cost reproducing or replacing the property, less depreciation from physical deterioration and functional obsolescence, if present and measurable.

During the third quarter of fiscal 2023, the Company determined its goodwill was fully impaired as the fair value was lower than the carrying value and recorded an impairment charge of $13,320,534. This non-cash charge was recorded to impairment of goodwill and intangible assets on the unaudited condensed consolidated statements of operations. As of April 30, 2023 this non-cash charge has been reported under discontinued operations. See Note P – Discontinued Operations, for more information.

Investment in Wagz

On December 31, 2021, the Company acquired 100% of the stock of Wagz under the terms of the Agreement and Plan of Merger dated July 19, 2021, as amended by the First Amendment to Agreement and Plan of Merger dated December 7, 2021 (the “Merger Agreement”). Wagz has developed and brought to market a high tech pet collar and has multiple other products in development. Wagz is an internet of things (“IoT”) company which both owns intellectual property and secures recurring revenue through subscriptions for its services.

Prior to the acquisition, the Company had an investment in Wagz of $600,000, Convertible Secured Promissory Notes issued by Wagz of $12,000,000 and Secured Promissory Notes issued by Wagz of $1,380,705. Pursuant to the Merger Agreement, prior to the acquisition, the Convertible Secured Promissory Notes converted to 12,000,000 shares of Wagz common stock, resulting in a 25.5% ownership in Wagz. The Company's 25.5% equity interest in Wagz common stock was remeasured to fair value of $6,299,765, resulting in a non-cash impairment charge of $6,300,235. The loss is included in Impairment of notes receivable and investment in operating expenses$6,300,235 within the Statements of Operations during fiscal year 2022.

Pursuant to the Merger Agreement, 2,443,870 shares of common stock of the Company were issued in the merger for a value of 25,245,177, of which 1,546,592 shares are allocated to Wagz shareholders (excluding the Company) for a total value of $15,976,295, and 897,278 shares are allocated to the Company and treated as treasury stock for a total value of $9,268,881, recorded in the Statements of Changes in Stockholders’ Equity for the for fiscal year ended 2022. The fair valuetreasury shares were retired as of April 30, 2022. On April 28, 2023, effective as of April 1, 2023, the Company’s noncontrollingCompany sold a majority of its interest in Wagz, was determined using a market approach. This fair value measurement is based on significant inputs that are not observable in the market and thus represents a fair value measurement categorized within Level 3 of the fair value hierarchy, with a key assumption being the revenue multiple of comparable public companies inwhich operated the Pet Tech market. Seebusiness. Please refer to Note F – Acquisition, for more information.

In November 2020, Wagz sought short-term financing for its operations

F-18


SigmaTron International, Inc. and secured a commitment from Angel Business Credit, LLC (“ABC”) for a loan of $250,000 conditioned on Wagz granting ABC a security interest in its assetsSubsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and Gary R. Fairhead executing a personal guaranty.  Mr. Fairhead is SigmaTron’s CEO; his personal guaranty requires the approval of the Audit Committee of SigmaTron’s Board of Directors.  After consideration, the Audit Committee determined that Mr. Fairhead’s 2022

guaranty was in the best interests of the Company and approved the guaranty.  The loan closed on November 12, 2020, and its principal, plus interest equal to $5,000, were due on the maturity date, December 10, 2020.  The loan was paid in full on December 8, 2020.  As a result, Mr. Fairhead’s guaranty was cancelled and ABC’s security interest was terminated.

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

Stock Incentive Plans

Under the Company’s stock option plans, options to acquire shares of SigmaTron’s common stock have been made available for grant to certain employees. Each option granted has an exercise price of not less than 100% of the market value of the common stock on the date of grant. The contractual life of each option is generally 10 years. The vesting of the grants varies according to the individual options granted. The Company measures the cost of employee services received in exchange for an equity award based on the grant date fair value and records that cost over the respective vesting period of the award.

The Company has a restricted stock plan under which non-employee directors may acquire shares of SigmaTron’s common stock.  The restricted stock plan has been approved by the Company’s stockholders.  The restricted stock plan is interpreted and administered by the Compensation Committee of SigmaTron’s Board of Directors. All awarded stock under the plan vests in six months from the date of grant. Awarded stock under this plan is granted at the closing price of SigmaTron’s common stock on the date of grant.

F-18


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2022 and 2021

NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued

New Accounting Standards

In June 2016, the FASB issued ASU No. 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13, as amended by ASU 2019-04 and ASU 2019-05, that introduces a new forward-looking approach, based on expected losses, to estimate credit losses on certain types of financial instruments, including trade receivables. The estimate of expected credit losses will require entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts. This ASU also expands the disclosure requirements to enable users of financial statements to understand the entity’s assumptions, models and methods for estimating expected credit losses. For smallsmaller reporting companies, ASU 2016- 13 is effective for annual and interim reporting periods beginning after December 15, 2022, and the guidance is to be applied using the modified-retrospective approach. Earlier adoption is permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements but is not expected to have a material impact on the consolidated financial statements.

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”, which provides optional expedients and exceptions for a period of time to ease the potential burden in accounting for the transition from reference rates that are expected to be discontinued. Regulators and market participants in various jurisdictions have undertaken efforts to eliminate certain reference rates and introduce new reference rates that are based on a larger and more liquid population of observable transactions. The amendments in this update apply only to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. In January 2021, the FASB issued clarification on the scope of relief related to the reference rate reform. In December 2022, the FASB extended the period of time entities can use the reference rate reform relief guidance by two years which defers the sunset date from December 31, 2022 to December 31, 2024. The Company is currently evaluating theadopted this ASU in fiscal 2023 and it had no impact of this guidance on its consolidated financial statements.

F-19


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE C - ALLOWANCE FOR DOUBTFUL ACCOUNTS

Changes in the Company’s allowance for doubtful accounts are as follows:

2022

2021

Beginning Balance

$

100,000

$

727,252

Bad debt expense

-

-

Bad debt recovery

-

(331,283)

Write-offs

-

(295,969)

$

100,000

$

100,000

2023

2022

Beginning Balance

$

100,000

$

100,000

Bad debt expense

-

-

Bad debt recovery

-

-

Write-offs

-

-

$

100,000

$

100,000

NOTE D - INVENTORIES

Inventories consist of the following at April 30:

2022

2021

2023

2022

Finished products

$

22,175,641

$

22,858,073

$

22,093,018

$

21,875,390

Work-in-process

5,907,766

5,601,560

5,415,917

5,907,766

Raw materials

140,118,156

72,033,278

142,612,325

140,118,156

168,201,563

100,492,911

170,121,260

167,901,312

Less obsolescence reserve

3,236,347

2,414,310

4,566,061

3,236,347

$

164,965,216

$

98,078,601

$

165,555,199

$

164,664,965

Changes in the Company’s inventory obsolescence reserve are as follows:

2022

2021

2023

2022

Beginning balance

$

2,414,310

$

1,350,362

$

3,236,347

$

2,414,310

Provision for obsolescence

1,711,599

1,172,995

488,000

1,711,599

Provision for Wagz inventory

1,441,063

-

Write-offs

(889,562)

(109,047)

(599,349)

(889,562)

$

3,236,347

$

2,414,310

$

4,566,061

$

3,236,347

F-20


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE E - PROPERTY, MACHINERY AND EQUIPMENT, NET

Property, machinery and equipment consist of the following at April 30:

2022

2021

2023

2022

Land and buildings

$

18,653,248

$

18,633,408

$

18,826,246

$

18,653,248

Machinery and equipment

81,551,714

73,922,923

85,895,593

81,551,714

Office equipment and software

13,934,074

11,943,605

14,675,432

13,738,965

Leasehold improvements

3,016,857

2,907,362

3,137,540

3,016,857

Equipment under finance leases

6,642,719

8,282,487

6,300,225

6,642,719

128,835,036

123,603,503

123,798,612

115,689,785

Less accumulated depreciation

and amortization, including accumulated

amortization of assets under

finance leases of $1,081,476

and $2,439,419 at April 30,

2022 and 2021, respectively

87,825,397

81,502,867

Less accumulated depreciation and amortization,

including accumulated amortization of assets

under finance leases of $1,006,128 and $1,081,476 at April 30,

2023 and 2022, respectively

93,046,679

87,825,397

Property, machinery and

equipment, net

$

35,788,357

$

35,778,106

$

35,973,215

$

34,186,918

Depreciation and amortization expense of property, machinery and equipment was $5,736,318$5,817,659 and $5,124,121$5,720,157 for the fiscal years ended April 30, 20222023 and April 30, 2021,2022, respectively.

NOTE F - ACQUISITION AND DISPOSITION

During the fourth quarter of fiscal 2023, the Company exited its active involvement in the Pet Tech business that is conducted by Wagz through the sale of a majority stake in Wagz, effective as of April 1, 2023. The Company entered into the SPA with Wagz, Buyer and Anderton, pursuant to which the Company sold to Buyer 81% of the Shares for the purchase price of one dollar. Under the SPA, the Company also agreed to provide a Wagz Loan to Wagz during the month of April 2023. The Company agreed to work with Wagz as an EMS provider pursuant to a manufacturing agreement, but the Company did not commit to extending any further financial support beyond the Wagz Loan. On April 28, 2023, the sale of the majority interest in Wagz pursuant to the SPA was consummated with effect as of April 1, 2023, and as a result, as of the closing, the Company holds a minority 19% ownership of the shares and Buyer holds a majority 81% of the shares. See Note P – Discontinued Operations, for more information.

On December 31, 2021, the Company acquired 100% of the stock of Wagz under the terms of the Agreement and Plan of Merger dated July 19, 2021, as amended by the First Amendment to Agreement and Plan of Merger dated December 7, 2021 (the “Merger Agreement”). Wagz has developed and brought to market a high tech pet collar and has multiple other products in development. Wagz is an internet of things (“IoT”) company which both owns intellectual property and secures reoccurringrecurring revenue through subscriptions for its services.

F-21


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE F – ACQUISITION AND DISPOSITION - Continued

Prior to the acquisition, the Company had an investment in Wagz of $600,000, and held Convertible Secured Promissory Notes issued by Wagz of $12,000,000 and Secured Promissory Notes issued by Wagz of $1,380,705. Pursuant to the Merger Agreement, prior to the acquisition, the Convertible Secured Promissory Notes converted to 12,000,000 shares of Wagz common stock, resulting in a 25.5% ownership in Wagz. As described in Note B – Summary of Significant Accounting Policies, theThe Company's 25.5% equity interest in Wagz common stock was remeasured to fair value of $6,299,765, resulting in a non-cash impairment charge of $6,300,235.$6,300,235 within the Statements of Operations during fiscal year 2022.

Pursuant to the Merger Agreement, 2,443,870 shares of common stock of the Company were issued in the merger for a value of $25,245,177, of which 1,546,592 shares are allocated to Wagz shareholders (excluding the Company) for a total value of $15,976,295, and 897,278 shares are allocated to the Company and treated as treasury stock for a total value of $9,268,881, recorded in the Statements of Changes in Stockholders’ Equity under Issuance of stock for acquisition and Purchase of treasury stock related to acquisition, respectively.the fiscal year 2022. The treasury shares were retired as of April 30, 2022.

F-21


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2022 and 2021

NOTE F – ACQUISITION - Continued

The following table summarizes the consideration for the acquisition of Wagz:

Consideration

Issuance of 1,546,592 common stock of SigmaTron

$

15,976,295

Fair value of consideration transferred

15,976,295

Secured Promissory Notes

1,380,173

Fair value of SigmaTron's equity interest in Wagz held
prior to the business combination (Note B)

6,299,765

$

23,656,233

The following table presents the purchase price allocation for Wagz. The Company is accountingaccounted for the acquisition under the acquisition method and is required to measure identifiable assets acquired and liabilities assumed of the acquiree at fair value on the closing date. The fair value of the majority of the assets was determined by a third party valuation firm using management estimates and assumptions including intangible assets of $9,730,000 for patents and $1,230,000 for trade names. The appropriate fair values of the assets acquired and liabilities assumed are based on estimates and assumptions.

The excess consideration was recorded as goodwill of $13,320,534, all of which is non-deductible for tax purposes. Goodwill represents future economic benefits arising from other assets acquired that could not be individually identified including workforce additions, growth opportunities, and increased presence in the Pet Tech market. The recorded goodwill has been assigned to the Pet Tech reportable segment.

Cash

$

508,274

Working capital

224,046

Property, plant and equipment

201,839

Acquired intangible assets

10,960,000

Right-of-use operating lease assets

647,076

Other assets

6,000

Operating lease obligations

(647,077)

Deferred tax liability

(215,000)

Other liabilities

(1,349,459)

Goodwill

13,320,534

Fair value of purchase consideration

$

23,656,233

F-22


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE F – ACQUISITION AND DISPOSITION- Continued

The intangible assets acquired in the Wagz acquisition consisted of the following:

Expected Weighted

Amortization

Fair Value

Period

Trade name

$

1,230,000

20 years

Patents

9,730,000

18 years

$

10,960,000

F-22


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2022 and 2021

NOTE F – ACQUISITION - Continued

The fair value recorded as of April 30, 2022 is based on significant inputs that are not observable in the market and thus represents a fair value measurement categorized within Level 3 of the fair value hierarchy. The key assumptions used in the fair value estimates under the royalty savings method are revenue and market growth, royalty rates, estimated tax rates, and appropriate risk-adjusted weighted-average cost of capital. These assumptions reflect the Company’s best estimates. The fair value of the acquired trade names and patents was determined using the relief from royalty method, which is a risk-adjusted discounted cash flow approach. The relief from royalty method values an intangible asset by estimating the royalties saved through ownership of the asset. The relief from royalty method requires identifying the future revenue that would be generated by the intangible asset, multiplying it by a royalty rate deemed to be avoided through ownership of the asset and discounting the projected royalty savings amounts back to the acquisition date using the internal rate of return.

Acquisition related costs of $592,238 were incurred in relation to the acquisition of Wagz for the fiscal year ended April 30, 2022, which have been reported in selling and administrative expenses in the Company’s Consolidated Statements of Operations.

The amounts of Wagz’s revenue and net income (loss) included in the Company’s Consolidated Statements of Operations for the fiscal year ended April 30, 2022; and the supplemental proforma unaudited revenue and net income (loss) of the combined entity had the acquisition date been May 1, 2020 for the fiscal year ended April 30, 2022, are as follows:

Revenue

Net Income (Loss)

Actual from January 1, 2022 to April 30, 2022

$

562,675

$

(2,651,082)

Supplemental proforma information:

Fiscal year ended April 30, 2022

379,715,845

6,180,584

Fiscal year ended April 30, 2021

278,053,248

(2,200,545)

Supplemental pro forma net income (loss) was adjusted to exclude $592,238 and $705,401 of acquisition-related costs incurred in the fiscal years ended April 30, 2022 and 2021, respectively. Supplemental pro forma net income (loss) was adjusted to include $597,722 of amortization costs incurred in the fiscal year ended April 30, 2022. Supplemental pro forma net income (loss) was adjusted to include $597,722 of amortization costs incurred in the fiscal year ended April 30, 2021.

NOTE G – SEGMENT AND GEOGRAPHIC AREA INFORMATION

The Company’s reportable segments are strategic business units that offer different products and services. They are managed separately because each business requires different technology and marketing strategies. Separate financial information is regularly evaluated by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources. For the Company, the CODM is the Company’s Chief Executive Officer.

The EMS reportable segment includes printed circuit board assemblies, electro-mechanical subassemblies and completely assembled (box-build) electronic products. In connection with the production of assembled products, the CompanyEMS segment provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; (6) assistance in obtaining product approval from governmental and other regulatory bodies and (7) compliance reporting. The EMS segment produces the Freedom Smart Dog Collar™ sold by the Pet Tech segment.

The Pet Tech reportable segment offersoffered electronic products such as the Freedom Smart Dog Collar,Collar™, a wireless geo-mapped fence and wellness system, andalong with apparel and accessories.

F-23


SigmaTron International, Inc. The Pet Tech Segment was sold, effective as of April 1, 2023. The results for the Pet Tech Segment are reported as discontinued operations for fiscal 2023 and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2022 and 2021

NOTE G – SEGMENT AND GEOGRAPHIC AREA INFORMATION - Continuedfiscal 2022.

The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in Note-A Description of the Business. The CODM allocates resources to and evaluates the performance of each operating segment based on operating income.

F-23


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE G – SEGMENT AND GEOGRAPHIC AREA INFORMATION - Continued

The tables below present information about the Company’s reportable segments.

Fiscal Year Ended April 30, 2022

Fiscal Year Ended April 30, 2023

EMS

Pet Tech

EMS

Pet Tech

Segment

Segment

Consolidated

Segment

Segment

Consolidated

Net sales

$

378,303,749

$

562,675

$

378,866,424

Net sales (1) (2)

$

414,435,845

$

1,598,929

$

416,034,774

Operating income (loss)(2)

18,180,961

(8,951,396)

9,229,565

24,957,646

(32,887,193)

(7,929,547)

Gain on extinguishment of long-term debt

(6,282,973)

Other income

(153,614)

632,223

Interest expense, net

1,500,294

(8,403,904)

Income before income taxes

$

14,165,858

Loss before income taxes

$

(15,701,228)

Purchases of machinery and equipment

4,742,716

6,816

4,749,532

4,334,169

134,419

4,468,588

Depreciation and amortization

5,519,471

216,847

5,736,318

5,817,659

45,877

5,863,536

Identifiable assets

$

269,945,611

$

23,685,666

$

293,631,277

$

268,627,199

$

$

268,627,199

(1)The EMS segment manufactures products sold to the Pet Tech segment. Related intersegment sales of $938,370 have been eliminated.

(2)The results for the Pet Tech Segment are reported as discontinued operations for fiscal 2023 and fiscal 2022.

Fiscal Year Ended April 30, 2021

Fiscal Year Ended April 30, 2022

EMS

Pet Tech

EMS

Pet Tech

Segment

Segment

Consolidated

Segment

Segment

Consolidated

Net sales

$

277,718,672

$

-

$

277,718,672

Net sales (1) (2)

$

378,316,495

$

549,929

$

378,866,424

Operating income

3,389,784

-

3,389,784

Operating income (loss) (2)

18,409,475

(9,180,064)

9,229,411

Other expense

81,000

Gain on extinguishment of long-term debt

6,282,973

Other income

153,614

Interest expense, net

1,210,024

(1,500,140)

Income before income taxes

$

2,098,760

$

14,165,858

Purchases of machinery and equipment

4,747,316

-

4,747,316

4,740,100

9,432

4,749,532

Depreciation and amortization

5,124,121

-

5,124,121

5,720,157

16,161

5,736,318

Identifiable assets(2)

$

194,173,407

$

-

$

194,173,407

$

268,350,438

$

25,280,839

$

293,631,277

(1)The EMS segment manufactures products sold to the Pet Tech segment. Related intersegment sales of $213,298 have been eliminated.

(2)The results for the Pet Tech Segment are reported as discontinued operations for fiscal 2023 and fiscal 2022.

F-24


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE G – SEGMENT AND GEOGRAPHIC AREA INFORMATION - Continued

The following tables set forth net sales from continuing operations and tangible long-lived assets by geographic area where the Company operates. Tangible long-lived assets include property, plant and equipment and operating lease assets.

Fiscal Year Ended

Fiscal Year Ended

April 30, 2022

April 30, 2021

April 30, 2023

April 30, 2022

Net sales:

U.S.

$

89,669,649

$

69,125,385

$

117,389,877

$

89,119,720

China

46,347,260

36,030,112

48,584,165

46,347,260

Vietnam

13,981,553

13,783,899

11,523,284

13,981,553

Mexico

228,867,962

158,779,276

236,938,519

228,867,962

Total net sales

$

378,866,424

$

277,718,672

$

414,435,845

$

378,316,495

Fiscal Year Ended

Fiscal Year Ended

April 30, 2022

April 30, 2021

April 30, 2023

April 30, 2022

Tangible long-lived assets, net:

U.S.

$

18,428,633

$

17,696,043

$

20,371,298

$

21,538,417

China

16,971,500

16,969,792

4,212,780

5,060,021

Mexico

9,340,161

10,144,530

17,574,899

18,839,855

Other

2,179,686

2,392,538

854,803

1,286,577

Total tangible long-lived assets, net

$

46,919,979

$

47,202,904

$

43,013,780

$

46,724,870

F-25


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE H - INTANGIBLE ASSETS

Intangible Assets

Intangible assets subject to amortization are summarized as of April 30, 2022 and April 30, 2021,2023 as follows:

April 30, 2022

April 30, 2021

April 30, 2023

Gross

Gross

Gross

Carrying

Accumulated

Carrying

Accumulated

Carrying

Accumulated

Impairment

Write Off

Net Intangible

Amount

Amortization

Amount

Amortization

Amount

Amortization

Amount

Amount

Asset Balance

Spitfire:

Non-contractual customer relationship

4,690,000 

3,039,837 

4,690,000 

2,693,251 

4,690,000

3,378,970

-

-

1,311,030

Wagz:

Trade name

1,230,000 

20,500 

-

-

1,230,000

68,380

813,960

347,660

-

Patents

9,730,000 

180,185 

-

-

9,730,000

586,313

8,713,813

429,874

-

Total

$

15,650,000 

$

3,240,522 

$

4,690,000 

$

2,693,251 

$

15,650,000

$

4,033,663

$

9,527,773

$

777,534

$

1,311,030

Estimated aggregateIntangible assets subject to amortization expense for the Company’s intangible assets, which become fully amortized in 2040, for the remaining fiscal years isare summarized as of April 30, 2022, as follows:

For the fiscal years ending April 30:

2023

$

941,184 

2024

933,898 

2025

926,758 

2026

919,751 

2027

912,956 

Thereafter

7,774,931 

$

12,409,478 

Amortization expense was $547,271 and $354,200 for the years ended April 30, 2022 and April 30, 2021, respectively.

April 30, 2022

Gross

Carrying

Accumulated

Net Intangible

Amount

Amortization

Asset Balance

Spitfire:

Non-contractual customer relationship

4,690,000

3,039,837

1,650,163

Wagz:

Trade name

1,230,000

20,500

1,209,500

Patents

9,730,000

180,185

9,549,815

Less intangible assets of discontinued operations

10,960,000

200,685

10,759,315

$

4,690,000

$

3,039,837

$

1,650,163

F-26


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE H - INTANGIBLE ASSETS - Continued

Estimated aggregate amortization expense for the Company’s intangible assets, which become fully amortized in 2028, for the remaining fiscal years is as follows:

For the fiscal years ending April 30:

2024

$

331,842

2025

324,702

2026

317,728

2027

310,900

2028

25,858

$

1,311,030

Amortization expense was $339,133 and $346,586 for the years ended April 30, 2023 and April 30, 2022, respectively.

NOTE I - LONG-TERM DEBT

Debt and finance lease obligations consisted of the following at April 30, 20222023 and April 30, 2021:2022:

2022

2021

2023

2022

Debt:

Notes Payable - Banks

$

56,830,377

$

32,137,919

$

90,968,000

$

56,830,377

Notes Payable - Buildings

6,459,340

6,937,763

417,143

6,459,340

Notes Payable - Equipment

4,202,292

3,923,639

3,524,115

4,202,292

Unamortized deferred financing costs

(401,040)

(353,438)

(1,608,558)

(401,040)

Total debt

67,090,969

42,645,883

93,300,700

67,090,969

Less current maturities

6,991,567

7,862,058

Less current maturities*

52,761,520

6,991,567

Long-term debt

$

60,099,402

$

34,783,825

$

40,539,180

$

60,099,402

Finance lease obligations

$

4,215,810

$

2,636,134

$

4,119,437

$

4,215,810

Less current maturities

1,410,675

1,455,638

1,523,259

1,410,675

Total finance lease obligations, less current portion

$

2,805,135

$

1,180,496

$

2,596,178

$

2,805,135

* Due to availability being less than 10% of the Revolving Commitment,the Facility (as defined below) has been classified as a current liability on the Consolidated Balance Sheet as of April 30, 2023.

Notes Payable - Banks

Prior to January 29, 2021, the Company had a senior secured credit facility with U.S. Bank National Association (“U.S. Bank”).  The revolving credit facility allowed the Company to borrow up to the lesser of (i) $45,000,000 (the“Revolving Line Cap”) less reserves or (ii) the Borrowing Base, but no more than 80% of the Company’s Revolving Line Cap. Prior to its payoff and termination, the U.S. Bank senior secured credit facility was due to expire on March 31, 2022. On January 29, 2021, the Company paid the balance outstanding under the senior secured credit facility in the amount of $25,574,733. The unamortized deferred financing costs of $158,476 were expensed in fiscal year 2021 upon extinguishment of the debt.– Secured lenders

On January 29, 2021, the Company entered into a Credit Agreement (the “Agreement”“JPM Agreement”) with JPMorgan Chase Bank, N.A. (“Lender” or “JPM”), pursuant to which Lender has agreed to provideprovided the Company with a secured credit facility maturing on January 29, 2026,consisting of which (a) up to $50,000,000 is available on a revolving loan basis,facility and (b) an aggregate of $6,500,000 was borrowed pursuant to twoa term loans (theloan facility (collectively, the “Facility”). The Facility is secured by substantially all of SigmaTron’ assets including mortgages on its two Illinois properties.

On July 18, 2022, SigmaTron, Wagz and Lender amended and restated the JPM Agreement by entering into an Amended and Restated Credit Agreement (as so amended and restated, the “JPM Credit Agreement”). The Facility, as amended, allows the Company to choose among interest rates at which it may borrow funds foron a revolving loans:  “CBFR Loans,” the interest on which is based on (A) the “REVLIBOR30 Rate” (as defined in the Agreement) unless the REVLIBOR30 Rate is not available, in which case the interest is generally the rate of interest last quoted by The Wall Street Journal as the “Prime Rate” in the U.S., plus (B) an applicable margin of 2.0% (effectively 2.41% per annum at April 30, 2022); or “Eurodollar Loans,” the interest on which is based on (X) an interest rate per annum (rounded upwards, if necessary, to the next 1/16 of 1%) equal to the LIBO Rate (as defined in the Agreement) for any interest period multiplied by the Standard Reserve Rate (as defined in the Agreement) plus (Y) an applicable margin of 2.0%.  Under the revolving portion of the Facility, the Company may borrowbasis up to the lesser of (i) $50,000,000$70,000,000 or (ii) an amount equal to a percentage of the eligible receivable borrowing base plus a percentage of the inventory borrowing base.base minus any reserves established by Lender (the “Revolving Commitment”). The maturity date of the Facility is collateralized by a lien on substantially allJuly 18, 2027. Deferred financing costs of $332,139 and $128,733 were capitalized during the fiscal year ended April 30, 2023 and April 30, 2022, respectively, which are amortized over the term of the assetsJPM Credit Agreement. As of April

F-27


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE I - LONG-TERM DEBT - Continued

Notes Payable – Secured lenders – Continued

30, 2023, there was $51,134,699 outstanding and $11,539,183 of unused availability under the Company. revolving loan facility compared to an outstanding balance of $51,392,158 and $5,691,855 of unused availability at April 30, 2022. As of April 30, 2023 and April 30, 2022, the unamortized amount offset against outstanding debt was $572,191 and $393,503, respectively.

Under the JPM Credit Agreement, a minimum Fixed Charge Coverage Ratio (“FCCR”) financial covenant of 1.10x is applicable only during an FCCR trigger period which occurs when (a) commencing on the Effective Date (as defined in the JPM Credit Agreement) and ending when the Term Loan Obligations (as defined in the JPM Credit Agreement) have been paid in full and (b) following the payment in full of the Term Loan Obligations, (i) an event of default (as defined in the JPM Credit Agreement) has occurred and is continuing, and Lender has elected to impose a FCCR trigger period upon notice to the Company or (ii) availability falls below the greater of (a) 10% of the revolving commitmentRevolving Commitment and (b) the outstanding principal amount of the term loans. In addition, prior to the amendment to the JPM Credit Agreement pursuant to the JPM Waiver (as discussed below under “

Waiver, Consent and Amendment to Credit Agreements”),the JPM Credit Agreement imposed a financial covenant that required the Company to maintain a leverage ratio of Total Debt to EBITDA (each as defined in the JPM Credit Agreement) for any twelve month period ending on the last day of a fiscal quarter through the maturity of the revolving Facility not to exceed a certain amount, which ratio (a) ranged from 5.00-to-1 for fiscal quarters beginning with the fiscal quarter ending on January 31, 2023 to 3.00-to-1 for the fiscal quarter ending on July 31, 2026 (if the Term Loan Borrowing Base Coverage Ratio (as defined in the JPM Credit Agreement) as of the end of the applicable fiscal quarter is less than or equal to 1.50-to-1) and (b) ranged from 5.50-to-1 for the fiscal quarter ending on January 31, 2023 to 4.00-to-1 for the fiscal quarters beginning with the fiscal quarter ending on July 31, 2026 (if the Term Loan Borrowing Base Coverage Ratio as of the end of the applicable fiscal quarter is greater than 1.50-to-1).

F-27


SigmaTron International, Inc.In addition, the JPM Credit Agreement imposes a cash dominion period if there is an event of default or if availability is less than 10% of the Revolving Commitment, and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

such requirement continues until there is no event of default and availability is greater than 10% of the Revolving Commitment, in each case for 30 consecutive days. Based on this criteria, the total debt balances for the Facility must be classified as a current liability on the Consolidated Balance Sheet as of April 30, 2022 and 2021

NOTE I - LONG-TERM DEBT - Continued2023.

Notes Payable – Banks - ContinuedIn connection with the entry into the JPM Credit Agreement, Lender and TCW Asset Management Company LLC, as administrative agent under the Term Loan Agreement (as defined below), entered into the Intercreditor Agreement, dated July 18, 2022, and acknowledged by SigmaTron and Wagz (the “ICA”), to set forth and govern the lenders’ respective lien priorities, rights and remedies under the JPM Credit Agreement and the Term Loan Agreement.

loans. The Company was not in a FCCR trigger period as of April 30, 2022. Deferred financing costs of $128,733 and $361,734 were capitalized during the fiscal year ended April 30, 2022 and April 30, 2021, respectively, which are amortized over the term of the Agreement. As of April 30, 2022, there was $51,392,158 outstanding and $5,691,855 of unused availabilityFacility under the revolving Facility compared to an outstanding balance of $24,967,668 and $15,947,990 unused availability at April 30, 2021. As of April 30, 2022 and April 30, 2021, the unamortized amount offset against outstanding debt was $393,503 and $343,890, respectively.

On November 17, 2021, the Company and Lender entered into an amendment of the Facility. The amended Facility allows the Company to borrow under the revolving portion of the Facility up to the lesser of (i) $53,000,000 or (ii) an amount equal toJPM Credit Agreement is secured by: (a) a percentage of the eligible receivable borrowing base plus a percentage of the inventory borrowing base minus any reserves established by Lender. Further, the Facility was amended to allow in some circumstances customer deposits to be deemed eligible for collateral purposes.

Effective as of December 31, 2021, Wagz joined the Facility as a loan guarantor, and granted to the Lender afirst priority security interest in SigmaTron’s and Wagz’s (i) accounts receivable and inventory (excluding Term Priority Mexican Inventory (as defined in the ICA) and certain inventory in transit, (ii) deposit accounts, (iii) proceeds of business interruption insurance that constitute ABL BI Insurance Share (as defined in the ICA), (iv) certain other property, including payment intangibles, instruments, equipment, software and hardware and similar systems, books and records, to the extent related to the foregoing, and (v) all of its assets, including its intellectual property.

On March 17, 2022, the Company and Lender entered into an amendmentproceeds of the Facility. The amended Facility allowsforegoing, in each case, now owned or hereafter acquired (collectively, the Company to borrow under“ABL Priority Collateral”); and (b) a second priority security interest in Term Priority Collateral (as defined below) other than (i) real estate and (ii) the revolving portionequity interests of the Facility up to the lesser of (i) $60,000,000 or (ii) an amount equal toSigmaTron’s foreign subsidiaries (unless such a percentage of the eligible receivable borrowing base plus a percentage of the inventory borrowing base minus any reserves establishedpledge is requested by Lender. Further, the Facility was amended to allow in some circumstances accounts arising from sales of inventory subject to bill and hold arrangements to be deemed eligible for collateral purposes. The interest rates based on LIBOR were changed under the Facility as follows:

Lender).

On April 25, 2022, the Company and Lender, entered into an amendment of the Facility. Under the amended Facility, Lender extended a term loan to the Company in the principal amount of $5,000,000 (the “FILO Term Loan”), the interest on which is based on (i) the “Adjusted Term SOFR Rate” for a one-month Interest Period (each, as defined in

F-28


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE I - LONG-TERM DEBT - Continued

Notes Payable – Secured lenders – Continued

the Agreement), plus (ii) an applicable margin of 4.0% (effectively 4.41% per annum at April 30, 2022). The FILO Term Loan will mature within 120 days from the date of the amendment. The amount outstanding as of April 30, 2022 was $5,000,000. There were no issuance costs associated with the FILO Term Loan. On July 18, 2022, a portion of the proceeds of the Term Loan Agreement (as defined below) was used to pay in full the FILO Term Loan extended by Lender.

On July 18, 2022, SigmaTron, Wagz and JPMorgan Chase Bank, N.A. (“Lender”) amended the Credit Agreement dated as of January 29, 2021, by entering into the Amended and Restated Credit Agreement (the “Facility” or “Credit Agreement”). The Facility, as amended, allows the Company to borrow on a revolving basis up to the lesser of (i) $70,000,000 or (ii) an amount equal to a percentage of the eligible receivable borrowing base plus a percentage of the inventory borrowing base minus any reserves established by Lender. The Facility bears interest at the adjusted REVSOFR30 rate (as defined in the Credit Agreement). The interest rate per annum applicable to the Facility will be the Adjusted Term SOFR Rate (“SOFR”), plusthe Applicable Margin of 2.0%. The maturity date of the Facility was extended to July 18, 2027.

In connection with the closing of the Credit Agreement, Lender and The Private Credit Group of TCW Asset Management Company LLC, as administrative agent, (the “Agent”) under the Term Loan Agreement (as defined below), entered into the Intercreditor Agreement, dated July 18, 2022, and acknowledged by SigmaTron and Wagz (the “ICA”), to set forth and govern the lenders’ respective lien priorities, rights and remedies under the Credit Agreement and the Term Loan Agreement.

F-28


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2022 and 2021

NOTE I - LONG-TERM DEBT - Continued

Notes Payable – Banks - Continued

The Facility is secured by: (a) a first priority security interest in SigmaTron’s and Wagz’s: (i) accounts and inventory (excluding Term Priority Mexican Inventory (as defined in the Intercreditor Agreement (“ICA”)) and certain inventory in transit, (ii) deposit accounts, (iii) proceeds of business interruption insurance that constitute ABL BI Insurance Share (as defined in the ICA), (iv) certain other property, including payment intangibles, instruments, equipment, software and hardware and similar systems, books and records, to the extent related to the foregoing, and (v) all proceeds of the foregoing, in each case, now owned or hereafter acquired (collectively, the “ABL Priority Collateral”); and (b) a second priority security interest in Term Priority Collateral (as defined below) other than (i) real estate and (ii) unless Lender requests a pledge thereof following July 18, 2022, the equity interests of SigmaTron’s foreign subsidiaries.

On July 18, 2022, SigmaTron, Wagz and The Private Credit Group of TCW Asset Management Company LLC, as administrative agent (the “Agent”), and other Lenders party thereto (collectively, “TCW”) entered into a Credit Agreement (the “Term Loan Agreement”) pursuant to which TCW made a term loan to the Company in the principal amount of $40,000,000 (the “TCW Term Loan”). The TCW Term Loan bears interest at a rate per annum applicable to the Term Loan Facility based on the Adjusted Term SOFR, Rate (“SOFR”), plus the Applicable Margin of 7.50% (as(each as defined in the Term Loan Agreement). The TCW Term Loan will havehas a SOFR floor of 1.00%. The maturity date of the TCW Term Loan is July 18, 2027. The amount outstanding as of April 30, 2023, was $43,867,135. Deferred financing costs of $1,233,894 were capitalized during the fiscal year ended April 30, 2023. As of April 30, 2023, the unamortized amount offset against outstanding debt was $1,036,367.

The Term Loan Agreement imposes financial covenants, including covenants requiring the Company to maintain a minimum Fixed Charge Coverage Ratio (as defined in the Term Loan Agreement) of 1.10-to-1 and maintain the same leverage ratio of Total Debt to EBITDA as described above under the JPM Credit Agreement. The Company is required to make quarterly repayments of the principal amount of the TCW Term Loan in amounts equal to $250,000 per fiscal quarter for the quarters beginning October 31, 2022 and $500,000 per fiscal quarter for quarters beginning October 31, 2024. The Term Loan Agreement also requires mandatory annual repayments equal to 50% of Excess Cash Flow (as defined in the Term Loan Agreement).

The TCW Term Loan is secured by: (a) a first priority security interest in all property of SigmaTron and Wagz that does not constitute ABL Priority Collateral, which includes: (i) SigmaTron’s and Wagz’s real estate other than SigmaTron’s Del Rio, Texas, warehouses, (ii) SigmaTron’s and Wagz’s machinery, equipment and fixtures (but excluding ABL Priority Equipment (as defined in the ICA)), (iii) the Term Priority Mexican Inventory (as defined in the ICA), (iv) SigmaTron’s stock in its direct and indirect subsidiaries, (v) SigmaTron’s and Wagz’s general intangibles (excluding any that constitute ABL Priority Collateral), goodwill and intellectual property, (vi) the proceeds of business interruption insurance that constitute Term BI Insurance Share (as defined in the ICA), (vii) tax refunds, and (viii) all proceeds thereof, in each case, now owned or hereafter acquired (collectively, the “Term Priority Collateral”); and (b) a second priority security interest in all collateral that constitutes ABL Priority Collateral. Also, SigmaTron’s three Mexican subsidiaries pledged all of their assets as security for the TCW Term Loan.

Waiver, Consent and Amendment to Credit Agreements

OnMarch2,2023, the Company received notices of default from both JPM and TCW. The Notices indicated the occurrence of certain events of default under the JPM Credit Agreement and the Term Loan Agreement (togetherwiththeJPMCredit Agreement the “Credit Agreements”). Inaddition,theCompanyreceivedadelinquencynotificationletterfromNasdaqindicatingthat theCompanywasnotincompliancewiththecontinuedlistingrequirementsofNasdaqforfailingtotimelyfiletheCompanysForm10-Qforthefiscal quarterendedJanuary31,2023.ThisnotificationalsoconstitutedadefaultundertheCreditAgreements. The delinquency was remedied on May 19, 2023.

The JPM Notice indicated that the Lender was informed of the occurrence of events of defaults and the continuation thereof under the JPM Credit Agreement as a result of the Company’s failure to maintain a FCCR for the twelve month period ending January 31, 2023 of at least 1.10x as required under the JPM Credit Agreement (the “JPM Covenant Defaults”).

F-29


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE I - LONG-TERM DEBT - Continued

Notes Payable – Secured lenders - Continued

The TCW Notice indicated that Agent and TCW Lenders were informed of the occurrence of events of default and the continuation thereof under the Term Loan Agreement (described below) as a result of the Company permitting the

Total Debt to EBITDA Ratio for the twelve month period ending on January 31, 2023 to be greater than 5.00:1.00 in violation of the Term Loan Agreement and the Company’s failure to maintain FCCR as required under the JPM Credit Agreement (the “TCW Covenant Defaults” and together with the JPM Covenant Defaults, the “Defaults”).

As a result of the Defaults, the Company was not in compliance with its financial covenants under the Credit Agreements as of January 31, 2023. Due to theNotices received on March 2, 2023, fromeachofJPMandtheTCWLendersandAgent, the total debt balances for both the Facility and the TCW Term Loan had been classified as a current liability on the Condensed Consolidated Balance Sheet on January 31, 2023.

OnApril28,2023,theCompanyenteredinto(i)a Waiver,ConsentandAmendment No.1tothe JPM CreditAgreement(“JPMWaiver”)with WagzandJPM,aslender, which waived certain events of default under and amended certain terms of theJPMCreditAgreementand(ii)a Waiver,Consent andAmendmentNo.1totheCreditAgreement(“TCW Waiver”)withWagz,thefinancialinstitutionsidentifiedtherein(the “TCWLenders”)and TCWAssetManagementCompanyLLCasadministrativeagentfortheTCWLenders(insuchcapacity,the“Agent”and collectivelywiththeTCWLendersandJPM,the“LenderParties”), which waived certain events of default under and amended certain terms ofthe Credit Agreements.TheCompanyenteredintotheJPM Waiverand TCW Waiver(together,theWaivers”)afterreceivingonMarch2,2023,the NoticesfromeachofJPMandtheTCWLendersandAgent.TheNoticesindicatedthe occurrenceofcertaineventsofdefaultundertheCreditAgreements. The Company was in compliance with its financial covenants under the Credit Agreements as of April 30, 2023.

Pursuanttothe Waivers,theCompanyhasagreed,amongotherthings,to (i)ifrequestedbytheAgent,effectacorporaterestructuringthatwouldcreateanewholdingcompanystructuretoownalloftheCompanysstock throughamergerpursuanttoSection251(g)oftheGeneralCorporationLawoftheStateofDelaware,afterwhichtheholdingcompanywouldcontinue asthepubliccompany,becomeaguarantorundertheCreditAgreementsandpledgetotheLenderPartiesalloftheequityoftheCompany (the “Corporate Restructuring”),(ii)engagea financialadvisortoreviewcertainoftheCompanysfinancialreportingtoJPMandtheAgentandparticipateinweeklyconferencecallswiththe advisor,JPMandtheAgenttodiscussandprovideupdatesontheCompanysliquidityandoperations,(iii)extendthe WagzLoan,(iv) paytoJPManamendmentfeeintheamountof$70,000,paidincash,and(v)paytotheTCWLendersanamendmentfeeof$395,000andadefaultrate feeof$188,301,bothofwhichwerepaidinkindbybeingaddedtotheprincipalofthe TCW TermLoan.The WaiversalsoamendedtheCreditAgreementsto,amongotherthings,(x)requirethattheCompanymaintainaminimumof$2.5millioninrevolver availabilityundertheJPMCreditAgreement,(y)modifythedefinitionofEBITDAtoallowadjustmentstoaccountfor Wagzoperatinglosses, impairmentchargesrelatingtothewrite-downofthe Wagzbusiness,the Wagz Loan andnetassetsoftheCompanyand Wagz,and expensesrelatingtothe Waivers,the WagzsaleandSPA,and(z)modifytheexistingTotalDebttoEBITDARatios(asdefinedinthe CreditAgreements)asfollows:

F-30


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE I - LONG-TERM DEBT - Continued

Notes Payable – Secured lenders - Continued

Fiscal Quarter

Total Debt to EBITDA Ratio* (as amended)

Total Debt to EBITDA Ratio* (prior to amendment)

October 31,2023

4.50:1.0

4.25:1.0

January 31, 2024

4.50:1.0

4.00:1.0

April 30, 2024

4.50:1.0

4.00:1.0

July 31, 2024

4.25:1.0

3.75:1.0

October 31, 2024

4.00:1.0

3.75:1.0

* Assumesthe TermLoanBorrowingBaseCoverageRatio(asdefinedintheCreditAgreements)islessthanorequalto1.50:1.0.

In addition, pursuant to the TCW Waiver, if the Total Debt to EBITDA Ratio for the trailing twelve monthperiodasoftheendofthethird quarter of fiscal 2023exceedstheratiosthatwereineffectpriortotheamendment(assetforthinthefarrightcolumnofthetableabove)fora fiscal quarterduringthePIKPeriod(defined in the Term Loan Agreement),thentheApplicableMarginundertheTerm LoanAgreement inrespectoftheoutstanding TCW TermLoanwouldincreasebyanamountequalto1.0%perannumforthefiscalquarter,withsuch interestbeingpaidinkind.Furthermore,theJPM WaivermodifiedthedefinitionofApplicableMarginfromafixedamountequalto2.00%toanamount thatvariesfrom2.00%(forrevolveravailabilitygreaterthanorequalto$20.0million),to2.50%(forrevolveravailabilitygreaterthanorequalto$10.0 million),to3.00%(forrevolveravailabilitylessthan$10.0million),andfixedtheApplicableMarginat3.00%forsixmonthsstartingApril1,2023.

Inexchangeforsuchagreements,theLenderPartieshaveagreedtowaivealloftheexistingeventsofdefaultundertheCreditAgreements throughMarch31,2023,consenttothesaleof WagzandreleaseWagzanditspropertyandtheCompanys81%interestin Wagz thatwassoldtoBuyer(asdisclosedbelow)fromthelienoftheLenderParties.

Inconnectionwiththe Waivers,theCompanyexiteditsactiveinvolvementinthePet Techbusinessthatisconductedby Wagzthrough thesalebytheCompanyofamajoritystakein Wagz,effective as of April1,2023.

On June 15, 2023, the Company entered into (i) Amendment No. 2 to the Credit Agreement (the “JPM Amendment No. 2”) by and among the Company and Lender, with respect to the JPM Credit Agreement and (ii) Amendment No. 2 to the Credit Agreement (“TCW Amendment No. 2”) by and among the Company, the TCW Lenders and the Agent with respect to the Term Loan Agreement. The JPM Amendment No. 2 and TCW Amendment No. 2 (together, the “Amendments”) amend the Credit Agreements to extend the date, from May 31, 2023 to July 31, 2023, after which the Agent may request that the Company effect the Corporate Restructuring.

On April 23, 2020, the Company received a PPP Loan from U.S. Bank, as lender, pursuant to the Paycheck Protection Program of the CARES Act, as administered by the U.S. Small Business Administration (the “SBA”) in the amount of $6,282,973 (the “PPP Loan”). The PPP Loan was scheduled to mature on April 23, 2022. The Company was notified of the forgiveness of the PPP Loan by the SBA on July 9, 2021 and all principal and accrued interest were forgiven. The accounting for the forgiveness is reflected in the Company’s Statement of Operations for fiscal 2022 as a non-cash gain upon extinguishment of long-term debt.

F-31


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE I - LONG-TERM DEBT – Continued

Notes Payable – Secured lenders - Continued

On March 15, 2019, the Company’s wholly-owned subsidiary,foreign enterprise, Wujiang SigmaTron Electronic Technology Co., Ltd., entered into a credit facility with China Construction Bank. On January 26, 2021, the agreement was amended and terminatedexpired in accordance with its terms on January 6, 2022. On January 17, 2022, the agreement was renewed, and expired in accordance with its terms on December 23, 2022. On February 17, 2023, the agreement was renewed, and is scheduled to expire on December 23, 2022.February 7, 2024. Under the agreement Wujiang SigmaTron Electronic Technology Co., Ltd. can borrow up to 9,000,00010,000,000 Renminbi, approximately $1,359,989$1,444,252 as of April 30, 2022,2023, and the

facility is collateralized by Wujiang SigmaTron Electronics Co., Ltd.’s manufacturing building. Interest is payable monthly and the facility bears a fixed interest rate of 3.8%. The term of the facility extends to December 23, 2022.3.35% per annum. There was $438,219no outstanding balance under the facility at April 30, 20222023 compared to an outstanding balance of $824,159$438,219 at April 30, 2021.

F-29


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2022 and 2021

NOTE I - LONG-TERM DEBT - Continued2022.

Notes Payable – Buildings

The Company entered into a mortgage agreement on December 21, 2017, in the amount of $5,200,000, with U.S. Bank to refinance the property that serves as the Company’s corporate headquarters and its Illinois manufacturing facility in Elk Grove Village, Illinois. The note required the Company to pay monthly principal payments in the amount of $17,333, bore interest at a fixed rate of 4.0% per year and was payable over a fifty one month period. Deferred financing costs of $74,066 were capitalized in fiscal year 2018 which were amortized over the term of the agreement. On January 29, 2021, the Company repaid its U.S. Bank mortgage in the amount outstanding$4,576,000, using proceeds from the Facility extended by Lender. The Company recorded a prepayment penalty of $120,842 in fiscal year 2021. The remaining deferred financing costs of $21,365 were expensed in fiscal year 2021.

The Company entered into a mortgage agreement on December 21, 2017, in the amount of $1,800,000, with U.S. Bank to refinance the property that serves as the Company’s engineering and design center in Elgin, Illinois. The note required the Company to pay monthly principal payments in the amount of $6,000, bore interest at a fixed rate of 4.0% per year and was payable over a fifty one month period. Deferred financing costs of $65,381 were capitalized in the fiscal year 2018 which were amortized over the term of the agreement. On January 29, 2021, the Company repaid its U.S. Bank mortgage in the amount outstanding of $1,584,000, using proceeds from the Facility extended by Lender. The Company recorded a prepayment penalty of $41,830 in fiscal year 2021. The remaining deferred financing costs of $18,859 were expensed in fiscal year 2021.

The Company’s Facility with Lender, entered into on January 29, 2021, also included two term loans, in the aggregate principal amount of $6,500,000. The loans require the Company to pay aggregate principal payments in the amount of $36,111 per month for 60 months, plus monthly payments of interest thereon at (A) the REVSOFR30 Rate, (as defined in the Agreement), plus (B) an applicable margin of 2.5%; (effectively 2.91% per annum at April 30, 2022). Deferred financing costs of $10,050 were capitalized during fiscal year 2021 which are amortized over the term of the agreement. As of April 30, 2022, the unamortized amount included as a reduction to long-term debt was $7,537. A final aggregate payment of approximately $4,368,444 iswas due on or before January 29, 2026. The outstanding balance was $5,994,445 at April 30, 2022 compared to an outstanding balance of $6,427,778 at April 30, 2021. On July 18, 2022, a portion of the proceeds of the TCW Term Loan Agreement was used to pay in full both term loans extended by Lender.There was no outstanding balance at April 30, 2023 compared to an outstanding balance of $5,994,445 at April 30, 2022.

The Company entered into a mortgage agreement on March 3, 2020, in the amount of $556,000, with The Bank &and Trust SSB to finance the purchase of the property that serves as the Company’s warehousing and distribution center in Del Rio, Texas. The note requires the Company to pay monthly installment payments in the amount of $6,103. Interest accrues at a fixed rate of 5.75% per year until March 3, 2025, and adjusts thereafter, on an annual basis, equal to 1.0% over the Prime Rate as published by The Wall Street Journal. The note is payable over a 120 month period. The outstanding balance was $464,895$417,143 and $509,985$464,895 at April 30, 20222023 and April 30, 2021,2022, respectively.

F-30


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2022 and 2021

NOTE I - LONG-TERM DEBT - Continued

Notes Payable - Equipment

The Company routinely entersentered into secured note agreements with Engencap Fin S.A. DE C.V. to finance the purchase of equipment. The terms of the outstanding secured note agreementsagreement mature from November 2022 through on May 1, 2023,, with a final quarterly installment payments ranging from $10,041 to $16,198payment of $9,310 and a fixed interest rate ranging from 7.35% toof 8.00% per annum.

The Company routinely enters into secured note agreements with FGI Equipment Finance LLC to finance the purchase of equipment. The terms of the outstanding secured note agreements mature from March 2025 through MayOctober 2027, with quarterly installment payments ranging from $10,723 to $69,439 and a fixed interest rate ofranging from 8.25% to 9.25% per annum.

F-32


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE I - LONG-TERM DEBT – Continued

Notes Payable – Equipment - Continued

Annual maturities of the Company’s debt, net of deferred financing fees for each of the next five years and thereafter, as of April 30, 2021,2023, are as follows:

Fiscal Year

Bank

Building

Equipment

Total

Bank

Building

Equipment

Total

2023

$

5,438,219 

$

481,085 

$

1,072,263 

$

6,991,567 

2024

-

483,904 

1,048,524 

1,532,428 

$

51,562,508

$

50,571

$

1,148,441

$

52,761,520

2025

-

486,890 

1,127,835 

1,614,725 

1,501,272

53,557

1,176,986

2,731,815

2026

50,998,655 

4,743,628 

756,195 

56,498,478 

1,751,272

56,719

841,614

2,649,605

2027

-

60,068 

197,475 

257,543 

1,751,272

60,068

291,085

2,102,425

2028

32,793,118

63,614

65,989

32,922,721

Thereafter

-

196,228 

-

196,228 

-

132,614

-

132,614

$

56,436,874 

$

6,451,803 

$

4,202,292 

$

67,090,969 

$

89,359,442

$

417,143

$

3,524,115

$

93,300,700

F-* Due to availability being less than 10% of the Revolving Commitment,31


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

the Facility (as defined above) has been classified as a current liability on the Consolidated Balance Sheet as of April 30, 20222023. The maturity date of both the Facility and 2021

NOTE I - LONG-TERM DEBT - Continuedthe TCW Term Loan is July 18, 2027 with an outstanding balance of $89,359,442.

Finance Lease and Sales Leaseback Obligations

The Company enters into various finance lease and sales leaseback agreements. The terms of the outstanding lease agreements mature through February 2026,April 1, 2027, with monthly installment payments ranging from $2,874 to $33,706 and a fixed interest rate ranging from 4.90%7.09% to 12.73% per annum.

Annual future minimum obligations under outstanding finance leases and sale leaseback agreements for each of the next five fiscal years and thereafter, as of April 30, 2022,2023, are as follows:

Fiscal Year

Total

Total

2023

$

1,749,125 

2024

1,418,540 

$

1,856,501

2025

1,197,692 

1,674,988

2026

530,423 

1,007,719

2027

-

177,772

2028

-

Total minimum lease payments

4,895,780 

4,716,980

Less: Amounts representing interest

679,970 

597,543

Present value of net minimum lease payments

$

4,215,810 

$

4,119,437

Other Long-Term Liabilities

As of April 30, 20222023 and April 30, 20212022 the Company had recorded $1,051,587$100,350 and $926,546,$1,051,587, respectively, for seniority premiums of which $957,528none and $837,528,$957,528, respectively, were for retirement accounts related to benefits for employees of the Company’s foreign subsidiaries.

F-3233


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE J - ACCRUED EXPENSES AND WAGES

Accrued expenses consist of the following at April 30:

2022

2021

2023

2022

Interest

$

156,776

$

102,906

$

505,423

$

156,776

Commissions

141,008

99,283

193,480

141,008

Professional fees

475,761

503,998

268,526

475,761

Other - Purchases

852,862

218,647

359,647

852,862

Other

1,546,515

1,533,048

1,606,354

1,126,695

$

3,172,922

$

2,457,882

$

2,933,430

$

2,753,102

Accrued wages consist of the following at April 30:

2022

2021

2023

2022

Domestic wages

$

2,700,045

$

2,706,677

$

2,184,469

$

2,597,312

Bonuses

3,624,794

830,246

2,282,927

3,624,794

Foreign wages

2,855,743

2,747,064

3,449,870

2,855,743

$

9,180,582

$

6,283,987

$

7,917,266

$

9,077,849

F-3334


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE K - INCOME TAX

U.S. and foreign income before income (loss) tax expense for the fiscal years ended April 30 are as follows:

2022

2021

2023

2022

Domestic

$

9,975,425

$

(440,472)

$

11,138,944

$

19,155,489

Foreign

4,190,433

2,539,232

6,047,021

4,190,433

$

14,165,858

$

2,098,760

$

17,185,965

$

23,345,922

Income Tax Provision

The income tax expense for the fiscal years ended April 30 consists of the following:

2022

2021

2023

2022

Current

Federal

$

1,705,323

$

1,131,710

$

3,219,203

$

2,255,406

State

432,206

334,781

742,275

560,436

Foreign

1,010,149

642,164

1,392,834

1,010,149

Total Current

3,147,678

2,108,655

5,354,312

3,825,991

Deferred

Federal

1,315,037

(1,188,728)

(2,282,300)

1,315,037

State

326,217

(276,999)

(459,788)

326,217

Foreign

(487,242)

(85,187)

379,317

(487,242)

Total Deferred

1,154,012

(1,550,914)

(2,362,771)

1,154,012

Income tax

$

4,301,690

$

557,741

$

2,991,541

$

4,980,003

F-3435


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE K - INCOME TAX - Continued

Income Tax Provision - Continued

The difference between the income tax expense and the amounts computed by applying the statutory Federal income tax rates to income from continuing operations before tax expense for the fiscal years ended April 30 are as follows:

2022

2021

2023

2022

U.S Federal Provision:

At statutory rate

$

2,974,831

$

440,738

$

3,609,047

$

4,902,642

State taxes

420,366

47,251

(1,007,854)

521,668

Change in valuation allowance

1,075,333 

-

5,909,955

1,179,616

Benefit of NOL carryforward

(428,662)

(130,834)

Foreign tax differential

338,435

189,241

477,375

338,435

Impact of state tax rate change

7,622

(1,602)

(3,177)

7,622

Nontaxable income (loss)

-

-

Global intangible low tax inclusion

135,721

-

Foreign valuation allowance

(663,025)

149,542

45,278

(663,025)

Impact of foreign permanent items
other non deductible items

312,372

73,540

142,303

311,172

PPP loan forgiveness income

(1,334,901)

-

-

(1,334,901)

Impairment loss

1,323,049 

-

Foreign currency exchange gain/loss
in local jurisdiction

51,179

(311,236)

Investment in subsidiary

(5,694,916)

-

Tax credits and other permanent differences

(76,654)

-

Foreign currency exchange (gain)/loss
in local jurisdiction

(47,951)

51,179

Foreign inflation adjustment

(107,608)

(33,576)

(78,625)

(107,608)

Stock based compensation

(95,963)

3,843 

Stock-based compensation

9,701

(95,963)

Provision for income taxes

$

4,301,690

$

557,741

$

2,991,541

$

4,980,003

F-3536


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE K - INCOME TAX - Continued

Deferred Tax Assets and Liabilities

Deferred income taxes reflect the net tax effects of loss and credit carryforwards and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the deferred tax assets and liabilities for federal, state and foreign income taxes are as follows:

2022

2021

2023

2022

Deferred Tax Assets

Federal, foreign & state NOL carryforwards

$

4,719,930

$

1,034,428

$

464,828

$

822,140

Foreign tax credit

78,100

78,100

Research and other credits

78,100

78,100

Other intangibles - US

443,460

527,469

Property, plant & equipment

113,338

-

-

113,338

Reserves and accruals

1,247,046

1,147,851

1,428,485

1,222,395

Stock based compensation

426,655

388,647

Stock-based compensation

452,858

426,655

Capital loss carryforward

5,833,375

-

Inventory

2,703,370

2,627,419

3,153,198

2,703,370

Other intangibles

-

829,559

Interest expense carryforward

1,009,274

-

Lease liabilities

2,909,748

2,881,193

2,079,443

2,909,748

Allowance for doubtful accounts

25,490

25,890

25,360

25,490

Other intangibles - foreign

11,536

-

-

11,536

Investment in subsidiary

1,349,152

-

Other

66,231

22,213 

34,065

66,231

Federal benefit of state taxes

16,800

-

-

16,800

Total gross deferred tax assets

12,318,244

9,035,300

16,351,598

8,923,272

Less: valuation allowance

(4,543,819)

(1,138,736)

7,703,517

1,703,141

Net deferred tax assets

$

7,774,425

$

7,896,564

$

8,648,081

$

7,220,131

Deferred Tax Liabilities

Other intangibles

$

(712,848)

$

-

Property, machinery & equipment

(3,539,648)

(2,934,496)

$

(3,641,468)

$

(3,488,320)

Prepaids

(464,706)

(454,648)

(329,062)

(459,588)

Operating Lease right-of-use assets

(2,779,092)

(2,808,571)

(1,956,894)

(2,779,092)

Federal benefit of state taxes

-

(51,706)

(79,755)

-

Total deferred tax liabilities

$

(7,496,294)

$

(6,249,421)

$

(6,007,179)

$

(6,727,000)

Deferred tax asset

$

856,863

$

1,647,143

$

2,640,902

$

856,863

Deferred tax liability

(578,732)

-

-

(363,732)

Net deferred tax asset

$

278,131

$

1,647,143

$

2,640,902

$

493,131

F-3637


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE K - INCOME TAX - Continued

Deferred Tax Assets and Liabilities - Continued

The CARES Act was signed into law by the President of the U.S. on March 27, 2020. This legislation is aimed at providing relief for individuals and businesses impacted by the COVID-19 outbreak. The CARES Act includes several significant business tax provisions that, among other things, would temporarily eliminate the taxable income limit for certain net operating losses (NOL), allow businesses to carry back NOLs arising in 2018, 2019, and 2020 to the five prior tax years, accelerate refunds of corporate Alternative Minimum Tax credits, temporarily increase the business interest limitation under section 163(j), and allow for deferral of payroll taxes.

The CARES Act also established the PPP, to be administered by the SBA, whereby certain businesses are eligible for a loan to fund payroll expenses, rent, and related costs. The PPP Loan may be forgiven if the funds are used for payroll and other qualified expenses within certain limits. As described in Note I – Long-Term Debt, the Company received a PPP Loan under the CARES Act of $6,282,973. For federal income tax purposes, the CARES Act expressly provides that any forgiveness or cancellation of all or part of such loans will not be treated as income for tax purposes. On January 6, 2021 the IRS issued Revenue Ruling 2021-02 allowing deductions for the payments of eligible expenses when such payments would result in the forgiveness of a loan under the PPP. The ruling supersedes previous IRS guidance stating that such deductions would be disallowed. The Company received full forgiveness of its PPP Loan on July 9, 2021. In accordance with the CARES Act and IRS Revenue Ruling 2021-02, the loan forgiveness amount was excluded from income for tax purposes.purposes in fiscal year 2022.

As of April 30, 2022, the Company has federal and state NOL carryovers totaling approximately $17,760,000 and $2,180,000, respectively. Such carryforwards were acquired in the Wagz merger and are subject to annual limitations under Internal Revenue Code Section 382. The federal NOLs have an unlimited carryforward period while the state NOLs begin to expire in 2029. The Company has foreign NOL carryforwards of approximately $3,680,000$2,302,000 as of April 30, 2022,2023, which will begin to expire in 2024. The Company recognizes a valuation allowance if, based on the weight of available evidence, it is more likely than not that some portion, or all, of a deferred tax asset will not be realized. SigmaTron and Wagz willfiled or are expected to file U.S. tax returns on a consolidated basis for periods ending after the merger. In evaluating the group’s ability to recover its deferred tax assets on a consolidated basis, and considering historical operating results of both companies, the group’s deferred tax assets are not more likely than not to be realized.during which Wagz was wholly owned. Therefore, a valuation allowance was previously established on the group’s U.S. deferred tax assets during fiscal year 2022. After the sale of Wagz, SigmaTron expects to file on a standalone basis and utilize its U.S. deferred tax assets with the exception of the capital loss on sale, its investment in subsidiary, and certain foreign tax credits. The Company has established a valuation allowance of $4,146,208$7,260,628 on its federalU.S. capital loss, its investment in subsidiary, and state NOL carryforwards and other U.S. deferredforeign tax assets as of April 30, 2022. The Company also determined during fiscal year 2022 based on historical operating income and recent financial results that the loss carryforwards and other deferred tax assets of one of its Chinese subsidiaries, which were previously offset by a full valuation allowance, would more likely than not be utilized. The reversal of this valuation allowance resulted in an approximate $444,000 tax benefit in the current year.credit carryforwards. The Company has also established a valuation allowance of $397,611$442,889 on NOLs attributable to its Vietnam subsidiary as of April 30, 2022.2023. Based on historical losses and forecasted future earnings, the Company has determined that the tax benefit from such assets are not more likely than not to be realized.

Cash and cash equivalents held internationally may be subject to foreign withholding taxes if repatriated to the U.S. Absent meeting an exception, unrepatriated foreign earnings generally remain subject to local country withholding taxes upon repatriation. The Company continues to apply its permanent reinvestment assertion on the cumulative amount of unremitted earnings of approximately $9,589,000$11,822,000 as of April 30, 2022,2023, from its foreign subsidiaries.

F-3738


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE K - INCOME TAX - Continued

Unrecognized Tax Benefits

The Company has not identified any uncertain tax positions to be taken in the Company’s tax returns. For the fiscal years ended April 30, 20222023 and April 30, 2021,2022, the amount of consolidated worldwide liability for uncertain tax positions that impacted the Company’s effective tax rate was $0.

Other

Interest and penalties related to tax positions taken in the Company’s tax returns are recorded in income tax expense and selling and administrative expenses, respectively, in the Company’s Consolidated Statements of Operations. For the fiscal years ended April 30, 20222023 and April 30, 2021,2022, the amount included in the Company’s Consolidated Balance Sheet for such liabilities was $0.

The Company is subject to taxation in the U.S. and various state and foreign jurisdictions. With few exceptions, the Company is no longer subject to state, local or foreign examinations by tax authorities for tax years before fiscal year 2016.2017.

NOTE L - 401(k) RETIREMENT SAVINGS PLAN

The Company sponsors 401(k) retirement savings plans, which are available to all non-union U.S. employees. The Company may elect to match 25.0% of the first 5.0% participant contributions up to $2,000 per participant annually. The Company contributed $199,054$204,924 and $186,870$199,054 to the plans during the fiscal years ended April 30, 20222023 and April 30, 20212022, respectively. The Company incurred total expenses of $20,280$17,325 and $20,569$20,280 for the fiscal years ended April 30, 20222023 and April 30, 2021,2022, respectively, relating to costs associated with the administration of the plans.

NOTE M - MAJOR CUSTOMERS AND CONCENTRATION OF CREDIT RISK

Financial instruments that potentially subject the Company to concentration of credit risk consist principally of uncollateralized accounts receivable. For the fiscal year ended April 30, 2022, 2 customers2023, the Company’s largest customer accounted for 21.8% and 11.7%13.4% of the Company’s net sales of the Company, and 4.0% and 3.2%, respectively,6.8% of accounts receivable. For the fiscal year ended April 30, 2021, 2 customers2022, the Company’s largest customer accounted for 17.9% and 16.2%21.8% of the Company’s net sales of the Company, and 3.8% and 5.6%, respectively,4.0% of accounts receivable. Further, the Company has $2,048,859$404,741 in cash in China as of April 30, 2022.2023. Effective May 1, 2015, China implemented a deposit insurance program to insure up to approximately $81,000 in deposits under certain circumstances. Funds above this amount are not insured by a guaranteed deposit insurance system. Under the Federal Deposit Insurance Corporation (“FDIC”) program, deposit insurance insures up to $250,000 held in participating U.S. banks.

F-3839


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE N - LEASES

The Company leases office and storage space, vehicles and other equipment under non-cancellable operating leases with initial terms typically ranging from 1 to 5 years. At contract inception, the Company reviews the facts and circumstances of the arrangement to determine if the contract is or contains a lease. The Company follows the guidance in Topic 842 to evaluate whether the contract has an identified asset; if the Company has the right to obtain substantially all economic benefits from the asset; and if the Company has the right to direct the use of the underlying asset. When determining if a contract has an identified asset, the Company considers both explicit and implicit assets, and whether the supplier has the right to substitute the asset. When determining if the Company has the right to direct the use of an underlying asset, the Company considers if it has the right to direct how and for what purpose the asset is used throughout the period of use and if it controls the decision-making rights over the asset.

The Company’s lease terms may include options to extend or terminate the lease. The Company exercises judgment to determine the term of those leases when extension or termination options are present and includes such options in the calculation of the lease term when it is reasonably certain that it will exercise those options.

The Company has elected to include both lease and non-lease components in the determination of lease payments. Payments made to a lessor for items such as taxes, insurance, common area maintenance, or other costs commonly referred to as executory costs, are also included in lease payments if they are fixed. The fixed portion of these payments are included in the calculation of the lease liability, while any variable portion would be recognized as variable lease expenses, when incurred. Variable payments made to third parties for these, or similar costs, such as utilities, are not included in the calculation of lease payments.

At commencement, lease-related assets and liabilities are measured at the present value of future lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company exercises judgment in determining the incremental borrowing rate based on the information available when the lease commences to measure the present value of future payments.

Operating lease expense is recognized on a straight-line basis over the lease term. Finance lease cost includes amortization, which is recognized on a straight-line basis over the expected life of the leased asset, and interest expense, which is recognized following an effective interest rate method.

Operating leases are included in other assets, current operating lease obligations, and operating lease obligations (less current portion) on the Company’s Consolidated Balance Sheet. Finance leases are included in property, plant and equipment and current and long-term portion of finance lease obligations on the Company’s Consolidated Balance Sheet. Short term leases with an initial term of 12 months or less are not presented on the balance sheet with expense recognized as incurred.

F-3940


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE N - LEASES – Continued

The following table presents lease assets and liabilities and their balance sheet classification:

April 30,

April 30,

April 30,

April 30,

Classification

2022

2021

Classification

2023

2022

Operating Leases:

Right-of-use Assets

Right-of-use assets

$

10,946,764 

$

13,015,986 

Right-of-use assets

$

7,225,423

$

10,946,764

Operating lease current
liabilities

Current portion of operating lease obligations

3,508,864 

2,843,758 

Current portion of operating lease obligations

2,908,213

3,508,864

Operating lease noncurrent
liabilities

Operating lease obligations, less current portion

7,903,898 

10,474,601 

Operating lease obligations, less current portion

4,723,867

7,903,898

Finance Leases:

Right-of-use Assets

Property, machinery and equipment

5,561,243 

5,843,068 

Property, machinery and equipment

5,294,097

5,561,243

Finance lease current
liabilities

Current portion of finance lease
obligations

1,410,675 

1,455,638 

Current portion of finance lease
obligations

1,523,259

1,410,675

Finance lease noncurrent liabilities

Finance lease obligations, less current
portion

2,805,135 

1,180,496 

Finance lease noncurrent
liabilities

Finance lease obligations, less current
portion

2,596,178

2,805,135

The components of lease expense for the fiscal years ended April 30, 20222023 and 20212022 are as follows:

April 30,

April 30,

April 30,

April 30,

Classification

2022

2021

Classification

2023

2022

Operating Leases:

Operating lease cost

Cost of products sold

2,403,465 

1,595,651 

Cost of products sold

2,544,415

2,403,465

Variable lease cost

Cost of products sold

216,042 

324,833 

Cost of products sold

223,431

216,042

Short term lease cost

Cost of products sold

7,200 

6,600 

Cost of products sold

9,000

7,200

Finance Leases:

Amortization of right-of-use assets

Cost of products sold

2,275,169 

1,868,592 

Cost of products sold

2,369,642

2,275,169

Interest expense

Interest expense, net

293,334 

252,208 

Interest expense, net

414,863

293,334

Total

5,195,210 

4,047,884 

5,561,351

5,195,210

The weighted average lease term and discount rates for the fiscal years ended April 30, 20222023 and 20212022 are as follows:

April 30,

April 30,

April 30,

April 30,

2022

2021

2023

2022

Operating Leases:

Weighted average remaining lease term (months)

45.9

55.4

36.3

45.9

Weighted average discount rate

3.2%

3.1%

3.3%

3.2%

Finance Leases:

Weighted average remaining lease term (months)

36.21

18.73

31.79

36.21

Weighted average discount rate

9.5%

7.5%

9.8%

9.5%

F-4041


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE N - LEASES – Continued

Future payments due under leases reconciled to lease liabilities are as follows:

Operating Leases

Finance Leases

Operating Leases

Finance Leases

For the fiscal years ending April 30:

2023

3,615,964 

1,749,125 

2024

3,144,003 

1,418,540 

2,974,745

1,856,501

2025

2,501,137 

1,197,692 

2,450,683

1,674,988

2026

2,019,160 

530,423 

1,921,052

1,007,719

2027

445,298 

-

343,006

177,772

2028

74,382

-

Thereafter

150,252 

-

63,717

-

Total undiscounted lease payments

11,875,814 

4,895,780 

7,827,585

4,716,980

Present value discount, less interest

463,052 

679,970 

195,505

597,543

Lease liability

$

11,412,762 

$

4,215,810 

$

7,632,080

$

4,119,437

Supplemental disclosures of cash flow information related to leases as of fiscal years ended April 30, 20222023 and 20212022 are as follows:

April 30,

April 30,

April 30,

April 30,

Other Information

2022

2021

2023

2022

Cash paid for amounts included in the measurement of lease liabilities

Operating cash flows from finance leases

293,334 

252,208 

414,863

293,334

Operating cash flows from operating leases

382,044 

208,639 

316,434

382,044

Financing cash flows from finance leases

1,855,822 

1,988,106 

1,695,829

1,855,822

Supplemental non-cash information on lease labilities arising from obtaining
right-of-use assets:

Right-of-use assets obtained in exchange for new finance lease liabilities

3,435,498 

837,224 

1,599,456

3,435,498

Right-of-use assets obtained in exchange for operating lease liabilities

2,716,298 

7,970,896 

3,721,341

2,716,298

F-4142


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE O - STOCK COMPENSATION AND EQUITY TRANSACTIONS

The Company has stock option plans (“Option Plans”) under which certain employees may acquire shares of SigmaTron’s common stock. All Option Plans have been approved by SigmaTron’s stockholders. At April 30, 2022,2023, the Company has 37,500187,900 shares available for future issuance to employees under the employee plans. The Option Plans are interpreted and administered by the Compensation Committee of SigmaTron’s Board of Directors. The maximum term of options granted under the Option Plans is generally 10 years. Options granted under the Option Plans are either incentive stock options or nonqualified options. Each option under the Option Plans is exercisable for one share of stock. Options forfeited under the Option Plans are available for reissuance. Options granted under these plans are granted at an exercise price equal to the fair market value of a share of SigmaTron’s common stock on the date of grant using the Black-Scholes option pricing model.

The Company did 0t grantThere were no options for shares of the Company’s common stock granted to employees in fiscal year 2021.2023.

The Company granted 102,000 options for shares of SigmaTron’s common stock to employees in the first quarter of fiscal year 2022, which fully vested in six months. The Company recognized approximately $245,770 in compensation expense in fiscal year 2022. There was 0no unrecognized compensation expense as of April 30, 2022.

The Company estimated the fair value of these stock options on the date of the grant using the Black-Sholes option pricing model with the following assumptions:

2019 Option Plan

Fiscal 2022 Awards

Expected volatility

57.0%

Risk-free interest rate

0.93%

Expected life of options (in years)

5.25

Grant date fair value

$

4.83

Expected volatility was based on the monthly changes in SigmaTron’s historical common stock prices over the expected life of the award. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant corresponding to the expected life of the options. The expected life of options is based on the terms of the options.

The Company authorized 400,000 shares under the Option Plans in fiscal year 2022. The Company granted 362,500 options for shares of SigmaTron’SigmaTron’s common stock to employees in the fourth quarter of fiscal year 2022, of which 25% vested immediately, 25% vested during the fourth quarter of fiscal year 2023 and 25% will vest each year for the next threetwo years. During fiscal year 2023, there were 138,750 forfeited options for shares. The Company recognized approximately$184,343 and $376,474 in compensation expense in fiscal year 2022.2023 and 2022, respectively. There was $368,685 and $1,129,423 of unrecognized compensation expense as of April 30, 2022.2023 and April 30, 2022, respectively.

The Company estimated the fair value of these stock options on the date of the grant using the Black-Sholes option pricing model with the following assumptions:

2021 Option Plan

Fiscal 2022 Awards

Expected volatility

67.0%

Risk-free interest rate

2.93%

Expected life of options (in years)

6.00

Grant date fair value

$

6.66

Expected volatility was based on the monthly changes in SigmaTron’s historical common stock prices over the expected life of the award. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of

F-4243


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE O - STOCK COMPENSATION AND EQUITY TRANSACTIONS – Continued

the grant corresponding to the expected life of the options. The expected life of options is based on the terms of the options.

The Company has a restricted stock plan under which non-employee directors may acquire shares of SigmaTron’s common stock.  The restricted stock plan has been approved by SigmaTron’s stockholders.  At April 30, 2022,2023, the Company has 60,00040,000 shares available for future issuance under the non-employee director plan.  The restricted stock plan is interpreted and administered by the Compensation Committee of SigmaTron’s Board of Directors. All awarded stock under the plan vests in six months from the date of grant. Awarded stock under this plan is granted at the closing price of SigmaTron’s common stock on the date of grant.

In November 2020, the Company issued 15,000 shares of restricted SigmaTron common stock pursuant to the 2018 Non-Employee Director Restricted Stock Plan, which fully vested on May 31, 2021. The Company recognized $8,716 and $57,963 in compensation expense in fiscal year 2022 and 2021, respectively.

In July 2021, the Company issued 7,500 shares of restricted SigmaTron common stock pursuant to the 2018 Non-Employee Director Restricted Stock Plan, which fully vested on January 8, 2022. The Company recognized $37,125 in compensation expense in fiscal year 2022.

The aggregate grant date fair value of restricted stock awards granted in July 2021 was computed in accordance with FASB ASC Topic 718. The aggregate number of shares of common stock of SigmaTron granted pursuant to the 2018 Non-Employee Director Restricted Stock Plan for each non-employee Director was as follows: Mr. Horek, 1,500 shares; Mr. Mantia, 1,500 shares; Mr. Plante, 1,500 shares; Mr. Rieck, 1,500 shares; and Mr. Vyas, 1,500 shares.

In January 2022, the Company issued 15,000 shares of restricted SigmaTron common stock pursuant to the 2021 Non-Employee Director Restricted Stock Plan, which fully vestsvested on July 8, 2022. The Company recognized $49,873 and $81,675 in compensation expense in fiscal year 2022.2023 and 2022, respectively. The balance of unrecognized compensation expense related to the Company’s restricted stock award was $0 and $49,873 at April 30, 2022.

2023 and 2022, respectively. The aggregate grant date fair value of restricted stock awards granted in January 2022 was computed in accordance with FASB ASC Topic 718. The aggregate number of

In September 2022, the Company issued 20,000 shares of restricted SigmaTron common stock of SigmaTron granted pursuant to the 2021 Non-Employee Director Restricted Stock Plan, for each non-employee Directorwhich fully vested on March 29, 2023. The Company recognized $98,199 in compensation expense in fiscal year 2023. There was as follows: Mr. Horek, 3,000 shares; Mr. Mantia, 3,000 shares; Mr. Plante, 3,000 shares; Mr. Rieck, 3,000 shares; and Mr. Vyas, 3,000 shares.no balance of unrecognized compensation expense related to the Company’s restricted stock award at April 30, 2023. The aggregate grant date fair value of restricted stock awards granted in September 2022 was computed in accordance with FASB ASC Topic 718. 

F-4344


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE O - STOCK COMPENSATION AND EQUITY TRANSACTIONS – Continued

The table below summarizes option activity through April 30, 2022:2023:

Number of

Number of

Number of

Number of

securities to be

Weighted-

options

securities to be

Weighted-

options

issued upon

average

exercisable

issued upon

average

exercisable

exercise of

exercise

at end

exercise of

exercise

at end

outstanding options

price

of year

outstanding options

price

of year

Outstanding at April 30, 2020

513,232 

5.13

513,232 

Options granted during 2021

-

Outstanding at April 30, 2021

513,232 

5.13

513,232 

513,232

5.13

513,232

Options granted during 2022

464,500 

6.26

464,500

6.26

Options exercised during 2022

(156,188)

5.02

(185,688)

5.02

Outstanding at April 30, 2022

821,544

$

5.79

549,669 

792,044

5.79

549,669

Options cancelled during 2023

(11,650)

3.60

Options forfeited during 2023

(138,750)

6.66

Outstanding at April 30, 2023

641,644

$

5.70

552,894

Intrinsic value is calculated as the positive difference between the market price of SigmaTron’s common stock and the exercise price of the underlying options. As of April 30, 2022, the aggregate intrinsic value of options exercised during 2022 was $465,487. As of April 30, 2023 and April 30, 2021,2022, the aggregate intrinsic value of the options outstanding was none and $715,678, respectively. As of April 30, 2023, the difference between the market price of the Company’s common stock and $362,281, respectively.the exercise price of the underlying options was negative.

Information with respect to stock options outstanding and exercisable at April 30, 20222023 is as follows:

Options outstanding and exercisable

Options outstanding and exercisable

Number

Weighted-average

Weighted-

Number

Weighted-average

Weighted-

outstanding at

remaining

average

outstanding at

remaining

average

April 30, 2022

contract life

exercise price

April 30, 2023

contract life

exercise price

Range of exercise prices

$ 3.20-6.66

549,669

6.17 years

$

5.36

552,894

5.72 years

$

5.54

549,669

$

5.13

552,894

$

5.54

As of April 30, 2022,2023, there were 271,87588,750 non-vested stock options.

F-4445


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 20222023 and 20212022

NOTE P – DISCONTINUED OPERATIONS

During the fourth quarter of fiscal 2023, the Company exited its active involvement in the Pet Tech business that is conducted by Wagz through the sale by the Company of a majority stake in Wagz, effective as of April 1, 2023. The Company entered into the SPA with Wagz, Buyer and Anderton, pursuant to which the Company sold to Buyer 81% of the Shares for the purchase price of one dollar. Under the SPA, the Company also agreed to provide a Wagz Loan to Wagz during the month of April 2023. The Company agreed to work with Wagz as an EMS provider pursuant to a manufacturing agreement, but the Company did not commit to extending any further financial support beyond the Wagz Loan. On April 28, 2023, the sale of the majority interest in Wagz pursuant to the SPA was consummated with effect as of April 1, 2023, and as a result, as of the closing, the Company holds a minority 19% ownership of the shares and Buyer holds a majority 81% of the shares.

In accordance with ASC 205-20 Presentation of Financial Statements: Discontinued Operations, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when the component of an entity meets the criteria in paragraph 205-20-45-10. In the period in which the component meets discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations.

Pet Tech Segment (Wagz Business)

The following amounts related to the Pet Tech Segment (Wagz Business) have been segregated from the Company’s continuing operations and are reported as discontinued operations:

Fiscal Year Ended April 30,

2023

2022

Net Sales

$

1,598,929

$

549,929

Cost of products sold

1,732,352

509,327

Gross (loss) profit

(133,423)

40,602

Selling and administrative expenses

9,656,999

2,920,277

Impairment of notes receivable and investment

-

6,300,235

Impairment of goodwill and other long-lived assets

23,096,771

-

Operating loss

(32,887,193)

(9,179,910)

Loss on sale of a business

(3,742,709)

-

Interest expense

-

154

Loss before income taxes from discontinued operations

(36,629,902)

(9,180,064)

Income tax benefit

1,860,093

678,313

Loss from discontinued operations

$

(34,769,809)

$

(8,501,751)

F-46


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE P – DISCONTINUED OPERATIONS – Continued

As noted above, the Company completed the sale of Wagz, effective as of April 1, 2023. The following amounts related to Wagz were classified as assets and liabilities of discontinued operations in the Consolidated Balance Sheet as of April 30, 2022:

April 30,

2022

Cash and cash equivalents

$

556,054

Accounts receivable

81,508

Inventories, net

300,251

Prepaid expenses and other assets

62,068

Total current assets

999,881

Property, machinery and equipment, net

195,109

Intangible assets, net

10,759,315

Goodwill

13,320,534

Other assets

6,000

Total other long-term assets

24,280,958

TOTAL ASSETS

$

25,280,839

Trade accounts payable

$

85,780

Accrued expenses

419,820

Accrued wages

102,733

Total current liabilities

608,333

Deferred income taxes

215,000

Total long-term liabilities

215,000

TOTAL LIABILITIES

$

823,333

F-47


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE Q - SELECTED QUARTERLY FINANCIAL DATA FROM CONTINUING OPERATIONS (UNAUDITED)

On April 1, 2023, SigmaTron completed the sale of its Wagz, Inc. business. The results of the Wagz, Inc. business have been reported as discontinued operations in the Consolidated Statements of Operations through the date of sale. These changes have been applied to all periods presented. See Note P — Discontinued Operations, for additional information.

The following is a summary of unaudited quarterly financial data for fiscal year 2023:

First

Second

Third

Fourth

2023

Quarter

Quarter

Quarter

Quarter

Net sales

$

105,189,979

$

108,221,068

$

92,736,725

$

108,288,074

Gross profit

11,577,220

13,306,079

11,160,904

15,409,394

Income before income

4,129,636

4,858,965

2,892,683

5,304,681

taxes (1)

Net income from continuing operations

3,600,236

3,602,998

2,949,459

4,041,731

Earnings per share from continuing operations

$

0.59

$

0.59

$

0.49

$

0.67

Basic

Earnings per share

$

0.58

$

0.59

$

0.49

$

0.67

Diluted

Weighted average shares- Basic

6,058,908

6,071,288

6,071,288

6,077,490

Weighted average shares- Diluted

6,191,395

6,145,223

6,071,288

6,077,490

The Company records inventory reserves for valuation and shrinkage throughout the year based on historical data. In the fourth quarter of fiscal year 2023 physical inventory results were completed resulting in an increase in income before taxes of approximately $650,000 net of a provision for inventory reserves of approximately $1,900,000.

F-48


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

NOTE Q - SELECTED QUARTERLY FINANCIAL DATA FROM CONTINUING OPERATIONS (UNAUDITED) - Continued

On April 1, 2023, SigmaTron completed the sale of its Wagz, Inc. business. The results of the Wagz, Inc. business have been reported as discontinued operations in the Consolidated Statements of Operations through the date of sale. These changes have been applied to all periods presented. See Note P — Discontinued Operations, for additional information.

The following is a summary of unaudited quarterly financial data for fiscal year 2022:

First

Second

Third

Fourth

First

Second

Third

Fourth

2022

Quarter

Quarter

Quarter

Quarter

Quarter

Quarter

Quarter

Quarter

Net sales

$

85,739,434

$

100,216,614

$

93,682,451

$

99,227,925

$

85,739,434

$

100,216,614

$

93,478,557

$

98,881,890

Gross profit

9,582,478

11,777,586

12,425,146

10,646,661

9,582,478

11,777,586

12,409,967

10,621,238

Income (loss) before income

9,553,661

(1)

4,663,717

(1,979,889)

(2)

1,928,369

9,553,661

4,663,717

(1,216,112)

10,344,656

taxes

taxes (1) (2)

Net income (loss)

8,796,716

3,150,205

(2,724,297)

641,544

Net income (loss) from continuing operations

8,796,716

3,150,205

(1,960,520)

8,379,518

Earnings (loss) per share

$

2.06

$

0.72

$

(0.58)

$

0.11

Earnings (loss) per share from continuing operations

$

2.06

$

0.72

$

(0.41)

$

1.39

Basic

Earnings (loss) per share

$

2.02

$

0.69

$

(0.58)

$

0.10

$

2.02

$

0.69

$

(0.41)

$

1.34

Diluted

Weighted average shares- Basic

4,275,410

4,313,623

4,729,619

6,021,803

4,275,410

4,313,623

4,729,619

6,021,803

Weighted average shares- Diluted

4,353,912

4,553,899

4,729,619

6,246,580

4,353,912

4,553,899

4,729,619

6,246,580

1.)1)The Company was notified of the forgiveness of the PPP Loan by the SBA on July 9, 2021 and all its principal and accrued interest were forgiven. The accounting for the forgiveness in the amount of $6,282,973 is reflected in the Company’s Statement of Operations as a non-cash gain upon extinguishment of long-term debt.debt in the first quarter of fiscal 2022.

2.)2)Prior toThe Company records inventory reserves for valuation and shrinkage throughout the acquisition,year based on historical data. In the Company had an investment in Wagzfourth quarter of $600,000, Convertible Secured Promissory Notes issued by Wagz of $12,000,000 and Secured Promissory Notes issued by Wagz of $1,380,705. As described in Note F-Acquisition, the Company's 25.5% equity interest in Wagz common stock was remeasured to fair value of $6,299,765,fiscal year 2022 physical inventory results were completed resulting in a non-cash impairment chargedecrease in income before taxes of $6,300,235.approximately $411,000. The Company did not record a provision for inventory reserves in the fourth quarter of fiscal 2022.

F-45


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2022 and 2021

NOTE P - SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED) - Continued

The following is a summary of unaudited quarterly financial data for fiscal year 2021:

First

Second

Third

Fourth

2021

Quarter

Quarter

Quarter

Quarter

Net sales

$

60,524,956

$

69,618,424

$

71,531,348

$

76,043,944

Gross profit

4,272,191

6,759,542

5,912,699

8,007,765

(Loss) income before income

(1,121,500)

1,069,801

223,358

1,927,101

taxes

Net (loss) income

(900,666)

626,858

249,268

1,565,559

(Loss) earnings per share

$

(0.21)

$

0.14

$

0.06

$

0.37

Basic

(Loss) earnings per share

$

(0.21)

$

0.15

$

0.06

$

0.36

Diluted

Weighted average shares- Basic

4,250,986

4,257,508

4,257,508

4,258,452

Weighted average shares- Diluted

4,250,986

4,257,508

4,310,290

4,357,478

NOTE QR - LITIGATION

From time to time the Company is involved in legal proceedings, claims, or investigations that are incidental to the Company’s business. In future periods, the Company could be subjected to cash cost or non-cash charges to earnings if any of these matters are resolved on unfavorable terms. However, although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including management’s assessment of the merits

F-49


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2023 and 2022

of any particular claim, the Company does not expect these legal proceedings or claims will have any material adverse impact on its future consolidated financial position or results of operations.

F-46


SigmaTron International, Inc. and Subsidiaries

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS – CONTINUED

April 30, 2022 and 2021

NOTE R - SUBSEQUENT EVENT

On July 18, 2022, SigmaTron, Wagz and JPMorgan Chase Bank, N.A. (“Lender”) amended the Credit Agreement dated as of January 29, 2021, by entering into the Amended and Restated Credit Agreement (the “Facility” or “Credit Agreement”). The Facility, as amended, allows the Company to borrow on a revolving basis up to the lesser of (i) $70,000,000 or (ii) an amount equal to a percentage of the eligible receivable borrowing base plus a percentage of the inventory borrowing base minus any reserves established by Lender. The Facility bears interest at the adjusted REVSOFR30 rate (as defined in the Credit Agreement). The interest rate per annum applicable to the Facility will be the Adjusted Term SOFR Rate (“SOFR”), plusthe Applicable Margin of 2.0%. The maturity date of the Facility was extended to July 18, 2027.

In connection with the closing of the Credit Agreement, Lender and The Private Credit Group of TCW Asset Management Company LLC, as administrative agent (the “Agent”) under the Term Loan Agreement (as defined below), entered into the Intercreditor Agreement, dated July 18, 2022, and acknowledged by SigmaTron and Wagz (the “ICA”), to set forth and govern the lenders’ respective lien priorities, rights and remedies under the Credit Agreement and the Term Loan Agreement.

The Facility is secured by: (a) a first priority security interest in SigmaTron’s and Wagz’s: (i) accounts and inventory (excluding Term Priority Mexican Inventory (as defined in the Intercreditor Agreement (“ICA”)) and certain inventory in transit, (ii) deposit accounts, (iii) proceeds of business interruption insurance that constitute ABL BI Insurance Share (as defined in the ICA), (iv) certain other property, including payment intangibles, instruments, equipment, software and hardware and similar systems, books and records, to the extent related to the foregoing, and (v) all proceeds of the foregoing, in each case, now owned or hereafter acquired (collectively, the “ABL Priority Collateral”); and (b) a second priority security interest in Term Priority Collateral (as defined below) other than (i) real estate and (ii) unless Lender requests a pledge thereof following July 18, 2022, the equity interests of SigmaTron’s foreign subsidiaries.

On July 18, 2022, SigmaTron, Wagz and The Private Credit Group of TCW Asset Management Company LLC, as administrative agent (the “Agent”), and other Lenders party thereto (collectively, “TCW”) entered into a Credit Agreement (the “Term Loan Agreement”) pursuant to which TCW made a term loan to the Company in the principal amount of $40,000,000 (the “TCW Term Loan”). The TCW Term Loan bears interest at a rate per annum applicable to the Term Loan Facility based on the Adjusted Term SOFR Rate (“SOFR”), plusthe Applicable Margin of 7.50% (as defined in the Term Loan Agreement). The Term Loan will have a SOFR floor of 1.00%. The maturity date of the TCW Term Loan is July 18, 2027.

The TCW Term Loan is secured by: (a) a first priority security interest in all property of SigmaTron and Wagz that does not constitute ABL Priority Collateral, which includes: (i) SigmaTron’s and Wagz’s real estate, (ii) SigmaTron’s and Wagz’s machinery, equipment and fixtures (but excluding ABL Priority Equipment (as defined in the ICA)), (iii) the Term Priority Mexican Inventory (as defined in the ICA), (iv) SigmaTron’s stock in its direct and indirect subsidiaries, (v) SigmaTron’s and Wagz’s general intangibles (excluding any that constitute ABL Priority Collateral), goodwill and intellectual property, (vi) the proceeds of business interruption insurance that constitute Term BI Insurance Share (as defined in the ICA), (vii) tax refunds, and (viii) all proceeds thereof, in each case, now owned or hereafter acquired (collectively, the “Term Priority Collateral”); and (b) a second priority security interest in all collateral that constitutes ABL Priority Collateral. Also, SigmaTron’s three Mexican subsidiaries pledged all of their assets as security for the TCW Term Loan.

F-4750